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The purpose of this Qualitative study was to explore HIV related stigma experienced by 
women enrolled in the Prevention of Mother to Child (PMTCT) prgramme in the 
EThekwini District, Kwazulu Natal. Descriptriptive phenomenology informed the study 
design, data collection and analysis.  
 
Despite increasing access to Prevention of Mother to Child Transmission initiatives, 
including anti-retroviral drugs, the Stigma of being HIV positive, particularly for women, 
largely outweigh the potential gains from available treatments. HIV/AIDS related stigma 
drives the epidemic underground and is one of the main reasons that people do not 
wish to know their HIV status 
 
Purposeful sampling was used to select seven women attending PMTCT programme in 
the EThekwini District. These women were selected in four clinics in the District. 
 
Data was collected through in-depth interviews lasting about 45 minutes to an hour. 
These interviews were tape recorded and later transcribed to aid analysis. The Colaizzi 
method of data analysis was utilized. 
 
Four themes emerge from the data, each with three to eight subthemes confirming the 
experiences and presence of stigma during programme participation. All participants 
reported incidence of being stigmatized, particularly in the Health care setting. They 
took great strides to keep their HIV status confidential to a point of going against 
programme directives to ensure secrecy of their status thus avoid HIV related stigma. 
 
 
Number of recommendations were made in relation to the PMTCT programme and if 
accepted will assist in mitigating stigma in HIV related stigma in the PMTCT progarmme 
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1.  INTRODUCTION TO THE STUDY 
 
The transition to motherhood and expecting a child is a big event in a woman’s 
life that calls for adjustment and preparation for the new life. For some women, 
this is complicated by being diagnosed with HIV/AIDS during pregnancy. 
HIV/AIDS is a disease that not only affects the physical and psychological 
wellbeing of people living with it, but also their ability to interact socially with 
others because of the stigma associated with the disease. This study aims to 
elicit the experiences of stigma in HIV positive pregnant women enrolled in the 
Prevention of Mother to Child Transmission of HIV/AIDS programme.  
 
1.2. Background to the study 
 
HIV/AIDS is an emotionally charged issue that is frequently associated with fear, 
stigma and prejudice. Myths, misunderstanding, and mistreatment of HIV 
infected people can result from the sense of panic that surrounds HIV/AIDS 
(Engenderhealth, 2004). AIDS-related stigma manifests as anger and negative 
feelings towards HIV positive individuals, the belief that they deserve their illness, 
avoidance of people with HIV/AIDS, and support for public policies that restrict 
the human rights of those with HIV/AIDS (Herek, Capitanio, & Widaman, 2002).  
 
1.2.1 Stigma Defined 
 
More than four decades ago, Goffman (1963, p 3) defined stigma as “an attribute 
that is deeply discrediting”, and proposed that the stigmatised person is reduced 
“from a whole and usual person to a tainted, discounted one”. Erving Goffman 
conceptualised a stigma framework and described it as an attribute that was 
deeply discrediting within a particular social interaction. His theory is grounded in 
the concept of social identity that is based on establishing those who are 
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“normal” as separate from those who are different or “deviant,” the stigmatised. 
Goffman also described the relationship between stigmatising attitudes and acts 
of discrimination, with the former often resulting in the latter. In the current 
literature, acts of discrimination are often referred to as “enacted stigma,” while 
stigmatising attitudes are often referred to as “expressed stigma”. According to 
Herek et al., (1988) AIDS shares many characteristics with other diseases that 
are highly stigmatised, such as its perception to be unalterable, degenerative, 
and fatal; its contagiousness and transmissibility; and the repellent, ugly, and 
upsetting appearance of the afflicted in the advanced stages of the disease. They 
go on to state that this reaction is amplified by a tendency among a significant 
portion of the public to blame people living with HIV/AIDS (PLWHA) for their 
illness, since the acquisition is perceived to be as the result of immoral and 
voluntary actions, for example, participating in homosexual and promiscuous sex 
and the sharing of infected needles among injection drug users (Andrien and 
Chien, 2008). 
 
Sabatier (1988) predicted discrimination at individual, community and national 
levels, which would have major implications for the epidemic. It was suggested 
that divides would be created between those who are vulnerable to infection and 
those who are more distant, and that the HIV epidemic has followed in many 
respects the trajectory of those who are most victimised by discrimination 
anyway has heightened that divide (Crewe, 1992).  
 
1.2.2 Outcome of Stigma 
 
The potential impact of stigma and discrimination has been of ongoing concern to 
those involved in addressing the HIV/AIDS epidemic. Jonathan Mann spoke of a 
third epidemic of discrimination that would follow the HIV and AIDS epidemic. He 
asserted that this third phase would be as central to the global AIDS challenge as 
the disease itself (Mann, 1987, cited in Parker, Aggleton, Attawell, Pulerwits and 
Brown, 2001). The first phase is the initial epidemic of HIV infection (i.e. the 
disease entering the community silently and unnoticed). The second phase is the 
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epidemic of AIDS, which appears when HIV triggers life-threatening infections. 
Thirdly, the phase of the epidemic of stigma, discrimination, blame and collective 
denial follows, which makes it difficult to tackle the first two effectively (UNAIDS, 
2000). Stigma is an important factor in the type and magnitude of societal 
reactions to the HIV/AIDS epidemic (Malcolm et al.,1998). Stigma and 
discrimination relating to HIV/AIDS undermine public health efforts to combat the 
epidemic (Cameron, 1993; Goldin, 1994; Malcolm et al., 1998). Therefore, it is 
important to identify the correct and effective interventions for reduction of 
HIV/AIDS stigma, and to translate such evidence into practice to combat the 
HIV/AIDS epidemic. The discrimination and stigma are as deleterious as the 
disease itself (Mann, as cited in Parker & Aggleton, 2003).  
 
 
Stigma is common when societies face problems that seem inexplicable or 
outside of their control, such as the HIV epidemic (Panos Institute, 1990). It is 
well documented that people living with HIV and AIDS experience stigma and 
discrimination on an ongoing basis. This impact goes beyond individuals infected 
with HIV to reach broadly into society. 
 
Epidemiologists initially linked AIDS to already marginalised groups, identifying 
AIDS as an illness of the four H’s: homosexuals; heroin addicts; Haitians; and 
haemophiliacs (Oppenheimer, 1988). When women were finally recognised as 
people with AIDS, they were perceived as vectors of the disease for their 
partners or their children (Triechler, 1999). As Farmer noted, “the majority of 
women with AIDS had been robbed of their voices long before HIV appeared to 
further complicate their lives” (1999, p.62). 
 
In other words, AIDS-related stigma reproduces and worsens existing 
inequalities. For example, women often experience the stigma of AIDS multiplied 
by the stigma that results from gender, sexuality, and racial/ethnic minority status 
(Parker & Aggleton, 2003; Sandelowski, Lame, & Barroso, 2004). Sandelowski et 
al. (2004) conducted a qualitative metasysnthesis that integrated the findings of 
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93 studies exploring HIV positive women’s experiences of HIV/AIDS related 
stigma. They concluded that perceived and actual stigma was pervasive in the 
women’s lives. HIV positive women lived in fear of social rejection, violence, and 
discrimination from their relationships with their children, partners, relatives, 
friends, and health care providers. Women described female-specific stigma 
including the stigma associated with the assumptions that they infected their 
children, or had been infected via prostitution, promiscuity, and drug use. 
HIV/AIDS researchers have conceptualised the notion that stigma can influence 
women’s sexual risk behaviour through its impact on HIV status disclosure to 
sexual partners (Gielen, O’Campo, Faden, & Eke, 1997; Gielen et al., 2000) and 
psychological distress (Clark, Linder, Armistead, Goffman, 1963). 
 
 
Stigma and discrimination have a shameful history internationally. The first cases 
of HIV positive individuals diagnosed happened to be gay men in America. They 
were labelled as promiscuous, and as such, deserved the diagnosis because of 
their “unnatural” life style (Shilts, 1988). Furthermore, the first women to be 
diagnosed with HIV/AIDS were prostitutes and drug users, which helped to fuel 
the stigma associated with the diagnosis (Burkett, 1995; Shilts, 1988). HIV/AIDS 
is highly stigmatised in many countries, and people with HIV may experience 
social rejection and discrimination (Karim et. al., 1995).  
 
In South Africa, it took a particularly horrendous form in the apartheid system. A 
major role that stigma plays in society is to create ‘difference’ and social 
hierarchy, and then, in turn, it legitimises and perpetuates this social inequality 
(Parker, Aggleton, Attawell et al., 2001). Discrimination arises out of any point of 
difference that can be consistently labelled; for example, physical deformity or 
disfigurement, racial differences, or any other factors that set up the person as 
different to the perceived norm. In this case the norm is generally defined in 
terms of who is powerful in the community (Goffman, 1963). Major focuses for 
discrimination have been on race, gender, sexual orientation, handicap, religion 
and age, amongst others. The attachment of discrimination to illness has a long 
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history with it impacting on people with mental illness and physical disorders 
such as cancer, TB, STDs and leprosy (Sontag, 1988).The nature of stigma and 
discrimination is complex, varying across time, person and context (Skinner and 
Mfecane, 2004). 
 
1.2.3 Consequences of Stigma 
 
This is mainly connected with sexual stigma. Stigma associated with HIV/AIDS is 
among the greatest barriers (Vidanapathirana et al., 2009) to preventing further 
infections, providing adequate care, support, treatment and alleviating the impact 
of the disease. There is evidence that HIV-related stigma makes it difficult for 
people to take actions to reduce their risks. For example, stigma can negatively 
affect people’s abilities to access HIV education (India, 2002); exchange needles 
(Ford et al., 2004) and negotiate condom use (Roth, 2001). Stigma may even 
lead women who know they are HIV positive to breast-feed their infants, rather 
than to arouse suspicion of their sero-status through formula feeding (Doherty, 
2006). It also can obstruct an array of HIV prevention interventions including HIV 
testing, harm reduction, treatment adherence support and prevention of mother 
to child transmission (Chesney & Smith, 1999). Evidence indicates that 
knowledge of one’s HIV sero-positivity can lead to earlier treatment and improved 
outcomes, (Herek, 1990) and voluntary counselling and testing can lead to the 
practice of safe sexual behaviours (Flaskerud, 1997; Coates, 2000). 
 
Even though HIV was first discovered in 1981 more than two decades ago, this 
disease continues to kill people like no other epidemic has done before. 
Internationally, studies and statistics indicate that HIV and AIDS is becoming a 
major health crisis, as the prevalence of HIV remains high. Globally, about 33.4M 
people were living with HIV by the end of 2008, (WHO/UNAIDS, 2009) with 70% 
of the HIV/AIDS burden in sub-Saharan Africa (SSA). South Africa has been 
identified as the epicentre of the HIV epidemic with an estimated 7.6 million 




HIV/AIDS remains a major cause of infant and maternal morbidity and mortality 
in resource limited settings (McIntyre, 2005a, 2005b; Newell et al., 2004). In 
Uganda, by the end of 2007, about 1M people were living with HIV. Women are 
infected more than men across the age spectrum from birth to ages between 45 
and 49 years (60% for women versus 40% for men) and this poses a high risk of 
mother-to-child transmission of HIV (MTCT). The annual incidence reached 
132,500 new cases in 2005, including 25,000 mother-to-child transmissions 
which account for 95% of paediatric HIV disease (UAC, 2008).The risk of MTCT 
HIV ranges from 25 to 48% in populations that practice prolonged breastfeeding 
(De Cock et al., 2000; Austin, 2003; Katz & Nevid, 2005). In addition, AIDS-
related stigma hinders the success of HIV prevention and care programmes by 
preventing women living with HIV from accessing the needed health and social 
services, disclosing their status to their partners, and talking openly about their 
sexual risk practices (Valdiserri, 2002). 
 
It has emerged widely in literature that one of the reasons for the failure of HIV 
prevention strategies is that people do not disclose their HIV status early enough 
in order to receive the necessary support (Kebaabetswe, 2007). Fear of being 
identified as someone infected with HIV increases the likelihood that people will 
avoid testing for HIV, disclosing their HIV status to health care providers and 
family members, or seeking treatment and care, thus compromising their health 
and wellbeing (Nyblade et al., 2009). Berger et al. (2001) mention disclosure 
concerns relating to controlling information, keeping one’s HIV status secret, or 
worrying that others who know the respondent’s HIV status will reveal their 
stigma status. The fear of stigma was so overwhelming that, on diagnosis, the 
women were not concerned with the possible physiologic changes or death, but 
rather the psychosocial ramifications that accompany this disease. This fear 
became a barrier to women achieving the goals necessary for them to maintain 
and enhance their health. Women who have tested and disclosed their status 
have related a number of negative responses to their disclosure. Physical abuse 
related to HIV is a reality throughout the world. HIV-positive women in India have 
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endured rape and forced prostitution from their partners. Medley et al. (2009) 
summarised 17 studies from peer-reviewed journal articles on barriers to the 
disclosure of HIV status among women in developing countries. This review 
builds a strong case for the impact of perceived stigma on fear of disclosure of 
HIV status as these articles suggested that between 3.5% and 14.6 percent of 
women reported experiencing a violent reaction from a partner after HIV 
disclosure. Barriers to disclosure included fear of accusations of infidelity, 
abandonment, discrimination, and violence. Varga et al. (2006) reported on HIV 
disclosure among 31 women from Johannesburg, South Africa. Their study 
further proved that while many women disclosed their status to secure adequate 
infant care, disclosure often resulted in rejection, stigmatisation, and the 
withholding of financial support (Daftary et al., as cited by Dlamini et al., 2009). 
Some of the barriers to disclosure include the fear of discrimination; the 
anticipated disruption of relationships; concern about insurance benefits and 
employment; a desire to protect oneself and others emotionally, and in some 
instances, the possibility of verbal and physical abuse. 
 
 
Furthermore, relevant studies done in Africa indicate that stigma is one of the 
causes of poor programme uptake in the area of HIV and AIDS (Peltzer, 2007). 
The literature reviewed has identified three main challenges which contribute to 
this poor PMTCT programme uptake, namely, 1) culture and gender related 
issues 2) stigma towards HIV positive individuals emanating from different levels 
within society and 3) poor resource utilisation (Thorsen et al., 2008). 
 
HIV and AIDS is the one disease that knows no age, gender, social class or any 
other form of discrimination (Pretorius et al., 2005). However, women and 
children tend to be more affected by the disease than men (Thorsen et al., 2008). 
Relevant studies have shown that women account for 55% of the people living 
with HIV, with women in the age group of 25 to 29 years of age mostly affected, 
with a prevalence of up to 40% (Health Systems Trust, 2004). The literature has 
shown that the highest incidence of HIV infections has been found in the age 
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group 15 to 49 years, peaking in women in the age group of 20 to 30 years 
(Health Systems Trust, 2004). The women in the 25 to 29 years age group have 
prevalence 5.6 times higher than that of males (UNAIDS, 2008). Worldwide, 200 
million women become pregnant annually, of which 2.5 million are HIV positive 
(UNAIDS, 2002).  
 
1.2.4 Societal Influence of HIV related Stigma 
 
Mann described male domination as a threat to the public health and the success 
of HIV prevention efforts (Mann, 1995). Sexism and gender inequity influence 
women’s sexual risk practices in complex ways. Firstly, patriarchy and sexism 
compromise women’s opportunities for economic and educational advancement. 
Poverty, racism, and sexism intersect to intensify women’s challenges. 
Therefore, women are at higher risk for participating in sexual risk behaviours 
because of the disadvantages and dependencies associated with poverty and 
racism as already described. 
 
In South Africa, stigma is of significant concern with this country’s history of 
racism and other stigmatising beliefs (Skinner & Mfecane, 2004). These include 
the murder of Gugu Dlamini in December 1998 for openly stating that she was 
HIV positive (Baleta, 1999; Kortjaas & Msomo, 1998; Nicodemus, 1999; Rusnak, 
1998); the murder of Mpho Mtloung and her mother by her husband, who then 
also committed suicide (TAC, 2000); not allowing HIV-positive children into 
schools (Sapa, 2002; Streak, 2001a); exclusions or attempted exclusions from 
the workplace (Ngqalaza, 2000a; Viol, 2000). Some authors in their study 
findings have argued that HIV and AIDS in the South African context is 
associated with black and poor women (Lercler-Madlala, 1997; Skinner and 
Mfecane, 2004). This form of prejudice results in pregnant black women being 
largely stigmatised at different levels of society (Lercler-Madlala, 2002). Other 
literature has shown that there is also an attachment of gender issues to the 
diseases, leading to women being blamed for spreading the disease. It has also 
been widely reported that in South Africa and other African countries, men blame 
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women for infecting them and spreading the virus (Lecler-Madlala, 1997; 2002). 
Reports of stigma are pervasive, extending even to the health professions. The 
AIDS Law Project reported that the Health Professions Council of SA did not act 
against 28 doctors who breached patient confidentiality. The patients were 
mostly domestic workers whose employers had been told of their diagnosis, 
many of whom were subsequently dismissed (Altenroxel, 2001). 
 
 
African countries are viewed as patriarchal, whereby women have very little 
autonomy over their lives, they become preoccupied with concealing their status 
and anxious about involuntary disclosure, and do not tell anyone that they are 
HIV infected (Shisana and Davids, 2004). Studies from Tanzania and Kenya 
have shown that women who share HIV test results with their partners may 
experience a range of reactions from support and understanding to denial, 
accusations, discrimination, physical violence and abandonment (Maman et al., 
2001; 2002; Temmerman et al., 1995). The findings of two studies conducted in 
Tanzania revealed that only 17% and 40% of the women, respectively, had 
disclosed their HIV status to their partners, even after a considerable follow-up 
period (Antelman et al ., 2001; Kilewo et al ., 2001). The main reasons cited for 
not disclosing their HIV status were fear of stigma and divorce (Antelman et al., 
2001; Kilewo et al.,2001); fear of losing confidentiality (Antelman et al., 2001); 
women’s low decision-making power, communication patterns between partners, 
and male partners’ attitudes to VCT (Maman et al., 2001). 
 
 
1.2.5 HIV/AIDS in Children 
 
In 2009 it was estimated that there were 2.5 million children living with HIV 
worldwide (UNAIDS, 2009). Furthermore, it has been argued in various literature 
that over 95% of HIV infections in children below the age of 15 years are due to 
vertical transmission or mother-to-child transmission (MTCT) (Peltezer et al., 
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2005; UNAIDS, 2006).According to the literature reviewed, the vast majority, 
about 90% of these HIV-infected children are in sub-Saharan Africa (UNAIDS, 
2004). Half a million children have already died from HIV and AIDS, and this is 
undermining child survival gains made in earlier years through child survival 
programmes (UNICEF,2003, p.8).In the absence of effective intervention, the risk 
of mother-to-child transmission of HIV is predicted to be around 15-30% without 
breastfeeding, and can go up to 30-45% with prolonged breast-feeding (UNAIDS, 
2005). 
 
1.2.6 The PMTCT Programme 
 
At the end of year 2000, a decision was made by the South African National 
Department of Health (NDoH) to implement a pilot programme for the prevention 
of mother-to-child HIV transmission (PMTCT) (NDoH, 2000). A total of 18 pilot 
sites, 2 in each of the 9 provinces, have been purposively selected to include an 
equal representation of urban and rural sites, as well as a mix of primary and 
secondary level facilities (NDoH, 2008). The aim of the PMTCT programme as 
explained by the NDoH (2000) was to offer voluntary counselling and testing, and 
to issue single dose Nevirapine to all women attending Ante Natal Care (ANC) 
clinics if identified as HIV infected, together with their infants (NDoH, 2004).  
 
HIV positive pregnant women who are not eligible for lifelong ART are given a 
PMTCT regimen for prophylaxis to reduce mother-to-child transmission. The 
regimen includes antenatal, intrapartum, and postnatal components. The 
maternal PMTCT regimen is: Antenatal Zidovudine (AZT) from 14 weeks; 
Intrapartum single-dose Nevirapine (sdNVP), 3 hourly AZT, and a postpartum 
single dose of Tenofovir (TDF) + Emtracitabine (FTC) Antenatal AZT which is 
initiated from 14 weeks gestation or as soon as possible thereafter. AZT is 
contra-indicated if laboratory findings indicate that the mother is severely 
anaemic (i.e. Hb<8g/dl) or if the woman is clinically pale. Iron and foliate 
supplementation are provided to all antenatal women routinely. Women return 




Initiation of ART is recommended for all HIV positive pregnant women with a 
CD4 cell count of 350 or less, irrespective of WHO clinical staging, and for all 
HIV-positive pregnant women in WHO clinical stage 3 or 4, regardless of CD4 
cell count, and women co-infected with TB/HIV. Pregnant women initiated on 
lifelong ART are seen two weeks after ART initiation, and then monthly. 
Monitoring for treatment failure and toxicity follows the recommendations in the 
adult ART guidelines. The HIV-exposed infants are initiated on NVP prophylaxis 
immediately after birth Infants born to HIV-positive women should receive daily 
nevirapine for six weeks, with dosing determined by the weight of the infant. 
(NDoH, PMTCT Guidelines, 2010) 
 
 
The women are counselled on infant feeding. To choose between exclusive 
breast-feeding on demand, or exclusive formula feeding. All women, whether on 
ART or not and their infants should receive follow-up consults at the health 
facility within the first three days postpartum, and should be seen again at the 
health facility prior to six weeks postpartum. Thereafter, follow-ups should occur 
at the well-infant clinics, as per the IMCI guidelines. HIV exposed infants then 
undergo a PCR test at six weeks. (NDoH, 2010) 
 
According to the South African NDoH, (2007) during the 2005/06 financial year, 
70% of the ANC attendees were counselled and tested, of whom 26% tested HIV 
positive, and 60% of those who tested positive received Nevirapine (NVP) 
(NDoH, 2007).These results show that even with PMTCT being universally 
accessible, not all women receive the full package of the prescribed PMTCT 
programme. 
 
Although the South African Government has put some strategies in place to 
ensure that ARVs are accessible to HIV positive women, there seem to be other 
stumbling blocks to the full utilisation of these services. The literature has 
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identified various reasons for women not to enroll or adhere to the PMTCT 
programme guidelines, and one of these reasons has been HIV related stigma 
(Pelzer et al., 2007). Studies done elsewhere on HIV and AIDS indicate that HIV 
related stigma is one of the barriers which insidiously undermines the PMTCT 
programme (Kebatatswe, 2007). This HIV related stigma has been demonstrated 
by poor adherence to treatment guidelines because of fear of revelation of being 
HIV positive (Thorsen et al., 2008; Kebaatswe, 2007) The findings of a study 
conducted in Malawi which aimed to identify potential stigma initiators in the 
PMTCT programme showed that, because of HIV related stigma, some pregnant 
women prefer not to test, as they fear that their husbands would accuse them of 
having been unfaithful, hence the need to test for HIV (Thorsen, Sundby and 
Martison, 2008). Women who do test positive and disclose their status face 
dramatic negative results on their own and with their children (Viva et al., 2008). 
Fear of being identified as someone infected with HIV increases the likelihood 
that people will avoid testing for HIV, thereby disclosing their HIV status to health 
care providers and family members, or seeking treatment and care, thus 
compromising their health and wellbeing (Nyblade et al., 2009).   
 
This argument is further supported by the findings of a study conducted in the 
Eastern Cape province of South Africa at 20 antenatal clinics (ANCs) whereby 
ANC records reviewed showed that 76% of ANC attendees received HIV 
counseling during their clinic visits, but only 67% end up undergoing HIV testing, 
(Peltzer et al., 2007) meaning that 33% of the women who attend the ANC clinic 
never undergo testing (Peltzer, 2007). These findings may be an indication that a 
number of HIV positive pregnant women miss the opportunity to benefit from the 
PMTCT programme for fear of being stigmatised because of their HIV status.  
 
 
1.2.7 Stigma in the Health Sector 
 
The literature has also indicated that the health sector is sometimes another 
setting, other than the community where HIV-positive individuals and those 
 17
perceived to be infected experience stigma and discrimination (Andrewin & 
Chien, 2007). Stigma and discrimination by health workers compromises their 
provision of quality care, which is critical for helping patients adhere to 
medications, and to maintain their overall health and wellbeing. Stigma also acts 
as a barrier to accessing health services for both the general population, as well 
as the health providers themselves if they contract the virus (Nyblade et al., 
2009). 
  
The renowned HIV physician and medical anthropologist Paul Farmer (2005) has 
referred to the harm inflicted upon individuals by systems of oppression and 
inequality collectively as “structural violence”,  and has insisted that mitigating 
HIV risk depends primarily on the freedom of disenfranchised women to make 
decisions, rather than their knowledge or skill levels (Farmer, 1999). This is seen 
as one of the reasons women don’t access health care. As a result of their 
culture and the place of women in the community, they feel they need permission 
to make decisions. In addition, HIV/AIDS researchers and clinicians 
conceptualise poverty as a root cause of HIV among women (Farmer, 1992, 
1999, 2005; Parker, Easton, & Klein, 2000; Poundstone, Strathdee, & Celentano, 
2004). Unequal access to education, employment and economic resources 
diminish women’s control over their lives and their negotiating power in 
relationships. Poverty also restricts women’s sexual networks, and increases 
their likelihood of unsafe injection drug practices and exchange or survival sex 
(Kalichman, 2000). Women’s lack of basic needs may prevent them from 
prioritising safe sex, forcing them into unhealthy and risky sexual situations, or 
preventing them from accessing prevention interventions and risking reduction 
messages.  
 
A study conducted in Botswana which aimed at identifying factors that hindered 
women from participating in PMTCT programmes, showed that the negative 
attitudes of health workers were some of the barriers to patient participation in 
PMTCT programme uptake (Kebaabetwe, 2007). A similar study conducted in 
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Belize, (Latin America) showed that pregnant women were more likely to 
participate in the PMTCT programme if the health providers had positive attitudes 
towards the HIV infected pregnant women (Andewin et al., 2007). Furthermore, it 
has been found that a lack of support from the male partners was cited as part of 
the reason for not wanting to participate in the PMTCT programme 
(Kebaabetswe, 2007).  
HIV-related stigmatisation is both a social phenomenon and a process that 
results in a powerful and discrediting social label (Link and Phelan, 2008). 
Stigmatising individuals due to their HIV status has been found to radically and 
negatively change the way these individuals are viewed and treated by others 
(enacted/attributed stigma), and how they view themselves (self/personal stigma) 
(Chiu et al., 2008). For pregnant women who consider disclosing their HIV status, 
the thought of being stigmatised by their community and significant others often 
elicits fears of abandonment, ostracism, domestic violence, or being blamed (felt 
stigma) (Viva, Thorsen et al., 2008). Studies have shown that such women tend 
to opt out of being tested (if tested, they rarely disclose), or do not complete their 
scheduled visits, or do not abruptly cease breastfeeding as recommended by the 
programme (Makin et al., 2007).  
Until recently, studies conducted on HIV related stigma have focused on the HIV 
programmes’ utilisation. No study has been conducted to determine how these 
women experience the stigma directed at them. In South Africa, there has been 
no study conducted to explore the how HIV positive pregnant women are 
experiencing HIV related stigma. 
1.3 Problem Statement  
Since their recognition in 1981, HIV and AIDS have evoked very strong 
emotional responses. Stigma often heightens existing prejudice and inequalities 
for people who are already socially marginalised and closely associated such as 
women, sex workers, men having sex with men, and drug users (Weiss and 
Ramakrshna, 2001). People who are, or are presumed to be HIV positive have 
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been subject to a variety of negative reactions, including physical and verbal 
abuse.  
 
In South Africa, the political response to the HIV and AIDS epidemic has resulted 
in further exposing those affected to stereotyping, prejudices and political 
injustice (Grundling, 2001, p.8). People living with HIV and Aids (PLWHA) in this 
country still have difficulties with stigma and discrimination, and this area of the 
disease is largely ignored. As with most other countries worldwide, South Africa 
has reported a large number of incidents linked to HIV related stigma, including 
the murder of the HIV infected and affected individuals. (Baleta, 1999; Kortjaas & 
Msomo, 1998; Nicodemus, 1999; Rusnak, 1998) and some suicides (TAC, 
2000). Studies conducted on HIV related stigma in South Africa have explored 
stigma in HIV infected people and adherence to treatment, but not specifically 
directed at pregnant women who are on a PMTCT programme (Mokoae et al., 
2007; Naidoo et al., 2007). It is therefore important to explore the stigma as 
experienced by the women enrolled in the programme, as this may give insight 
as to how these women experience this stigma, and how it affects their 
participation and adherence to the PMTCT programme guidelines. Little attention 
has been paid to this issue, particularly in low-resource countries grappling with 
the rapidly increasing HIV epidemic.  
 
1.4 Purpose of the Study 
 
The purpose of this study is to explore the HIV positive pregnant women’s lived 
experiences on HIV related stigma with the focus on those who are participants 
in the PMTCT programme.  
 
 
1.5 Objectives of the study  
 




1.6 Research Question 
1. What are the HIV positive pregnant women’s lived experiences of HIV related 
stigma? 
 




As a noun this refers to knowledge and familiarity (Collins, Thesaurus A-Z, 
2004,p 253). 
Operational Meaning: 
It is the perception of the women in relation to their feelings during the PMTCT 
programme. 
 
Pregnant woman:  
General Definition: 
The period from conception to birth. After the egg is fertilized by a sperm and then implanted in 
the lining of the uterus, it develops into the placenta and embryo, and later into a fetus. 
Pregnancy usually lasts 40 weeks, beginning from the first day of the woman's last menstrual 
period, and is divided into three trimesters, each lasting three months. (Rao, 2010) 
Operational Meaning:  
Women who have had their pregnancy confirmed by a health worker. 
 
HIV Exposed Babies: 
General Definition: 
Infant born to an HIV-positive woman (PMTCT guidelines, 2010). 
 
Operational Meaning:   






People living with HIV-Aids (UNAIDS Terminology, 2008). 
Operational Meaning:  
People who have been tested and have been found to be HIV positive or to have 
full-blown Aids. 
 
HIV positive woman:  
General Definition: 
Refers to women who have taken an HIV test which showed a positive result and 
who know their result. (PMTCT Guidelines, 2010). 
Operational Meaning:   
This refers to pregnant women who have contracted HIV, who test positive for 
antibodies to HIV.  
 
PMTCT Repeat cases 
General Definition: 
Prevention of mother-to-child transmission in HIV cases enrolled more than once 
on the programme. 
Operational Meaning:   





Transmission of HIV from an HIV-positive woman to her child during pregnancy, 
delivery, or through breastfeeding. The term is used because the immediate 
source of the infection is the mother, and does not imply that any blame is 






This means methods used to prevent the transmission of HIV from mothers to 
their babies during pregnancy, intra-partum and post-delivery including modified 
delivery methods and feeding practices. 
 
Rural Clinic:  
General Definition: 
Pertaining to less populated non-urban areas (en.wiktionary.org/wiki/rural). 
Operational Meaning: 
Clinics serving the informal settlements and/or areas under Kings and Indunas. 
 
HIV related Stigma:  
General Definition: 
According to Collins Thesaurus (2001, p.694) stigma can also be called disgrace 
or dishonour.  
Operational Meaning: 
For the purpose of this research stigma will be viewed as any action inflicted on 
HIV positive pregnant women to embarrass or belittle them because of their HIV 
status. 
 
Urban Clinic:  
General Definition: 
Relating to, or concerned with a city or densely populated area; "urban 
sociology"; "urban development"(wiktionary.org, 2010). 
 Operational Meaning: 
Based within the CBD or within a 20 km radius of the city of Durban. 
 
Mother to Child Transmission:  
General Definition: 
Vertical transmission, also known as mother-to-child transmission, is the 
transmission of an infection or other disease from mother to child immediately 
before and after birth during the perinatal period. (Answers .com, 2010). 
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Operational Meaning: 
Transmission of HIV from an HIV positive woman during pregnancy, delivery or 
breast feeding to her child. In this study this term will be used interchangeably 
with vertical transmission. 
 
1.8 Significance of the Study  
 
Paediatric HIV remains an important public health problem in HIV high-burden 
countries, with more than 90% of new HIV infections in children occurring 
through mother-to-child transmission (MTCT). 
 
In South Africa in 2006, an estimated 38 000 children acquired HIV infection 
around the time of their birth, and an additional 26 000 children were infected 
through breastfeeding (Risspel et al., 2009). This is in spite of the availability of 
preventive services such as the PMTCT programme. Studies have shown that 
such women tend to opt out of being tested (if tested, they rarely disclose), opt 
out of PMTCT programmes, do not complete the scheduled visits, or do not 
abruptly cease breastfeeding as recommended by the programme (Rispel et al., 
2009; Delva et al., 2006; Spensley et al.,2009). The 2002 evaluation of South 
Africa’s PMTCT of HIV at 18 sites reported that 56% of antenatal attendees were 
tested (Thorsen et al., 2008). Studies indicate that women identify programme 
characteristics and activities that might inadvertently disclose their HIV+ status 
potentially initiating the stigmatisation process. They would rather not test so as 
to avoid testing positive. 
 
Effective implementation of the PMTCT programme has the potential to allow 
South Africa to fulfil the Millennium Development goals (MGD) 4, 5 and 6 
(PMTCT Guidelines,2010).  The direct experience of stigma is terrible when you 
consider how it impacts on those who feel the discrimination. Stigma impacts 
beyond the individual infected with HIV, to affect all those associated with the 
disease. It can also impact on society more generally, by extending the epidemic, 
and undermining whatever behaviour and treatment interventions are already in 
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place. Thus interventions need to be introduced to reduce stigma and encourage 
acceptance (Skinner and Mfecane, 2004). 
 
The health care setting has been identified as one of the major settings in which 
stigmatisation urgently need to be addressed. While many of the studies 
conducted thus far were conducted among health care workers (HCWs) in 
Africa (Nyblade et al., 2009; Nassali et al., 2009), fewer studies have investigated 
the phenomena among HCWs in Latin America and the Caribbean. A study 
conducted among sports coaches in Barbados emphasised the need for 
understanding the experience and expression of AIDS stigma among those 
delivering HIV/AIDS services (such as health care providers) in diverse cultures, 
as a first step towards the development and cross-cultural validation of tools for 
assessing stigma, and subsequently, for the design of targeted interventions. As 
a corollary, little is known or documented about the attitudes and practices of 
HCWs in Belize regarding the treatment of HIV/AIDS patients. (Chien and 
Andrewin, 2006). 
 
The attachment of gender discrimination to HIV stigma has led to women being 
blamed for spreading the epidemic. Thus women are contradictorily expected to 
provide sexual services to men generally, to be chaste and pure, and to take on 
the responsibility of preventing pregnancy and disease (Crewe, 1992; Leclerc-
Madlala, 2002). There are many examples at a national level of discrimination 
introduced by socially conservative governments, including policies of restriction 
of admissions, deportation of foreigners and  mandatory testing A prime impact 
of discrimination is that it pushes the epidemic underground, forcing people who 
have contracted HIV, and anything else associated with the disease, into hiding. 
An acknowledgement of HIV becomes difficult, if not impossible. Likewise, any 
association with the disease or people with HIV can be a basis for that person 
being excluded from their community, so it is denied. The disease itself then 
remains hidden, so its perceived threat is reduced. It also makes the disease 
someone else’s problem. The stigmatising beliefs then facilitate the use by 
individuals and communities of denial and distancing as defensive processes 
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against the epidemic, again reducing the need to adapt (Skinner, 2001). 
Distancing or creating barriers between those infected and the rest of the 
population consumes considerable energy that could be more profitably used, 
and robs the intervention of some of the best advocates for behaviour change, 
namely those who are directly affected. Thus the epidemic disappears, or at least 
has few public faces, leaving the space open for the scape-goating of any person 
or group associated with the disease. These scape-goating processes can be 
dangerous, as they pin the blame on a small section of the population, leaving 
the rest with the mistaken belief that they are safe (Douglas, 1995; van der Vliet, 
1996). A greater problem arises when those with the power to construct 
interventions use discrimination as a basis for not implementing such 
programmes. For communities as a whole, or for those responsible for 
structuring interventions, blaming infected people can be a substitute for tackling 
the problem itself. So even when interventions are developed on this basis, they 
are constructed in such a way as to discriminate against those in affected 
groups, and to reinforce a false sense of safety in the majority of the population. 
 
 
Discrimination has significant impacts on diagnosis and treatment. For the 
individual, it can delay diagnosis, and can therefore also delay entry into 
treatment and adoption of a healthy lifestyle. There is no motivation to be tested, 
as the person sees no benefit, when the diagnosis of HV is seen as equivalent to 
death, and they are likely to experience discrimination (Abdool Karim,Tarantola, 
Sy & Moodie, 1992). In certain contexts, research respondents have been shown 
to be more fearful of the stigma than of the disease itself, so even with treatment, 
stigma may be a block to access (Lie & Biswalo, 1994).This has already been 
shown to be a problem in the case of PMTCT, where HIV-positive women fed 
into their sense of self, causing them to feel compromised and to blame for their 
situation. Similar results were found with a sample of HIV positive women 
(Strebel, 1993). When this stigma is internalised it might influence the ways 
affected individuals look at themselves and how they interact with others, 
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including health care providers (Lee, Kochman & Sikkema, 2002). This again 
impacts on a person with AIDS coming to terms with his/her illness.  
 
 
The results of the study will be shared with programme managers to help review 
programme processes that may be stigmatising women in the PMTCT 
programme unduly, causing them to drop out of the programme.   
 
As programme participants, HIV positive women were given a voice to share 
their experiences. Such experiences are used to empower other women who find 
themselves pregnant and HIV positive, and who need to be part of the PMTCT 
programme. The findings and recommendations will be forwarded to PMTCT 




This chapter discusses the background of the study, the purpose of the study, 
research objectives and the significance of the study for HIV positive women 
enrolled in the PMTCT programme in the eThekwini District. The outcomes of 
this study are hopefully going to give insight to the Health Care workers who 
work with the HIV positive women on a daily basis on how to mitigate the stigma 
that may be felt by the women in the PMTCT programme. The aim is to increase 












2. LITERATURE REVIEW 
2.1 INTRODUCTION 
 
This chapter reviews the empirical evidence on HIV and AIDS related stigma, 
with a special emphasis on pregnant women. The following search databases 
were utilised for the literature review, Medline-Ebscohost, Pubmed, CINAHL, 
Science Direct, Cochrane Library, LWW Journals full text and Biomed Central. 
The following search terms were entered on the data bases: “PMTCT and 
stigma”, “HIV and AIDS related stigma”, “Stigma in the health care setting”,” 
Barriers to PMTCT”, HIV and AIDS disclosure” and “gender issues in HIV and 
AIDS”. Approximately 165 articles were retrieved, and 118 were found to be 
relevant to the study. 
 
2.2 Introduction to the Phenomenon of HIV related stigma 
Although the study is phenomenological in approach, literature review was 
done to provide context of the phenomenon of stigma in relation to 
HIV/AIDS and in particular to PMTCT. 
 
Most of the research on HIV/AIDS stigma has been conducted in the US, a 
country with large research resources, an early epidemic, and pronounced 
stigmatisation of gay men, and African-Americans and Haitian immigrants as 
carriers of HIV/AIDS (HSRC, 2005). Considerable research attention is now 
being focused on HIV/AIDS research in general in Africa, because of the severity 
of the African epidemic, the politicization of the HIV/AIDS issue, and the fact that 
HIV/AIDS seems to be highly stigmatised in the region. However, the relative 
lack of scientific research on the manifestations of HIV/AIDS-related stigma in 
sub-Saharan Africa still presents a serious challenge to the understanding, 
alleviation and prevention of HIV/AIDS-related stigma (Lorentz & Morris, 2003). 
The problem of HIV/AIDS stigma in Africa has been raised in related research on 
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barriers to VCT, treatment, care and adherence (Uys, 2003; Weiser, Wolfe, 
Bangsberg, Thior, Gilbert, Makhema, Kebaabetswe, Dickenson, Mompati,  
Essex & Marlink, 2003); on quality of life (Kigozi, Wabwire-Mangen, Black, 
Sewankambo, Serwadda, Gray, Wawer & Wu, 2004); and on social responses to 
HIV/AIDS and gender related stigma (Leclerc-Madlala, 2002). 
 
2.3 Stigma defined 
 
In regard to racism, the tendency to define a concept so that it includes an ever-
widening range of phenomena has been dubbed ‘conceptual inflation’ (Miles, 
1989). Like racism, stigma has suffered from conceptual inflation because much 
of the research on stigma defines it as something that results in discrimination 
(Link & Phelan, 2001), or does not clearly separate the two concepts. Conflating 
stigma and discrimination is not often perceived as a problem, because the major 
concern about stigma is that it can cause unfair discrimination.  
 
‘Stigma’ is a Greek term denoting a mark that, in ancient times, was burned or 
cut into the flesh of an unsavory character, a traitor, criminal, or slave (Harvey, 
2001). Goffman (1963, p.3) defined it as “an attribute that is deeply discrediting 
within a particular social interaction”, as a “spoiled social identity” and “a 
deviation from the attributes considered normal and acceptable by society”  
Following this interpretation, Herek (2002) defines HIV/AIDS stigma as an 
enduring attribute of an individual infected with HIV who is negatively valued by 
society, which thus disadvantages and discriminates  against people perceived 
as having HIV/AIDS, and is directed at individuals, groups, and communities 
which  are seen, or assumed to be associated with HIV positive individuals. 
Alonzo and Reynolds, (1995) for example, provide a more complex reading of 
Goffman, suggesting that stigma is not merely an attribute, but represents a 
language of relationships, as labelling one person as deviant reaffirms the 
normalcy of the person doing the labelling (Goffman, 1963 , as cited in Alonzo & 
Reynolds, 1995). UNAIDS defines HIV-related stigma and discrimination as: "... a 
'process of devaluation' of people either living with or associated with HIV and 
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AIDS ... Discrimination follows stigma and is the unfair and unjust treatment of an 
individual based on his or her real or perceived HIV status." 
 
People allocate more blame to those who contract stigmatised diseases that are 
perceived as controllable and stable, than to those who have supposedly less 
controllable and less stable stigmatised diseases (Weiner, Perry & Magnusson, 
1998). Attributing stigmatized medical conditions such as obesity or HIV/AIDS to 
a lack of personal responsibility, (such as over-eating) or to the perceived 
negative characteristics or behavior of a specific group (such as promiscuity 
among gay men) helps to distance the ‘moral majority’ from risk (Munyinda et al., 
1997). Risks perceived to be the most serious and the most easily controllable 
are those which help people to legitimise moral principles (Joffe ,1999). STIs 
form a potent moral vehicle, since both disease and sexuality have long been 
associated with the ‘other’ (Crawford, 1994). People with HIV/AIDS may not have 
any visible signs of the disease, yet they are more likely to be stigmatised 
because others may view them “as contributors to their own problems and 
unworthy of the care directed to more legitimate victims of illness” (Jillings & 
Alexus, 199162). Alonzo and Reynolds (1995304) defined stigma as “a powerful 
and discrediting social label that radically changes the way individuals view 
themselves and are viewed as persons”. Insideout Research (2003) describes a 
large collaborative study on stigma in South Africa, and reports that stigma “can 
be felt (internal stigma), perceived or emic. Felt stigma is seen as a complex 
process that involves internalising and devaluation from people around the 
PLWHA (Nyblade, 2003). This type of stigma includes the thoughts and 
behaviors of the person’s own negative perception based on his or her own 
knowledge of his/her HIV positive status (Geef et al., 2008). Emic refers to the 
felt part of the stigma leading to unwillingness to seek help and access 
resources. Perceived stigma refers to an individual’s perception of social 
attitudes towards the PLWHA, and his or her personal knowledge of being 
infected (Berger et al., 2001; Sandelowiski et al., 1995). The indicators for 
internal stigma are self-exclusion and social withdrawal (Siyamukela, 2003).On 
the other hand, enacted stigma refers external stigma, and etic, leading to 
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discrimination on the basis of HIV status, or association with someone who is 
living with HIV/AIDS. External stigma refers to all types of stigma directed at 
PLWHA as experienced and described by them. This refers to the enacted type 
of stigma leading to discrimination on the basis of HIV status (Siyamukela, 2003). 
Studies indicate that people often act in ways to reduce opportunities for enacted 
stigma as a form of self-protection. External stigma is demonstrated and 
indicated by avoidance, moral judgment and rejection. The third type of stigma is 
associated stigma; this is another form of external stigma. Associated stigma is 
stigma that is directed at people who work or associate with 
PLWHA.(Siyamukela,2003)  
 
Nyblade (2003) reported on the results of 700 interviews with community 
members, persons living with HIV/AIDS, youths, caregivers, religious leaders, 
NGOs, and employers in Ethiopia, Tanzania and Zambia. The objective was to 
disentangle stigma, and thus provide a four-part framework based upon the 
content analysis of their interviews. The study suggested that stigma could best 
be understood from the perspective of (i) causes of stigma; (ii) context of stigma; 
(iii) experiences of stigma; and (iv) effect of stigma on programmatic efforts.  
 
2.4 Stages of Stigma 
 
Biology is a vital factor in understanding variations in the strength and content of 
stigma within a disease. Stigma is not static, Stigmatisation changes as the 
disease itself progresses through various biological stages. These changes can 
affect how stigma is experienced by PLWHA. Alonzo and Reynolds (1995,310) 
suggest that in different phases of HIV/AIDS, PLWHA experience stigma 
differently. They describe this changing experience of stigmatisation as a ‘stigma 
trajectory’ with four phases: “(1) at risk: pre-stigma and the worried well; (2) 
diagnosis: confronting an altered identity; (3) latent: living between illness and 
health; and (4) manifest: passage to social and physical death”. They argue that 
we need to “conceptualize how individuals with HIV/AIDS experience stigma and 
to demonstrate how these experiences are affected by changes in the 
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biophysical dimensions of HIV/AIDS”. Link and Phelan (2001) articulate three 
mechanisms of stigma. One is direct discrimination on a person-to person level, 
where activities devalue, reject, exclude or blame the other person. The second 
is structural discrimination, in which social contexts, such as a sign identifying an 
HIV/AIDS clinic enforce stigma without person-to-person actions. The third 
mechanism is self-stigmatization, a socio-psychological process that operates 
through the stigmatized person. Stigmatised persons apply labels to themselves, 
believe in these labels, and live accordingly. (Link & Phelani,2001) 
 
In the case of care-givers stigmatising the patients, evidence of stigma appears 
in three forms in nursing and patient care, according to Jillings and Alexus (1991, 
305): “(1) the labels and stereotypes attached by society to particular illnesses; 
(2) the patient’s behaviors toward others as a result of feeling stigmatised; and 
(3) the values and assumptions of nurses themselves in relation to selected 
illnesses”. Nurses and other health workers who care for persons living with 
HIV/AIDS have their own emic view of stigma that may lead them to promulgate 
prejudice and discrimination toward their patients (Jillings and Alexus, 1991,304). 
 
2.5 Stigma, discrimination and power 
 
The blaming model of stigma as described in the HSRC (2005) documents 
explains the politics of stigma without resorting to a functionalist definition of 
stigma. The process of stigmatisation helps to create a sense of control and 
immunity from danger, at an individual and a group level, as it distances people 
emotionally from risk (HSRC, 2005). The choice of who is identified as the 
outgroup depends on personal identities and historical power relations, and is 
thus highly variable. For example, Joffe’s work has shown that some black South 
Africans blame Western scientists for HIV/AIDS, while some white heterosexual 
British men blame black Africans for it ( Joffe, 1999). These socially constructed 
representations are all functional to the individual in distancing him or her from 
risk and thus reducing anxiety, but they only result in discrimination, and the 
reproduction of structural inequalities when other enabling circumstances such 
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as the power and opportunity to discriminate, come into play. The status loss 
ascribed to the stigmatised by the stigmatiser may lead to discrimination against 
stigmatised people, depending on the existence of power differentials and an 
enabling context. It may also result in an internalization of stigma. When a 
particular group of stigmatising ideas is validated by a powerful person or group, 
(in the media, in communities and so on) and deployed as part of broader power 
struggles, it becomes pervasive, entrenched and very difficult to shift. The 
powerful nature of dominant group ‘othering’ in a society can override other 
representations, and can even cause widespread self-stigmatisation (HSRC, 
2005). A major role that stigma plays is that it separates people, creating a 
feeling of superiority for those who are not affected by the stigmatising trait, and 
establishing a feeling of shame in or towards the group which is stigmatised 
(Skinner & Mfcecane, 2004). To stigmatise, the stigmatiser, the person who 
inflicts stigma is in a position of power, and this also allows the stigma to take 
effect. This means that those in positions of power like health workers, who hold 
power, are effectively able to stigmatise PLWHA. 
 
2.6 Mechanism of Stigma and adherence 
 
For those people who have access to ARV medications, adherence is essential. 
In contrast to other chronic illnesses, HIV requires very high medication 
adherence rates in order to decrease the viral load, and to increase CD4 counts. 
Strict adherence is also required in order to avoid the development of medication 
resistance which would render the drugs ineffective at preventing viral replication. 
Researchers have investigated stigma as one of a number of factors related to 
varying ARV medication adherence.(Dlamini et al,2009) There have been several 
studies on ARV medication adherence in Southern Africa that have 
demonstrated the challenge of maintaining high medication adherence, as well 
as pinpointing stigma as one of the significant barriers to medication adherence. 
Nachega et al. (2001) documented a strong relationship between the failure to 
refill ARV medication prescriptions and survival in a large sample of patients in 
South Africa. This further supports the need for maximum adherence to HAART. 
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 It is possible that refilling a prescription is a trigger that results in increased 
stigma. Wolfe et al. (2003) interviewed 112 patients in Botswana and explored 
the relationship between HIV stigma and adherence to ARV medications. Ninety-
four percent of the patients reported keeping their HIV status secret from their 
community and 69% from family members. Forty percent reported that they had 
delayed getting tested for HIV. Much of the failure to disclose was described as 
being related to perceived HIV-related stigma. Nachega et al. (2001) examined 
adherence in a sample of 66 patients with HIV in Soweto, South Africa. They 
reported that adherence decreased considerably, in relation to the fear of being 
stigmatised by a sexual partner (Nyblade et al., 2009). 
 
Stigma and discrimination have been identified internationally as the main 
barriers to HIV control and prevention in every country and region of the world, 
posing challenges to preventing further infections, alleviating the impact, and 
providing adequate care, support, and treatment. In health care settings, HIV-
related stigma discourages people living with HIV and AIDS (PLWHA) from 
seeking care if they have previously experienced unwelcoming treatment, or if 
their confidentiality has not been respected.  Previous studies have documented 
service providers’ discriminatory attitudes and behaviours toward PLWHA, and 
the direct negative consequences of this on the quality of life for PLWHA. Factors 
contributing to these stigmatising and discriminatory responses include lack of 
knowledge, such as basic knowledge of HIV/ AIDS and universal precautions, 
provider attitudes, and perceptions that caring for PLWHA is pointless because 
HIV and AIDS is incurable (Sheng wu et al., 2008). There have been several 
studies on ARV medication adherence in Southern Africa which have 
demonstrated the challenge of maintaining high medication adherence as well as 
indicating stigma as one of the significant barriers to medication adherence. 
Weiser et al. (2005) examined barriers to medication adherence in a sample of 
109 patients, using both qualitative and quantitative research methods. The 
principal barriers to medication adherence were financial constraints (44%), 
stigma (15%), travel/migration (10%), and side-effects (Dlamini, et al., 2009). 
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Experienced and perceived stigma and discrimination are associated with a 
reduced utilisation of prevention services, including programmes to prevent 
mother-to-child transmission (Zukoski and Thornburg, 2009). 
 
Studies in Senegal and Indonesia documented that men who have sex with men, 
and injecting drug users, respectively, often avoid or delay accessing HIV-related 
services, including treatment for other sexually transmitted diseases. Likewise, 
researchers in Botswana and Jamaica found that stigma leads many people to 
seek testing and treatment services late in the progression of their disease, often 
beyond the stage of optimal drug intervention (Bond et al., 2002). (Nyblade, 
Stangl et al., 2009). Researchers have investigated stigma as one of a number of 
factors related to varying ARV medication adherence. Using a three-item 
assessment to quantify stigma, Rintamaki et al. (2008) found that people in the 
United States with high HIV stigma concerns were 3.3 times more likely not to 
adhere to their medication regimen than those with low concerns.   
 
There is extensive literature available on the medical management of HIV/AIDS, 
which often leads to the assumption that people living with HIV infection want to 
be tested and, if found to be positive, want to engage with care. In the United 
States (USA) however, it is estimated that as many as one-third of the HIV-
positive population do not know their HIV status (Kaiser Family Foundation, 
2004). Even in countries where studies have documented high rates of HIV 
infection, many individuals are reluctant to get tested, and are often slow to 
access care (Newman, Grusky, Roberts & Rivkin, 2002).The stigma of HIV/AIDS 
is one factor affecting people's decisions to get HIV tested and seek care. AIDS 
stigma and discrimination have a considerable influence on people living with 
and affected by HIV, as well as on their health care providers, particularly in 
southern Africa, where the burden of AIDS is so significant (African Development 
Forum, 2000). Stigma has emerged as a major limiting factor in primary and 
secondary HIV/AIDS prevention and care (Weiss & Ramakrishna, 2001). It 
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interferes with voluntary testing and counseling, and access to care and 
treatment, increasing suffering and shortening life (Newman et al., 2002).  
 
Many health care workers in southern Africa have come to the conclusion that, 
unless stigma is conquered, the illness will not be defeated (Uys, 2000). In a 
study of women who refused to be tested for HIV at Ethiopian antenatal clinics, 
Kumbi, Bedri, Abashawl, Isehak, Coberly and Ruff (2002) concluded that fear of, 
and the stigma associated with HIV was significantly related to the women’s 
decision. Munhenga, Chiwara, Jena et al. (2002) reported similar results 
regarding antenatal clinics in Zimbabwe. In preparing patients for lifelong HIV 
care, stigma should form part of the discussion, as it would appear that it plays a 




When the HIV-infected individuals first learn their status, they experience an 
internal struggle about whether or not to disclose their HIV-seropositive status 
(Marks et al., 1992). The decision to disclose is selective, and consists of several 
steps including adjusting to the diagnosis, assessing one’s disclosure skills, 
deciding whom to tell, evaluating the recipient’s circumstances, anticipating the 
recipient’s reaction and having a motivation to disclose (Kimberly et al., 1995). 
The decision to tell one’s family members is reported to be especially difficult 
(Kimberly et al., 1995; Serovich et al., 1998). A certain level of disclosure is 
necessary to access AIDS-related health care resources. HIV-infected individuals 
who disclose their seropositive status have been found to make fewer physicians’ 
visits and have better immune functioning (Pennebaker et al., 1990). Choosing to 
disclose may result in less social isolation, and facilitate accessing social 
support, health. Disclosure of one’s HIV status to sexual partners is essential in 
stopping the spread of HIV infection (Kalichman and Nachimson, 1999). Over 20 
states have enacted laws, making it a criminal offence for an HIV-infected 
individual to fail to reveal to a sex partner that he or she is HIV-infected (Lisko, 
1998). Yet many HIV-infected individuals do not disclose to all sex partners. 
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Kalichman and Nachimson concluded that HIV-seropositive women have greater 
difficulty disclosing their HIV status to sexual partners than do men (Kalichman 
and Nachimson, 1999). 
 
Unfortunately, disclosure doesn’t always have the desired outcomes, as 
indicated in the study by Medley (2004). He summarised 17 studies from peer-
reviewed journal articles on barriers to the disclosure of HIV status among 
women in developing countries. These articles suggested that between 3.5% and 
14.6% of women reported experiencing a violent reaction from a partner after 
HIV disclosure. Disclosure of HIV infection by women may present unique risks. 
A woman’s disclosure of her own HIV status may lead to stigmatisation and 
discrimination of her children (Moneyham et al., 1996). Simoni et al. (1995) found 
that one in five women who disclosed her HIV status to her partner was 
abandoned. A woman’s disclosure of her HIV infection to sexual partners may 
trigger violent episodes (Rothenberg and Paskey, 1995; Zierler, 1997; Zierler et 
al., 2000). Gielen et al. (1997) found that one-fourth of the women in their study 
had experienced negative consequences of disclosure that included rejection, 
abandonment, and verbal and physical abuse. 
 
Barriers to disclosure included fear of accusations of infidelity, abandonment, 
discrimination, and violence. This review builds a strong case for the impact of 
perceived stigma on the fear of disclosure of HIV status. In turn, no disclosure 
makes it difficult to access HIV care.  
 
2.8 Stigma and Community 
 
The communities view HIV/AIDS with fear and awe. It is something they talk 
about in lowered voices and in veiled words. The general view is that people with 
this illness have no hope. Nyblade et al.’s (2003) study in three African countries 
points out that much of the stigma is being caused by a lack of in-depth 
knowledge, the fear of casual transmission, and the fear of death. The songs 
quoted by Lwanda (2003) show the same trend, although one of the songs 
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indicates an understanding that only a concerted community-level response will 
be effective in stemming the tide. In the song, “Kunja Kuno Kwaopsya,” the 
epidemic is equated to a war, with the virus as the weapon and the condom as 
the shield (Lwanda, 2003). It might be that the community uses indirect and 
metaphorical descriptions to cope with the serious threat that HIV/AIDS poses for 
families and communities. For instance, in Malawi, the population is encouraged 
to be open about the illness, but they still use words to lighten and soften 
references to the illness. People in African societies often create their own 
language to talk about private or sensitive issues (Uys et al., 2005). Sex and 
sexual behavior is a very private topic in most of the communities studied, and it 
should therefore not be surprising that oblique terminology is developed to talk 
about it. It is also true that even some of the PLWHA used such terms to talk 
about their status in a veiled way, for example, “I am nice, are you too?” 
However, most of the descriptions apportion blame, are negative, and hurtful. 
Nyblade et al. (2003) also list some of these descriptions, and point out that they 
highlight deviant behavior, are euphemisms for death, and blame people for their 
infection and for being a burden on those around them. In the Tswana 
community of South Africa where research was done, there is an idiom, leso 
legolo ke ditshego, which means that when the situation is bad, we make a joke. 
Many of the descriptions reported in this study are sharp and witty and may 
reflect this kind of community coping. (Nyblade et al.2003)  
 
 Muyinda et al (1997) described two processes by which societies make the 
unfamiliar familiar. The first is anchoring, which refers to naming the unfamiliar in 
terms that compare it with what is known. In this study, terms such as the clothes 
hanger and lightning are examples of anchoring. The second process is 
objectification, which refers to names that make abstract notions concrete. The 
terms drum and ladybird are examples of this (Uys et al, 2005). Parker and 
Aggelton (2003) suggest the need for community-level mobilisation, with the goal 
of unleashing the power of resistance on the part of PLWHA, in tandem with 
intervention at the structural level to respond to stigma effectively. Important 
structural targets include religious leaders, the judiciary and the legislative arenas 
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(Parker et al., 2003; Ehiri at al., 2003). Parker et al. (2003) suggest that in certain 
settings, specific manifestations of stigma are indeed more psychologically 
damaging than others. Psychological distress was most strongly predicted by 
three specific manifestations of stigma occurring in family settings – avoidance, 
exaggerated kindness and being told to conceal one’s HIV status. Stigmatisation 
by family may be particularly detrimental, as families are not chosen, and are 
often considered an important source of unconditional love and support. 
Stigmatisation by family may thus threaten a fundamental human need, namely 
the need to belong (Lekas et al., 2006).  
 
In South Africa, a large number of incidents of stigma have been reported. These 
include the murder of Guru Lamina in December 1998 for openly stating that she 
was HIV positive (Balata, 1999; Kortjaas & Msomo 1998; Nicodemus 1999; 
Rusnak 1998); the murder of Mpho Mtloung together with her mother by her 
husband, who then also committed suicide. The connection of stigma around HIV 
to historical racism and gender has developed a particular form of discrimination. 
Blame is often assigned to black people or to women. Men blame women for 
infecting them and spreading the virus (Leclerc-Madlala, 1997, 2002; Shefer, 
1999). In couples, this can lead to violence against the woman, or her exclusion 
from the household (Strebel, 1993). Many research studies have found a 
significant number of respondents who want people living with HIV (PLWH) to be 
clearly identifiable, to be separated from the rest of the population, or excluded 
from contact in schools, the workplace and the general community (Skinner and 
Mfecane, 2004). 
 
A judgmental discourse has distinguished sharply between those ‘innocents’ who 
contract HIV via organ or blood transfusions, the children of women with HIV, 
and women whose partners are unfaithful; and those who are considered guilty 
and almost ‘deserve it’ (Schellenberg, Keil & Bem, 1995). Religious groups may 
intentionally or inadvertently contribute to discrimination by making explicit or 
implicit judgments against those who are infected with HIV (Paterson, 1996). 
Attempts to label the epidemic as God’s punishment for sinners, especially gays, 
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prostitutes and drug users, have often been documented (Crawrod, Allison, 
Robinson, Hughes & Samaryk, 1992; Johnson, 1995).  
 
Communities are where most of the stigma plays out. The Health care workers 
also form part of the community, and as such, their stigmatising behavior can be 
read as signs and symptoms of the community at large. Sadly, even the religious 
fraternity, where people would normally hope for comfort and protection, are 
shown to be just as judgmental. 
 
 2.9 HIV/AIDS in Southern African. 
 
The global epidemic appears to have stabilized in most regions. The UNAIDS 
2009 Report states that of  22.4 million HIV positive individuals worldwide, sub-
Saharan Africa remains the most heavily affected region, accounting for 67 per 
cent of all HIV infections worldwide, 68% of new infections among adults and 
91% of new HIV infections among children . The sub-Saharan region also bore 
the brunt of the world’s AIDS-related deaths, at 72% of AIDS’ deaths worldwide 
(National Antenatal Sentinel HIV & Syphilis Prevalence Survey, 2009). 
South Africa has the highest number of people infected globally, estimated at 
around 5.3 million, including 220 000 children under the age of 15 years, in 2008 
(UNAIDS 2009). 
South Africa ranks in the top five highest HIV prevalence countries in the world, 
with 17.5% of the population estimated to be infected. The UNAIDS 2009 
Global Report Epidemic Update estimated that in 2008, 310 000 people died 
from AIDS in South Africa. South Africa is regarded as having the most severe 
HIV epidemic in the world. 
In South Africa, the National Antenatal Sentinel HIV & Syphilis Prevalence 
Survey, 2008 reveals that the estimated national HIV prevalence amongst 
women has remained stable over the past three years at around 29%. This 
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concurs with the projections by UNAIDS that the HIV epidemic curve is reaching 
a plateau. However, the UNAIDS Global Report on HIV, 2008 suggests that this 
plateau does not appear to be indicative of major behavior changes, but rather 
the natural progress of a long wave epidemic.(UNAIDS,2008)  
The burden is not felt evenly across the country. The results show that the 
highest HIV prevalence are recorded on the north-eastern side of the country, 
and the lowest prevalences in the western regions of South Africa. While the 
national average of HIV-positive women attending antenatal clinics in 2008 was 
29.3%, the province of KwaZulu-Natal continues to have the highest prevalence 
at 38.7%, followed by Mpumalanga at 35.5%. The lowest recorded prevalence of 
women attending antenatal clinics is in the Western Cape, at 16.1% (National 
Antenatal Sentinel HIV & Syphilis Prevalence Survey, 2008). 
2.10 HIV/AIDS in women. 
From June 2008 to March 2009, South Africa conducted the third in a series of 
national population-based surveys to assess HIV prevalence, incidence and HIV-
related knowledge and behaviour. A comparison of data from this survey with the 
data from the two previous surveys conducted in 2005 and 2002 shows a very 
sizeable increase in the proportion of respondents reporting access to HIV 
testing services in all provinces. Only 20% of respondents aged 15 years and 
older had ever done an HIV test in 2002, increasing to about 50% in testing 
uptake was reported by respondents in the recent survey in 2008. Progress is 
evident among both sexes, although it is more marked among women. In 2002, 
an equal proportion of female and male respondents (21%) reported ever having 
received an HIV test. In 2005, 33% of the women and 28% of the men had never 
had an HIV test, with the figures increasing further to 57% and 43%, respectively, 
by 2008. Between 2005 and 2008, the percentage of women and men who 
reported having received an HIV test and the test results in the 12 months 
preceding the survey increased nearly two-fold, from 13% to 29% among 
women, and from 10% to 20% among men (UNAIDS, 2007).The effects of the 
AIDS epidemic is reflected in the dramatic change in South Africa’s mortality 
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rates. The overall number of annual deaths increased sharply from 1997, when 
316,559 people died, to 2006 when 607,184 people died. This rise is not 
necessarily due solely to HIV and AIDS, but it is young adults, the age group 
most affected by AIDS, who are particularly shouldering the burden of the 
increasing mortality rate. In 2006, 41 percent of deaths were attributed to 25 to 
49 year olds, which had increased from 29 percent in 1997. This is a strong 
indicator that AIDS is a major, if not the principal factor in the overall rising 
number of deaths. (Shisana et al,2009) 
The South African Government launched a major HIV counselling and testing 
campaign (HCT) in 2010, by raising awareness of HIV Prevention of mother-to-
child transmission. The national transmission rate of HIV from mother-to-child is 
approximately 11%, because the virus is transmitted from the child's mother in 
cases of mother-to-child transmission; the HIV-infected child is born into a family 
where the virus may have already had a severe impact on health, income, 
productivity and the ability to care for each other (Chiu et al., 2008). 
An unacceptably high number of babies, around 70,000, are born with HIV every 
year, reflecting poor PMTCT uptake. HIV and AIDS is one of the main 
contributors to South Africa’s infant mortality rate which increased significantly 
between 1990 (44 deaths per 1000 infants) and 2008 (48 per 1000), when all 
other regions of the world saw decreases. The campaign aims to reduce the HIV 
incidence rate by 50 percent by June 2011 (NDoH, 2010). 
 
HIV prevalence among pregnant women in SA has increased from 1.7% in 1991 
to 30.2% in 2005. Early and routine identification of HIV-infected pregnant 
women facilitates access to ART, contributes to the postponement of orphan 
hood for children and results in decreased HIV transmission to children. Although 
counseling and voluntary HIV testing for pregnant women was introduced in SA 
in 2002, uptake is limited, and the majority of women attending antenatal care do 
not know their HIV status. If HIV diagnosis occurs during pregnancy, women 
need sufficient time, accurate information and support to enable them to explore 
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all options before making decisions. South African research has, however, shown 
that HIV positive women are more likely to experience adverse pregnancy 
outcomes, complications and mortality than HIV-negative women (Garenne et al., 
2001).   
 
HIV positive pregnant women were more likely to develop anaemia, pregnancy-
induced hypertension, have lowered maternal weight, double the risk of 
developing urinary tract infection, a five-fold increase in the rate of syphilis, a 
higher rate of abnormal vaginal discharge, slightly earlier delivery, and a 5% 
chance of in-utero growth retardation of the baby.(PMTCT Guidelines,2010)  
 
South Africa’s HIV prevalence is one of the highest in the world. Annual sentinel 
site HIV prevalence studies in antenatal clients have been ongoing since 1990, 
and reveal the explosive growth of the HIV epidemic from a prevalence of less 
than 1% among pregnant women in 1990, to 29% in 2004. In the country’s 9 
provinces at least 25% of pregnant women are now HIV positive, the highest 
number being in the KZN province. In 2005, the HIV prevalence in KZN among 
antenatal clinic attendees was estimated to be at 39.1 %. (NSP, 2007-2011), 
making KZN the province with the highest HIV prevalence amongst pregnant 
women. 
 
A high number of babies born to HIV positive women are likely to be infected 
(Muko et al., 2004). Every day, an estimated 1 800 children under 15 years of 
age become infected, and 1 400 children die from the disease, with the majority 
of these in sub-Saharan Africa. HIV infection in children is preventable. In Europe 
and the United States, MTCT rates have been reduced to fewer than 2%, and 
few HIV-infected babies are born in these countries (HST, 2006). 
 
UNICEF in its ‘Unite for Children, Unite against AIDS’ campaign of 2005 
estimated that 42% of deaths in children under 15 in 2004 were due to HIV. 
Pregnant women have a higher risk of acquiring HIV than non-pregnant women, 
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and the risk of transmission is increased in women with high viral loads, found 
primarily in patients with acute primary HIV infection (HST, 2006).  
 
The primary aim of the PMTCT programme is to decrease the number of HIV 
infected babies born to HIV positive mothers. Primary prevention remains 
paramamount in women of childbearing age. Optimal prevention of MTCT of HIV 
requires identification of the mother's HIV status during pregnancy.  Universal HIV 
testing of pregnant women is standard care in developed countries like the 
United States of America (Link and Phelan, 2000). Identification of HIV infection 
early in pregnancy allows the greatest ability to treat the pregnant woman for her 
HIV infection for her own health, and to prevent MTCT of HIV. Rapid HIV 
antibody testing allows for timely identification of HIV infection in women even 
late in pregnancy, during labour, or in the immediate postpartum period, as well 
as HIV exposure in their newborn infants. The results can be available quickly 
enough to implement successful ARV interventions that can reduce MTCT of HIV 
when administered to the mother during pregnancy, in labour, or to the infant 
when administered within the first few hours of life (Link and Phelan, 2000). 
 
In recent years, lack of identification of maternal HIV-infection status has been 
the primary reason for new infant HIV infections; effective interventions cannot be 
implemented unless maternal HIV status is known. Rapid HIV antibody testing 
methods now allow identification of HIV-infected women or HIV-exposed infants 
in 20 to 60 minutes (Piot, 2004). 
 
According to the 2005-2007 saving mothers report AIDS was the most common 
non obstetric cause of maternal deaths in. The increasing availability of 
antiretroviral therapy makes maternal deaths due to AIDS avoidable and it is not 
surprising there has been an increase of clearly avoidable deaths from 9.1% of 
the non-pregnancy related infections and 4.5% of the AIDS deaths in 2002-2004 
to 23.4% of non-pregnancy related infections and 17.6% of AIDS deaths...  
(Saving Mothers report, 2005-2007) 
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HIV testing during pregnancy allows identification of HIV infection in women who 
might not know they are infected. This is important for the health of the woman, 
because knowledge of her HIV-infection status will allow appropriate evaluation, 
including CD4+ T-lymphocyte count and HIV viral load quantification, initiation of 
comprehensive care, and appropriate ARV treatment. HIV antibody testing early 
in pregnancy has the added benefit of allowing the most effective interventions to 
prevent MTCT of HIV being initiated, including ARV prophylaxis, planning an 
appropriate mode of delivery (elective caesarean delivery or vaginal delivery, 
depending on maternal viral load near delivery), and avoidance of breastfeeding. 
HIV antibody testing later in pregnancy, or even after delivery of the newborn 
infant, still allows initiation of effective ARV interventions that can reduce the risk 
of MTCT of HIV (Garenne et al., 2001). 
 
 The Saving Children 2004 report which reviews the causes of and factors related 
to infant and under-5 child deaths in several sites across South Africa. One of the 
most striking findings of this report is that over 50% of all deaths are associated 
with HIV-related disease or AIDS. It can be assumed that almost all of these 
deaths resulted from mother-to-child transmission of HIV. 
 
Africa is a patriarchal country, with many rules and practices favoring men. 
Women don’t have a voice, and, as such, they bear the brunt of stigma. In most 
cases, they are seen as the people who bring HIV to the family by virtue of 
testing first, and thus are blamed for infecting their unborn children (Perez et al., 
2004). In testing, part of the support should be helping and supporting the 
women through the journey and facing the community, rather than once-off post-
test counseling. Traditional attitudes towards women in South Africa help fuel the 
stigma and stereotypes in which women are seen as subordinate to men, 
socially, psychologically and economically. This shapes the way in which the HIV 
positive women are seen by society (Bennette, 1990). In African societies, men’s’ 
needs are seen as paramount. This makes it difficult for women to negotiate 




2.11 Stigma and access to treatment 
 
Discrimination has a significant impact on diagnosis and treatment. For the 
individual, it can delay diagnosis and therefore also delay entry into treatment 
and adoption of a healthy lifestyle. There is no motivation to be tested, as the 
person sees no benefit when the diagnosis of HV is seen as equivalent to death 
and they are likely to experience discrimination (Abdool Karim, Tarantola, Sy & 
Moodie, 1992). 
 
In certain contexts, research respondents have been shown to be more fearful of 
the stigma than of the disease itself, so even with treatment, stigma may be a 
block to access (Lie & Basal, 1994). This has already been shown to be a 
problem in the case of PMTCT, where women have expressed fear of being 
tested (Grange, Story & Zumla, 2001). In the same way, the use of formula 
feeding rather than breastfeeding can become a problem. Many women feel 
restricted from being able to breastfeed for fear of family observation and 
questions. Stigma and discrimination by health workers compromises their 
provision of quality care, which is critical for helping patients adhere to 
medication, and to maintain their overall health and wellbeing. Stigma also acts 
as a barrier to accessing services, both for the general population, and the health 
providers themselves. This can have serious implications for health workers and 
health facilities when HIV-infected health workers delay or avoid care and 
become seriously ill or die, causing further strain on an overburdened health care 
system. Secondly, there is insufficient capacity among health care managers 
regarding how to effectively address stigma and discrimination through 
programmes and policies (Uys et al.,2009). 
 
Even for those who are aware of their status, discrimination can limit access to 
care and treatment (Grange, Story & Zumla, 2001; Rehm & Franck, 2000). Many 
are not able to acknowledge, even to their families, that they are infected, and so 
are denied that level of care.  
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 2.12 Coping with HIV Stigma 
 
Stigma impacts on the PLWH themselves, as it is internalised into their self-
perception and sense of identity, impacting on their perceptions and how they 
interact in the world. Research has found that people with HIV feel isolated, 
guilty, dirty and full of shame which is then often incorporated into their identity 
(Kalichman, 2004). 
 
Stigma often heightens existing prejudices and inequalities. HIV-related stigma 
tends to be most debilitating for people who are already socially marginalised, 
and who are closely associated with HIV and AIDS, such as sex workers, men 
who have sex with men, injecting drug users, and prisoners (Nyblade et al., 
2009). Conversely, other studies have shown that women are particularly 
vulnerable to stigma, including violence, one of the harshest and most damaging 
forms of stigma. 
A major concern in relation to a stigmatised disease is that the social marks of 
inferiority or blemish may lead patients and their caretakers to conceal their 
disease. This has serious consequences for both the health of the individual and 
the containment of infectious diseases for the population. It was mentioned 
earlier that bearers of stigmatised diseases are seen as a great danger to the 
community, because of the assumptions that they have somehow violated the 
moral taboos, especially those on sexuality. This leads to feelings of guilt and 
shame. Obviously then, diseases that directly relate to sexually taboo behaviour 
bring questions of guilt and shame much closer to the surface (Veena, 2008). 
However, it is not only individuals who are targeted as the bearers of stigma and 
blame in the case of sexually transmitted diseases, there is also a political 
geography of blame that comes to arrange the world in terms of “guilt” and 
“innocence”. The case of sexually transmitted diseases such as syphilis and 
AIDS provides telling examples of the way in which stigma of various kinds 
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comes to be configured together in informing the public discourse on stigmatised 
diseases, (Veena, 2008) and behavior that symbolically marks the bearer as 
“culturally unacceptable” or inferior, with the consequent feelings of shame, guilt 
and disgrace. 
 
It has been said that the decision to carry out an alternative feeding method 
could not be taken by the women alone. The involvement and support of the 
husbands was regarded as essential for women who chose to carry out an 
alternative feeding strategy, and the reactions of the local community were 
perceived to be a substantial obstacle. Neighbours and close relatives will start 
questioning why you are not breastfeeding your child. You will lose your hope 
and become very skinny because of lack of support and worry about your child 
(De Paoli, Manongi and Klepp, 2004). In Tanzania, the medical 
recommendations for the prevention of mother-to-child transmission (PMTCT) of 
HIV made by the PMTCT programmes are often difficult for women to implement 
because of community norms, values and beliefs. For example, taking 
medication during pregnancy, and using a breast milk substitute or exclusively 
breastfeeding and then weaning early are not normative practices for women. 
Many women are uncertain of the effect of these recommendations on their 
pregnancy and infant. Moreover, women may face stigma and other social costs 
if they follow providers’ PMTCT recommendations (Baeketal, 2007). Increased 
rates of disclosure may, in turn, facilitate other positive behaviours around HIV 
and AIDS such as adherence to ARV prophylaxis and treatment, and an 
exclusive method of infant feeding.  
 
2.13 Mechanism to Reduce HIV/AIDS in South Africa 
According to statistics obtained from the Ministry of Health’s statement, and the 
HST report, more than 90% of government clinics (3382 out of 3663) are 
currently providing PMTCT services. Of the approximately 800,000 public sector 
births in South Africa in 2006, about 580,880 pregnant women were offered 
PMTCT services. From the antenatal survey, we can estimate that about 168,000 
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(i.e. 29%) were HIV-positive in 2006. Yet only 74,052 women received nevirapine 
prophylaxis i.e. less than half the eligible women. Of this amount, the sub-set of 
babies who were tested for HIV was just 19,758. About 18% tested positive. 
This means that, of the approximately 800,000 public sector births, we know the 
HIV status of less than 3% of the infants. And of these, the results are poor – far 
above the 5% transmission rate target (NDoH, 2007). 
The 19th National Antenatal Women HIV and Syphilis Sero-prevalence Survey 
has provided further evidence that the national HIV prevalence in South Africa is 
stabilising at around 29% since 2006. 
 
This is a trend observed in many countries with generalised epidemics. The 
results of this survey show that the HIV prevalence among women in the age 
group 15 to 19 years has increased from 13.1% in 2007, to 14.0% in 2008 (Table 
3). The HIV prevalence estimate in the 20 to 24 year age group, the target age 
group for the MDG 6, stands at 28.0% in 2006 and 2007 compared to 26.9% in 
2008. The HIV prevalence in the older age groups (30 to 34, 35 to 39; and above 
40 years) remains high (above 30%) with a slight decrease from 20.6% in 2007, 
to 17.6 % in 2008 for the 45 to 49 year olds. 
 
At the end of 2000, a decision was made by the National Department of Health of 
South Africa to implement a pilot programme for the prevention of mother-to-child 
HIV transmission (PMTCT). A total of 18 pilot sites, 2 in each of the 9 provinces, 
were purposively selected to include an equal representation of urban and rural 
sites, as well as a mix of primary and secondary level facilities. These were to 
serve as research and learning sites to assess the feasibility of, and 
requirements for implementing PMTCT services more widely. The package of 
care for the pilot programme included offering all antenatal clients voluntary 
counselling and testing (VCT) and a dose of Nevirapine to those women 
identified as HIV infected, and their infants. The efficacy of single-dose 
Nevirapine in PMTCT of HIV in the HIVNET012 trial was 11.9 %. This means that 
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a vertical transmission rate of 12% was expected with the single dose 
Nevirapine. As part of the programme, free formula milk was provided for a 
period of 6 months for women choosing not to breastfeed. The programme also 
stipulated that all infants should be followed-up and tested for HIV with a rapid 
antibody test at 12 months. There has been progress in increasing the uptake of 
Mother-to-Child Transmission Prevention (MTCTP) services, and in providing 
dual ARV therapy to infants, which is more effective than the single dose 
Nevirapine at first grudgingly provided by the government. There is also 
recognition of the need to focus on saving mothers’ lives and parents’ lives, not 
just babies’ lives. The need for HIV to be integrated into health services, and for 
TB and HIV to be addressed in tandem has also been acknowledged. 
 
The South African PMTCT programme offers testing and counseling services, 
single dose nevirapine (sdNVP) to mother and baby, and free formula milk 
(Pelargon®) for six months. 
 
The plan was to pilot the programme to explore the side-effects as well as the 
operational requirements. A total of 18 pilot facilities were selected to serve as 
research and learning sites to assess the feasibility of, and requirements for 
implementing the PMTCT services more widely (NDoH, 2008).  
 
In 2008, the PMTCT guidelines were updated to add Zidovudine (AZT) 
prescribed from 28 weeks pregnancy, and during labour 300mg 3 hourly. In 
addition, the Infant was also to be given AZT syrup for seven days of 28 days 
depending on the mothers’ duration on AZT (NDoH, 2008). Furthermore, infants 
were to undergo a PCR test at six weeks. 
More recently, the SA government’s response to the HIV and AIDS epidemic 
made a commitment to an ambitious, but achievable National Strategic (NSP). 
The NSP identifies four priority areas: (Two of the areas related to the PMTCT 
are mentioned below) 
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Priority Area 1: Primary Prevention 
Target: reduce the national HIV incidence rate by 50% by 2011. 
Priority Area 2: Treatment Care & Support 
Target: provide an appropriate package of treatment, care and support services 
to 80% of the people living with HIV and their families by 2011 (NSP, 2007). 
Several studies conducted in sub-Saharan Africa have shown that despite the 
availability of the PMTCT, vertical transmission remains high (NSP, 2007-2011). 
An evaluation of the PMTC programme conducted in 18 sites in the year 2002 in 
South Africa indicated that 18% of the infants born to HIV positive mothers tested 
positive. This is further confirmed by NSP (2007-2011). In 2006, an estimated 38 
000 children acquired HIV infection around the time of birth, and an additional 26 
000 children were infected through breastfeeding. The results of another study 
done in Kwazulu-Natal whereby dry blood spot testing was used at immunisation 
clinics to test the prevalence of HIV, revealed that, despite the availability of the 
PMTCT programme, the transmission rate was estimated at 20.8 % (Rollins et 
al., 2006).  
 
The main reasons for this appear to be pervasive stigma and discrimination, and 
the inability of current health services to ensure the uptake of prescribed 
medications (NVP). In 2006, it is estimated that only 14.6% of pregnant women 
received prophylaxis to reduce MTCT. Many pregnant women do not take up 
voluntary counseling and testing (VCT). PMTCT data from the 53 health districts 
in SA for 2004 indicated that a relatively low proportion of mothers were actually 
tested for HIV, resulting in many deliveries of women of unknown HIV serostatus, 
and missed opportunities to prevent MTCT. 
 
A couple of studies have been done to indentify factors that prevent PLWHA from 
participating in the HIV and AIDS programmes, and in particular, pregnant 
women from partaking in the PMTCT programme. Many countries reported low 
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uptake of HIV testing. The most important barrier to using the services was found 
to be the fear of stigma and discrimination among HIV positive pregnant women 
(Nguyen et al., 2008). 
 
HIV infected mothers are faced with coping, both with the physical demands of 
their illness and child care, and with the emotional burden of decision-making 
about the disclosure of their HIV status, custody, fertility options, the use of 
health care services, and the use of ART. This may be compounded by 
additional problems, such as the death or illness of a spouse, worries about a 
child’s future, about their own death, about establishing and maintaining the 
mother-child relationship and grieving over the death of HIV-positive children. 
Motherhood may be characterised by feelings of guilt, especially if a child is 
infected. There is also the burden that children (if uninfected) are likely to be 
orphaned before adulthood. NDoH, 2008). 
 
2.14 Stigma and PMTCT Programme 
 
The PMTCT is part of the preventive measures available to HIV positive women 
to reduce vertical infection, stigma and to prevent mother-to-child transmission. 
Pregnant women may avoid participating in PMTCT programmes because of the 
fear of stigma, discrimination and violence, particularly from partners when 
disclosing their HIV status (Eide et al., 2008; Vagra et al., 2006). Numerous 
studies have demonstrated that going against community norms of feeding leads 
to questions about mothers’ HIV status, unwanted disclosure, and the fear of 
stigma from partner, family and the community (Thairu et al., 2005). Interventions 
aimed at engaging male partners in PMTCT services, such as sending an 
invitation home with the partner with a direct request that the man attend the 
clinic with his partner to receive HIV testing or couples counseling, have been 
tried with varying success . Community-level education about specific PMTCT 
services, targeting pregnant women, community leaders and people of 
childbearing age is critical to improving the acceptability of services and 




2.14.1. Disclosure through PMTCT Guidelines 
 
Programme guidelines disclose the HIV status of women, e.g. infant formula 
distribution at clinics was identified as a barrier to the PMTCT programme. 
Rejecters mentioned that they were discouraged by bad remarks about formula 
feeding which they heard from other women. These remarks occurred when a 
mother, who was seen going into the nurses’ room empty-handed, returned with 
many cans of formula and people concluded that she was HIV-positive. This 
finding is consistent with other studies which show that where breast-feeding is 
universally accepted and stigma is high, formula distribution and feeding may be 
perceived as a way of revealing one’s HIV status to family (Nyblade et al., 2009). 
 
The most commonly recommended infant feeding options for HIV-positive 
women in South Africa (SA) are replacement feeding with commercial infant 
formula provided free through public health services. Approaches to reducing or 
preventing the risk of postnatal transmission through breastfeeding include the 
avoidance of all breastfeeding through the use of exclusive replacement feeds, or 
exclusive breastfeeding for a limited duration with early and rapid cessation of 
breastfeeding around 4-6 months of age, or exclusive breastfeeding with early 
cessation (SAHR, 2006). A study in SA found that infants who received both 
breast milk and other feeds were significantly more likely to be infected by 15 
months of age, (36%). Twenty women, (80%) who had chosen exclusive 
breastfeeding had introduced other liquids within the first month because of 
pressures placed on them by family. The experiences of individual mothers were 
echoed by the community health workers who confirmed the authority that family 
members have over infant feeding practices. The influence of family members 
may be related to the extremely vulnerable situation of these women. Thirty, 
(75%) of them lived with their mothers, mothers-in-law or grandmothers. These 
participants were financially dependent on family members since partners or 
fathers of their children were largely absent (Doherty et al., 2006).  
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Early identification of HIV-infected children is vital for a child’s entry into 
comprehensive care and to monitor the efficacy of the PMTCT programme. HIV 
Deoxyribonucleic acid (DNA) PCR testing was introduced in 2004 for early 
diagnosis of infants from 6 weeks of age. In January 2006, approximately 5 500 
PCR tests were performed nationally, equating to 22% of the total capacity 
required. Cotrimoxazole (CTZ) prophylaxis for the prevention of pneumocysitis 
jirovecii pneumonia (PCP) and other commonly acquired infections reduces 
mortality in HIV-infected children by as much as 43%. 71 PCP has a peak 
incidence in children between 3 and 6 months of age, carrying a very high 
mortality. SA follows WHO guidelines in advising CTZ prophylaxis from 4-6 
weeks of age for all HIV-exposed infants, continuing with those with a definitive 
diagnosis of HIV until such time as a demonstrated CD4 response has occurred 
on ART (NDoH, 2008).  
 
Disclosure to children is probably one of the most difficult tasks faced by HIV-
infected women and requires considerable courage, preparation and time. 
Women throughout the world are faced with the complexity of HIV disclosure to 
their children. (Greenberg,1999). 
 
According to Greenberg, (1999) common negative factors related to disclosure to 
children include the fear of the emotional burden; the fear that the child will 
experience rejection, changes in children’s behavior, as well as uncertainty as to 
when, how and what to say to children. Other considerations include: protecting 
the child from the fear of death, worrying about the ability of the child to be 
discreet, and the fear of public disclosure of the family condition, children’s 
reactions and (potential) questions about survival and disease transmission, and 
the impact of disclosure on the health of the child. Adults (caregivers and health 
care providers) tend to disregard or ignore children’s capacity to understand. 
They fear that children may be sad, rebellious, angry or depressed after 
disclosure. For these reasons, mothers may delay disclosing their HIV status to 
their children, and some may decide never to disclose (Makhokha, 2000). 
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Muyinda et al. (1997) noted that, for communities as a whole, or for those 
responsible for structuring interventions, blaming infected people can be a 
substitute for tackling the problem itself. So, even when interventions are 
developed from this basis, they are constructed in such a way as to discriminate 
against those in affected groups, and to reinforce a false sense of safety in the 
majority of the population. 
 
Discrimination has significant impacts on diagnosis and treatment. For the 
individual it can delay diagnosis, and can therefore also delay entry into 
treatment and the adoption of a healthy lifestyle. In certain contexts, research 
respondents have been shown to be more fearful of the stigma than of the 
disease itself, so even with treatment, stigma may be a block to 
access.(Kebaatswe,2007) 
 
Other researchers have also reported low levels of disclosure in mothers 
diagnosed with HIV during antenatal care. This lack of disclosure makes 
adherence to drug regimens or infant-feeding guidelines difficult. For example, 
even in a well-resourced setting such as Botswana, only 40% of HIV-positive 
women who started a short course of Zidovodine completed their treatment. In 
Zambia, more than a quarter of women (26%) were not adherent to the even 
simpler single-dose nevirapine regimen (Doherty et al., 2006). The phrase 
‘prevention of mother-to-child transmission’ is most commonly used to refer to 
programmes whose goal is to prevent HIV infection among unborn children and 
newborns (and children under two who may be breastfed) during pregnancy, 
childbirth or breastfeeding. This terminology can imply that pregnant women, or 
new mothers living with HIV are solely responsible for the transmission to their 
newborn infants (Thorsen, Sundby and Martinson, 2008). Alternative phrases 
that the PMTCT program could consider using as references are: prevention of 
‘parent-to-child transmission’ or ‘perinatal transmission’, as considered by 
UNAIDSs. As the HIV and AIDS pandemic continues to evolve, much has been 
documented of the social, as well as the bio-medical impact that it has on 
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individuals, their families and their communities. HIV and AIDS-related stigma, 
and its associated discrimination, is known to negatively affect all aspects of HIV 
prevention, diagnosis, treatment and care (Bond et al., 2002). HIV related stigma 
has been problematic for people living with HIV since the beginning of the 
epidemic, and has been associated with several health outcomes including HIV 
testing and health care seeking behaviours, psychosocial functioning, and sexual 
risk behaviours. Studies have documented that the stigma and the shame 
associated with HIV represents a significant barrier to screening for the disease 
(Dowshen, 2008). Reports of stigma are pervasive, extending even to the health 
professions.  
 
It is evident that disclosure is still very difficult for most PLWHA, because of the 
fear of being stigmatised (UNAIDS, 2002). Despite efforts to provide greater 
access to HIV specific services, a number of issues continue to adversely affect 
those infected with HIV. This is common, even in communities with specialised 
services. People decide not to access social and medical care as this will reveal 
their HIV status and, in this way, they will expose themselves to being 
stigmatised (Kegeles et al., 1989). There is a high degree of denial and secrecy 
around HIV/AIDS. People try to search for any possible cause to explain the high 
morbidity and mortality, looking for supernatural causes. Stigmatisation results in 
silence, secrecy and denial. This has serious implications for the prevention of 
HIV with such a long subclinical phase causing people not to want to be tested 
and this leads to personal denial. (Duffy, 2001).  
2.16 Stigma in the health care setting 
At least 70% of the caseload in the public health system is taken up by HIV 
and AIDS cases, many relating to increasingly drug-resistant TB. (Skinner and 
Mfecane, 2004).   
Health care workers have been overwhelmed by the impact of the epidemic on 
the public health service, with the majority of resources in many facilities going 
to treat people presenting with opportunistic infections or dying from AIDS-
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related illnesses (Blackstock, 2005).This has resulted in overcrowding of 
under-resourced hospitals, meaning that patients cannot receive adequate 
care, and health professionals are working under very difficult conditions. Many 
health workers are living with untreated HIV and AIDS and bear the brunt of 
complaints about the health system. The working conditions are made worse 
by the lack of specialised training and staff shortages. In KZN, the worst 
affected province, 37% of the health posts in the province were vacant in early 
2005 – and some hospitals did not have pharmacists (NDoH, 2006). 
One research study (Centre for International Health, CIC, 2005) found the 
attrition rate among nurses in the public sector to be more than 9% in 2004. In 
that study, the burden of work, excessive patient loads, poor working 
conditions and stress/depression from dealing with increased HIV-related 
morbidity and mortality were among the reasons that nurses gave for 
resigning. 
In their research into the prevalence of HIV infection among health care 
workers at two Johannesburg hospitals in 2005, the Centre for International 
Health (CIC) found that 11.5% of hospital employees were HIV-positive. Of 
these, at least 19% should have been on ART already, since they had a CD4 
count of less than 200 (CIC, 2005). 
While many health workers have responded to the crisis by leaving the country to 
work in better-resourced clinics and hospitals overseas, many others have joined 
the lobby for access to treatment as part of a wider campaign to build the public 
health service (Dlamini et al., 2009). 
There are many ways in which HIV-related stigma manifests in health care 
settings. A study in Tanzania documented a wide range of discriminatory and 
stigmatizing practices, and categorized them broadly into neglect, differential 
treatment, denial of care, testing, and disclosing of HIV status without consent, 
and verbal abuse/gossip (Reynaut, 2003). Similarly, a study in Ethiopia found 
that common forms of stigma in health facilities took the form of designating 
 57
patients as HIV positive on charts or in wards, gossiping about patients' status, 
verbally harassing patients, avoiding and isolating HIV-positive patients, and 
referring patients for HIV testing without counseling.   
Health workers also stigmatise their peers. In Zambia, health workers report 
knowing peers who are hiding their own HIV status, are afraid to talk about their 
situation to others, and are suffering in silence. One indication of health workers' 
fears around HIV testing is their interest in self-testing. A national study of health 
providers in Kenya found that nearly three-quarters of them would be interested 
in testing themselves for HIV if such an option existed. Interest was greatest 
among those who had never tested, among medical doctors, and among health 
providers from the province with the highest prevalence of HIV in the country. 
The main reasons given for their interest are that self-testing eliminates a 
potential breach in confidentiality, and pre-empts stigma and suspicion from 
colleagues, since they would not know that someone had tested for HIV (Makin 
et al., 2007). 
While health workers living with HIV may face the same kinds of stigma as their 
patients because of perceived improper or immoral behaviours, their self-blame 
and shame may be compounded by their relatively higher social and educational 
status in the community. As noted by one hospital manager in a Zambian study, 
"In the end it was us that were stigmatising ourselves. I feel people that are more 
educated, like nurses, find it most difficult to discuss and disclose their status 
(Perez et al., 2004). 
Health providers interviewed in another study in Zambia reported that medical 
personnel who become infected with HIV are commonly seen as failures in the 
community. Nurses in Thailand expressed concern that their professional status 
would not give them the benefit of the doubt from their colleagues regarding 
whether they acquired their infection occupationally, or through sex or drugs. For 
them, women with HIV violate gender norms and thus are guilty of being 
promiscuous. This suggests that health providers fear a loss of status and moral 
integrity if their peers find out they are HIV positive.  
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With regard to moral judgements, studies have demonstrated that the 
assumption that people with HIV have conducted themselves in some improper 
or immoral way contributes to health workers' negative attitudes toward HIV-
positive people, and permeates client-provider interactions Researchers in 
Botswana and Jamaica found that stigma leads many people to seek testing and 
treatment services late in the progression of their disease, often beyond the 
stage of optimal drug intervention (Kebaabetswe, 2007).  
 
Although stigma is a pervasive and daunting problem in the health care setting, 
much can be done to address its causes and consequences. A key lesson that 
has emerged from recent research and field experiences is that to combat stigma 
in the health care setting, interventions must focus on the individual, 
environmental and policy levels, raising awareness about stigma, and allowing 
for critical reflection on the negative consequences of stigma for patients, such 
as reduced quality of care and patients' unwillingness to disclose their HIV status 
and to adhere to treatment regimens, can be considered important first steps in 
any stigma-reduction programme (Vidanapathirana, 2009). 
 
A better understanding of what stigma is, how it manifests, and what the negative 
consequences are can help reduce stigma and discrimination and improve 
patient-provider interactions. In the physical environment, programmes need to 
ensure that health workers have the information, supplies and equipment 
necessary to practice universal precautions and prevent occupational 
transmission of HIV. This includes the use of gloves for invasive procedures, 
sharps containers, adequate water and soap or disinfectant for hand washing, 
and post-exposure prophylaxis in case of work-related, potential exposure to 
HIV. Posting relevant policies, hand washing procedures or other critical 
information in key areas in the health care setting enables health workers to 
maintain a better quality of patient care (Vidanapathirana, 2009). 
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The lack of specific policies or clear guidance related to the care of patients with 
HIV reinforces discriminatory behaviour among health workers. Health facilities 
need to enact policies that protect the safety and health of patients, as well as 
health workers to prevent discrimination against people living with HIV. Such 
policies are most successful when developed in a participatory manner, clearly 
communicated to staff, and routinely monitored (Nyblade et al., 2009). 
 
Three types of stigma were identified from the data: received, internal and 
associated. The stigma process can be triggered or activated by a variety of 
factors, such as an HIV diagnosis or disclosure of HIV status. A trigger is any 
action that allows people to label themselves or others as HIV-positive. In the 
view of many authors, the trigger includes an element of “a marker of difference” 
(Royal Tropical Institute, 2004). Received stigma can be triggered by, for 
example, disclosure. Continued association with a person(s) who is either 
suspected of being HIV-positive or having AIDS, or is definitely infected can 
trigger associated stigma. Internal stigma can be triggered by the suspicion of 
being infected, or the confirmation of an HIV-positive diagnosis. This duality (fact 
or suspicion) also activates received and associated stigma. Many persons living 
with and affected by HIV and AIDS indicate that the suspicion of being HIV-
positive is enough to trigger stigma towards a person living with HIV and AIDS, 
as experienced or described by themselves or others (Weiss et al., 1992). Sub-
categories of received stigma include neglecting, fearing contagion, avoiding, 
rejecting, labelling, pestering, negating, abusing and gossiping. Internal stigma  
comprises thoughts and behaviours stemming from the person’s own negative 
perceptions about themselves based on their HIV status (Stein, 2003). 
 
 Sub-categories of internal stigma include perception of self, social withdrawal, 
self-exclusion and fear of disclosure. Associated stigma involves examples of 
stigma that result from a person’s association with someone living with, working 
with, or otherwise associated with people living with HIV and AIDS. This can 
include, for example, having a family member who is HIV-positive, or working 
with people who are HIV-positive (Holzemer et al., 2006). 
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However, the current national guidelines clearly reflect a western country’s 
context. Paradoxically, local cultural dynamics have major implications for the 
initiation of risk behaviours, such as drug use and sexual activities, leading to 
HIV transmission. Cultural factors also closely interlink with the process of the 
stigmatisation of people living with HIV and those practicing risk behaviours. 
Almost all HIV and AIDS-related interventions in Nepal are funded by donor 
countries, bilateral agencies and the United Nations (Chandra and Madison, 
2009).  
To be able to enroll in the programme, pregnant women have to submit to 
Voluntary Testing and Counseling (VCT). Skinner and Mfecane (2004) suggest 
that stigma introduces a desire not to know one’s HIV status, thus delaying the 
testing and accessing of care. This can be quite dangerous in the case of the 
PMTCT as it may result in vertical transmission. 
 
Nurses have been cited as also perpetuating the HIV and AIDS stigma. This may 
be due to their fear for personal safety, as with exposure to HIV positive patients 
they may fear infection. Personal prejudices may play a role as well as a lack of 
knowledge (France, 2001, as cited by Poku et al., 2005). The nurses and other 
health workers dealing with HIV positive people are also targets of stigma. There 
is some literature available which can be used for the health workers to mitigate 
stigma and to deal with their own prejudice. Abdool (2004) indicated that it is 
important to study the role of the health workers in HIV stigma, as they may be 
the people who are likely to help combat stigma. In addition, some of the 
recommendations of the PMTCT may inadvertently disclose the women’s status; 
many people know that breast feeding is not recommended in HIV positive 
women, so failure to breastfeed in to the community may mean that the women 
are HIV positive (Muko, Tchangwe et al., 2004). 
 
Stigma is common in HIV and AIDS, and this calls for the health workers to 
combat this stigma, as the confidentiality surrounding the disease may simply be 
informing the communities that HIV is something to be feared and hidden (Boyer 
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et al., 1997). In the case of the PMTCT, perhaps some of these 
recommendations to help the mothers could be reviewed, so that the mothers are 
not so easily exposed to stigma. Stigma and discrimination by health workers 
compromises their provision of quality care which is critical in helping patients 
adhere to medication and maintain their overall health and wellbeing. Stigma also 
acts as a barrier to accessing services, both for the general population, as well 
as the health providers themselves (Andrewen and Chien, 2007).  
 
There are many ways in which HIV-related stigma manifests in health care 
settings. In Indian hospitals, stigma and discrimination manifested itself in the 
form of health workers informing family members of a patient's HIV status without 
his or her consent, and doing the following only with HIV-positive patients: 
burning their bedding upon discharge, charging them for the cost of infection 
control supplies, and using gloves during all interactions, regardless of whether 
physical contact occurred (Behet et al., 2006). 
 
Wright (2000) advocates that stigma and discrimination in the health care setting 
and elsewhere contributes to keeping people, including health providers from 
adopting HIV preventive behaviours and accessing needed care and treatment. 
Fear of being identified as someone infected with HIV increases the likelihood 
that people will avoid testing for HIV, and will avoid disclosing their HIV status to 
health care providers and family members. Both experienced and perceived 
stigma and discrimination are associated with reduced utilisation of prevention 
services, including programmes to prevent mother-to-child transmission or 
seeking treatment and care, thus compromising the health and wellbeing of those 
infected (Andrewen and Chien, 2008). 
 
2.17 Strategies to prevent stigma 
 
Stigma penetrates deeply, impacting on multiple aspects of the lives of people 
living with HIV/AIDS, and more broadly on members of society, creating 
disruptions in social functioning, and increasing people's vulnerability to infection 
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and reducing the overall caring capacity of communities. Stigma has had 
particular implications for South Africa (SA) given our history of racism and other 
stigmatising beliefs (Skinner and Mfecane, 2005). Goffman (1963) defined stigma 
as a deeply discrediting attribute that reduces a person to someone who is in 
some way tainted and can therefore be denigrated.  
 
Some strategies have been introduced in South Africa with the aim of dealing 
with HIV and AIDS stigma, such as living positively, which aims to challenge the 
expectation that HIV necessarily leads to rapid death, an assumption which 
contributes to fear and stigmatisation. Stigma reduction is also a first step in 
creating services to address the needs of HIV-positive health workers. The 
availability of tested stigma-reduction tools and approaches has moved the field 
forward. What is needed is the political will and resources to support and up-
scale stigma reduction activities throughout health care settings globally. Given 
the detrimental effect of stigma on both individual health and wellbeing and public 
health outcomes, it is clear that health care managers cannot afford inaction any 
longer (Nyblade et al., 2009). 
With its potentially devastating consequences on care-seeking behaviour, stigma 
represents a major "cost" for both individuals and public health. Both experienced 
and perceived stigma and discrimination are associated with reduced utilisation 
of prevention services, including programmes to prevent mother-to-child 
transmission, HIV testing and counselling, and accessing care and treatment. In 
addition, research has demonstrated that the experience or fear of stigma often 
results in postponing or rejecting care, seeking care far from home to protect 
confidentiality, and non-adherence to medication. It is important to include stigma 
prevention education as part of clinical training on HIV/AIDS, as fear of stigma 
may hinder the preventive and management effort of the disease. This means 
the HCW should be competent in the management of the clinical side of 
HIV/AIDS and the stigma attached. 
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2.18 Coping with Stigma 
 
Siegel (1998) described strategies of coping with stigma among gay/bisexual 
men. They described a variety of strategies that could be arranged in a 
continuum from reactive to proactive, based on the extent to which the person 
implicitly accepted or challenged the social norms underlying the stigmatization 
of HIV. Reactive strategies were used by respondents to avoid being discredited 
through hiding their HIV status and controlling information about HIV within their 
close social networks. Proactive strategies were used to construct and promote 
alternative views of HIV that undermined societal stigma. The most proactive 
responses addressed the meanings, values, beliefs, practices, and power 
imbalances behind the stigma, rather than situations in which stigma might be 
experienced. Moneyham et al. (1998) noted that avoidance was used as a 
coping strategy in the early stages of the disease when symptoms were fewer, 
while the onset of disease-related symptoms evoked the use of active coping 
strategies. 
 
Rationalization is one of the emotional coping strategies used by PLWHA. This 
was identified by Mokoae et al. (2008) in a study done in five African countries. 
This refers to utilizing the cognitive processes to make the stigma less painful. 
This is done by focusing on positive thinking, and having alternative explanations 
for the illness (Mokoae et al., 2008). In some cases, problem-based coping 
methods are employed, such as joining a support group. This befits the PLWA by 




HIV/AIDS related stigma is the greatest obstacle to action against the epidemic 
for individuals and communities including religious leaders and government 
(UNAIDS, 2002). HIV stigma is a mental and social reaction related to many 
factors including culture and personal and social fears, denial and misconception 
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and myths about the epidemic. Ultimately, the women bear the brunt of HIV 
stigma, especially at a community level. 
 
Strategies such as education and legislation to combat stigma are vital, but these 
need to be accompanied by community mobilization (Duffy, 2005). HCW can play 
a vital role in linking communities and legislators to enhance understanding of the 
contextual issues in people’s lives in relation to HIV/AIDS stigma, and thus to 






3. RESEARCH METHODOLOGY 
 
3.1 Study approach and design 
 
The study utilized a qualitative approach. Qualitative approach enabled the 
researcher to study the phenomenon under study in depth and detail, producing 
a wealth of information about a much smaller number of people (Patton, 1990). 
To be able to extract the richness of the human experiences of this group, the 
study utilized   Heidegger’s phenomenological research approach. 
 
The primary aim of the study is to explore the lived experiences by women 
enrolled in the PMTCT programme in the eThekwini PHC facilities in the 
Ethekwini District KZN, South Africa. This was done by describing how 
individuals make sense and give meaning to the stigma experiences due to their 
HIV diagnosis. The Heidegger phenomenological approach was chosen to guide 
the study, as this approach emphasizes the lived experiences as a source of 
knowledge and also because this methodology allows for analysis and for 
presentation of these experiences in a systematic and rigorous manner. 
Phenomenology emphasis the world as lived by a person and not world and 
reality being separate from a person. (Van Manen, 1990) Phenomenology is an 
essential study with a purpose to understand the phenomenon from the 
participant’s point of view. Phenomenology is the study of experience or 
consciousness. Phenomenology has been described by psychologists as 
subjective point of view or as the world seen in the eyes of that individual’s 





3.3 Study approach 
 
Phenomenology is concerned with studying the lived experiences and description 
of phenomenon presented into the conscious mind. Even though Edmund 
Husserl (1859-1938) is regarded as the founder of phenomenology, there are two 
schools of phenomenology, as described in Polit and Beck (2008: 228). These 
are descriptive (Husserl, 1962) and interpretive (Heidegger, 1962) 
phenomenology. Both Husserl and Heidegger argue that phenomenology is an 
approach to exploring and understanding people’s everyday life experiences 
(Polit & Beck , 2008: 227). By phenomenology Husserl (1913, 1962) meant the 
study of how people describe things and experience them through their senses 
(Patton, 1990: 69) Husserl rejects the notion that perception is a result of stimuli 
imposed from outside. The idea of phenomenology is that individual’s reality is as 
the individual sees it. Husserl developed this phenomenon of the response to the 
dominant positivism scientific approach dominant at the time. He argued that 
scientific investigations failed to include lived experiences in subjective form and 
resulted in one sided forms of understanding (Held, 2003) As a result Hussel 
designed a preprositionless science based on the conviction that if we refrained 
from accepting preconceived ideas and existing theories, we could attend to and 
describe phenomenon as they present to awareness (Giorgi and Giorg, 2003) 
Heidegger, a former assistant to Hussel disagreed with the notion that 
phenomenology is a preposition less science. He believed that social, personal 
and personal experiences form part of humans report and understand the world. 
He felt that the presuppositions need to be incorporated rather than set aside. 
(Polkinghorne, 1983) Heidegger’s hermeneutic approach opened other ways of 
conceptualizing and extending and describing lived experiences. In the recent 
years Spielberg (1982) describes phenomenology as a movement rather than a 
discreet period time. This means that the view of is not static but ever evolving 
(Laverty, 2003). This witnessed by the fact that ideas vary between philosophers 
and within philosophers. 
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Even though at a glance the approaches may look different each a based on the 
premise that the starting point of investigating a phenomenon should be 
everyday lived experiences. (Patton, 2002) Phenomenology approach explores 
lived experiences by describing the meant features of an object, the qualities of 
an act as well as the correlation between them. (Steinbock, 2001) Hesserl’s 
approach confirms that phenomenology is descriptive and not explanatory 
(Welton, 2003) One of the implications of phenomenological studies is that it 
focuses on what the people experience and how they interpret the world, in 
which case one can use interviews without actually experiencing the 
phenomenon oneself (Patton, 1990: 69) Phenomenology makes a number of 
assumptions including the meaning making experience in lived experiences is an 
individual one and the individuals are reliable witnesses of their subjective 
experiences.(Ashworth,2006).The primary task of phenomenology is to describe 
everyday experiences as they are told by the participants.  
 
Descriptive phenomenology was used utilized in this study since the researcher 
aims to only describe and not to interpret the phenomenon under study. The 
study aims to describe the experiences of stigma in patients enrolled in the 
PMTCT programme. The goal was to describe the lived experiences and to 
determine how the stigma manifests. Experience is a product of intrinsic 
relationship between the individual and the world (Polkinghorne, 1989) as people 
continually interact with the world, they form and create experiences. 
Phenomenological study tries to understand these experiences from the 
perspective of the individual. Experience is the reality that occurs as people 
become aware and open to the world, cannot be reduced to either mental or 
physical sphere (Kruger, 1997) Husserl introduced the term “lived-world or “lived 
experiences” This is the world as lived by humans and not as seen by the 
positivists as independent from humans (Valle, et al., 1989)   
 
One of the strategies of Phenomenological research is Bracketing. This was 
utilized by the researcher to ensure that pre conceived ideas don’t cloud the data 
results from the study to ensure that data is approached in its pure form (Polit 
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and Hungler 1995). The participants were viewed as expects of their 
experiences, as such this required continuous bracketing of theoretical and 
personal presupposition about the experience at hand. (Giorgio, 2006) Ahern’s 
method was utilized; a reflective journal was utilized to help with bracketing. I 
addition none directive interviewing technique was used to, this allowed each 
participant to describe their experience as openly as possible rather then 
following a preset method by the researcher (Ashwoth, 1996) 
 
Intuiting was done by the researcher to ensure that she remains open to the 
meanings attached to the topic as described by the subjects who have 
experienced the phenomenon.  
 
3.3. Research paradigm 
 
The study adopted a naturalistic paradigm. Qualitative are naturalistic in that the 
researcher does not attempt to manipulate the research setting (Patton, 1990: 
39). Qualitative research is a method of inquiry aims to gather an in depth 
understanding of human behavior and the reasons that govern such behavior. 
The qualitative method investigates the why and the how of the decision making, 
not just what, where, when. In this way smaller samples are utilized, the belief is 
that reality is not a fixed entity but rather a construction of the individuals 
participating in the research and those realities exist within a context (Polit & 
Beck, 2008). Furthermore, the naturalistic paradigm assumes that knowledge is 
maximized when the distance between the inquirer and the participants in the 
study is minimized. Hence, interviews were conducted with the participants. 
 
3.4 Study setting  
 
The study was conducted in selected Primary Health Care clinics in the in the 
eThekwini District. This is a city within the province of Kwazulu Natal.(Please see 
appendix 6 for the map of the district) The district has 113 primary health care 
clinics, 60% of the clinics belong to the Provincial government and the rest are 
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run by the Local Authority Government. All these clinics offer Primary Health 
Care services including maternal and child health services such as; PMTC, Post 
natal care, including immunization services for babies. 
 
3.5 Sampling Strategy of the Primary Health Care facilities. 
 
The EThekwini district is divided into three sub districts, South, West and the 
North sub districts. Permission was sort from the Municipal head of health to 
conduct the study. (Please see letter granting permission in appendix 5).This was 
followed by request of permission from the respective area managers and the 
facility operational managers. Two high volume PMTCT clinics were purposively 
sampled per sub district ,this made it six PHC facilities. This allowed for equal 
representation of the three sub districts. In Ethekwini District. The participants 
who met the inclusion criteria were selected from these facilities. .  
 
3.5.1 Sampled Participants: 
 
Participants were selected from PHC Facilities that gave permission for the 
study. Because of the sensitivity of the subject, the clients were not approached 
directly, but rather through the Professional Nurses running the PMTCT clinic. 
The Professional Nurses then referred those women who agreed to be 
interviewed. Purposive theoretical sampling was utilized to obtain a sample of 
seven participants. This involves selection of sample as the study progresses. In 
addition participants were selected using the criteria advocated by Polkinghorne 
(1989), which states that the participants need to have experienced the 
phenomenon under the study and willing to talk about it.  
 
This type of sampling is suitable for this type of study as the aim was to interview 
women who have been through the PMTCT program, to Explore HIV related 
stigma experienced by women enrolled in the PMTCT in Ethekwini. In the end 
seven participants were interviewed. The researcher stopped interviewing the 
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participants were the point of saturation was reached in terms of information from 
the interviews. 
 
The intention of using this type of sampling was for the researcher to be able to 
purposefully select the suitable participants (Polit & Hungler 2005: 297).  
 
The subjects were both pregnant women attending PMTCT clinic and those who 
have already delivered their babies and therefore have been through the 
programme process partially. These women were identified while bringing their 
children for Polymerase Chain Reaction for HIV testing and/or immunization. 
  
3.5.2. Inclusion Criteria 
 
Subjects were selected according to the following criteria: 
 They were all able to communicate in IsiZulu. 
 They were all HIV positive 
 They have been through the PMTCT programmed at least once in the 
past six months. 
 They were 21 years or older. 
 Delivered a live baby or in the second or third trimester of their 
pregnancy. 
 Willing to be interviewed and tape recorded. 
 
3.7. Data Collection process and instrument 
 
Data collection was done through individual in depth interviews. The interviews 
were conducted within the PHC facilities using private consulting rooms provided 
by the staff at the facility. Interviews allowed participants to give a rich and 
detailed account of their experiences.    In depth individual interviews were 
conducted, the researcher used probes to encourage discussion    and allowed 
participants enough time to discuss the phenomenon. The interviews were 
conducted in IsiZulu and tape recorded following permission from the participants 
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to do so. The phenomenological interview principles require   interpersonal 
engagement within a relationship of safety and trust; this calls for rapport 
between the researcher and the participant. Because of the nature of the subject, 
some participants became emotional, the researcher as a trained nurse offered 
debriefing at the end of all the interviews. In a case one participant, formal 
counseling was suggested. 
 
Techniques such as probing, paraphrasing questioning and summarizing to were 
used to obtain more information from the participants. The questioning included 
questions about HIV testing, disclosure, adherence to the programme and stigma 
in the context of PMTCT programme. (Refer to tool in appendix 4) 
 
The Primary Health clinics were used be used as the interview venue but a 
private space was requested for use during interviews. Participants who agreed 
to participate in the study were taken into a private room in the clinic, where 
further information regarding the study was being given. Once the consent had 
been signed, the researcher using a self-developed interview guide conducted 
individual interviews. All interviews were recorded on a tape recorder and notes 
were taken for non-verbal cues, with the permission of the participants.  
 
The role of the researcher during the interviews was that of facilitator. In addition, 
the role of the researcher was clearly explained to the participants, as 
participants perception of the researcher could have implications on how they 
respond to the questions and how they inter act with the researcher, as the role 
of the researcher may be a foreign concept to the participants and this may have 
implications how they respond to the questions. Further more the researcher did 
not discuss own knowledge of stigma in the PMTCT programme context. It was 
also kept in mind that some differences such age, social class may have 
influenced how much the participants share with the researcher as well as the 
view that the researcher may part of the HCW may have influenced the 
responses, although not explicitly stated during the interview. (Ashwin, 1996) The 
participants were assured of confidentiality and anonymity throughout the 
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process. Keeping in mind also is that   many respondents were reporting 
retrospectively on incidents that happened a couple of months ago. As such their 
reliability is only as good as respondents' memory, which is likely to retain 
selectively the less pleasant experiences. 
 
3.8 Data analysis 
 
Data analysis represents a critical stage of phenomenological research study; it 
is intended to extract from collected data a description of critical and essential 
features of an experience. (Valle et all. 1989) Data analysis started 
simultaneously with data collection.  
 
To analyze the data Colaizzoi’s method (1978) was utilized to guide the analysis, 
using the seven stage phases as described by Colaizzi.  
 
To begin a phenomenological   analysis the concept of epoche need to be 
applied. Epoche is a Greek word that means refrain from judgment and stay 
away from everyday way of perceiving things (Patton, 2002). 
 
With this in mind, the researcher read the narratives by participants in order to a 
feeling of their ideas to understand them. 
Colaizzi. Seven-step analysis is as follows: 
. 
• The first step in analysis depth with extracting words, phrases and 
sentences relating to the stigma. This was done with the aid of the NVIVO 
08 programme. These were called free nodes. 
• At this point an attempt was made to formulate meanings for each 
significant statement. 
• Once these means were formulated, and they were grouped into clusters, 
making clusters of themes or tree nodes according to NVIVO 08 
programme. 
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• The next step involved integrating the resultant clusters into exhaustive 
descriptions of stigma. At this point an excel table was designed to further 
make data more manageable and form structure. 
• This was then reduced to an essential structure. This was then written out 
as will be seen in chapter four and giving meaning to the statements. 
• The last phase is to   return to the participants, to further interview to 
validate the researcher’s description to see if the full meaning has been 
carpeted. This was telephonically done with two of the participants 
because of the nature of the topic, and to further maintain confidentiality. 
 
These steps flowed and were fluid and required a lot of flexibility. 
 
Literature review of qualitative studies discussing HIV and AIDS stigma, PMTCT 
were identified. These were read in conjunction with the South African PMTCT 
Policy and guidelines.  
 
In finding out experiences the researcher explored how clients experienced the 
HIV positive status as some were finding out for the first time during pregnancy. 
Explore the role of Health workers in stigmatizing the clients. In addition discover 
self-imposed stigma by the clients. 
 
3.9 Data management 
 
The researcher herself did data collection, by doing in-depth interviews. This was 
done to ensure that confidentiality is maintained as much as possible. A 
computer with a special log in code known to the researcher only was used. The 
interview data was locked in a locker accessible to the researcher only during the 
research period. Data will then be kept for a period of five years in a secure 
location with arrangement by the supervisor at school. After five years data will 
be disposed of by incineration.  
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The interviews were conducted in IsiZulu and recorded in IsiZulu. The voice 
recordings were then transcribed in IsiZulu and then translated to English 
verbatim. After the formal interview, the tape recorder was turned off and a more 
informal discussion took place, which served as a form of debriefing and 
generally showed the researchers interest on participants as individuals rather 
than just research subjects. 
 
The formal interviews took about 30 minutes to an hour. These transcripts were 
then transferred to NVIVO 08 programme for the purpose of analysis. 
 
3.9.1 Data Quality 
 
A well designed study should convince the researcher and the readers that it is 
credible by maintaining certain standards. (Rubin and Rubin, 1995). Quantitative 
researchers use credibility and validity to refer to these standards. In the case of 
qualitative research these concepts are known as trustworthiness, credibility and 
transferability. According to Polkinghorne (1989) suggest that data should be 
grounded on evidence and remove the following dout: 
 
 That researcher did not influence the participant’s interview responses? 
 The transcriptions are true reflection of the participant’s utterances. 
 The data analyses of statements are accurate and no other conclusion 




This refers to the extent to which the research findings can be applied to other 
contexts. When the study is read by the researcher of any reader, the themes 






Conformability of data will be ensured through having two independent 
researchers who will asses data for relevance and meaning. 
 
3.9.1.3 Credibility and confirmability 
 
Credibility focuses on how interpretations are grounded on data and whether 
they are formulated in ways consistent with the available data. (Graneheim and 
Kudman, 2004)  
 
Credibility of data was ensured  by collecting Data or conducting interviews from 
multiple sites and three different sub districts of EThekwini. Additionally, two 
participants were called to confirm the themes extracted from the transcripts. 
(Sandelowiski, 1993) 
 
Additional Colaizzi’s method of data management and representation is another 




All the participants were interview using and probes were used to encourage 
discussion.. This was to ensure that all the participants respond to the same 
questions. Additional all the interviews were done  were tape recorded. (Polit and 




3.9.1.5 Time Triangulation 
 
This was done by collecting data from those who have delivered and from 
pregnant women still taking part in the PMTCT programme. Data was also 
collected in six different facilities at different times. 
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3.10 Ethical Considerations 
 
Permission to undertake research was sort with the UKZN ethics committee 
(Please see appendix 5). Permission was also sort with eThekwini health District 
and PHC supervisors in charge of the clinics. All communication to the 
participants will include the researcher’s name and contact details contact 




The participating clinic names will not be divulged rather the clinics will be called 
clinic A, B and so on. 
Real Participants’ names will not be used in any part of the study, rather 
pseudonyms chosen. The master copy with the codes will be kept under lock and 
key. This will be communicated to the participants. They will also be informed 
that when the data is published their names will not be mentioned. 
 
3.10.2 Informed Consent 
 
Informed consent was drawn (Please see appendix 2). The risks and benefits 
were explained. Permission to record the participants will form part of the 
informed consent; they were informed of their right to refuse. Additional 
permission was sort from the participants to record the interviews. It was 
explained that this will ensure that all the discussion are captured accurately. All 
the participants gave permission for recording the interviews. 
 
 
3.10.1 Voluntary Participation 
 
The clients will be made aware that participation is voluntary and declining to 
take part will not disadvantage them as participants in the PMTCT programmed 
in any way. Participants were informed of their right not to participate. 
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The study was explained in full to the participants and their right to withdraw at 
any point of the study. 
 
3.10.2 Respect for dignity 
 
This principle includes the right to self-determination and the right to full 
disclosure. Self Determination: this means that the participants have the right to 
decide voluntarily whether to participate in the in a study without the risk of 
incurring any penalties. This includes freedom from coercion. Full disclosure: 
The researcher described the study fully; explained potential risks and benefits of 
the study and the patients’ rights to refuse participation. (Polit and Hungler 




All participants have a right to privacy. The researcher ensured that the questions 
were not more intrusive into people’s personal lives than necessary and privacy 
was maintained at all times. At no point will the names of participants any 
identifying information of the individuals be used. Research report was done 
using aggregate information. 
 
3.10.4 Beneficence  
 
This principle of not doing any harm to the participants. This principle contains 
multiple dimensions namely: Freedom from Harm, because this is a Qualitative 
study about experiences, care was taken to not to cause psychological harm. 
The Questions were phrased carefully to ensure minimal psychological harm. 
Another one is Freedom from exploitation: The participants were assured that 
the information they shared with the researcher would not be used to 
disadvantage them or expose them in any way. 
 
3.10.5 Potential benefits 
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There will be no direct personal benefit for the participants nor monetary benefits 
for taking part in the interview.  
  




This is a qualitative study and data analysis was done while collecting the data. 
According to (Burns &Grove, 2005, pp 569) some researchers are concerned 
about the fact that results from the qualitative studies can not be replicated. To 
solve this problem the qualitative researcher forms a trail of information of how 
data was collected and analyzed by the original researcher to obtain the same 
results. This is called audit ability. 
. 
Another issue phenomenological research is that the researcher may have 
preconceived ideas about the subject and research topic because of prior 
knowledge; this may have had an effect on how she collects and interpret data. 
The process of bracketing, setting aside previous beliefs and knowledge, 
enabled the researcher to remain neutral. 
 
The other limitation is that the results cannot be generalsable, as the purposive 
sample will be utilized as the aim of the study is to gain in depth insight of the 






Chapter 4  
 
 4. Introduction 
 
This chapter discusses and presents the findings of the study. The presentation 
of the results will be according to the aim of the study, namely, exploring HIV 
related stigma experienced by women enrolled in the Prevention of Mother-to-
Child Transmission (PMTCT) Programme in Ethekwini, KwaZulu-Natal, using 
phenomenological analysis. Interviews were the main data collection tool. All the 
participants were asked the same questions, with the difference being in the 
sequence of questions, depending on how each individual responded to the 
questions. The answers were recorded verbatim.  
 
To start off with, a brief description of the study setting and a concise description 
of the participants’ profiles will be presented. 
 
4.1 Data Collection Setting 
 
The data was collected in the Primary Health Care Clinics (PHC). The interviews 
were often conducted in the consulting rooms allocated to the researcher by the 
clinic staff. The PHC clinics, in general, are like a market, a hive of activity with 
large numbers of clients who are there for various services.  
 
There are usually large numbers of people moving up and down the passages to 
various rooms, and just as many people seated in long lines, all awaiting their 
turn to be seen by the Heath Care Workers (HCW). The place is often noisy and 
chaotic, what with the voices of people chatting and the voices of crying babies. It 
is in the midst of all this that the researcher tried to find a quiet place conducive 





4.2. Participants description: 
 
Below is a table summarising participant’s information. A thick description of the 
participants follows below. 
 











































31 3 Single 1 Yes 
 
 
4.3 Thick Description of the participants 
 
All the participants were asked to choose a pseudonym which could be used 
when referring to them as part of the analysis of the research. This would 
contribute to preserving confidentiality, and offer some form of respect and 







4.3. 1. Participant 1 
 
She will be known as Nikiwe.  
 
Nikiwe is a 28 year old women, she came across as a self-confident, eloquent 
woman. She is the only pregnant participant. The only time this polished well-
groomed exterior fell apart is when she was talking about her partner and the 
father of the child she is carrying. 
 
Nikiwe became quite agitated and emotional. Strangely, she kept on going back 
to discuss him, and how, after she had disclosed her status, he abandoned her. 
Nikiwe said she had come to terms with this fact, but her body language told 
another story, and indicated her desire to have him support her. It may be that 
this was the first time she had had a chance to share these intimate feelings with 
anyone, and that she saw the interview as an outlet for her feelings, hence she 
kept on discussing her partner, although it was clear that this caused her a great 
deal of distress. She was most disturbed because she felt he had brought the 
disease to her, and that the least he could do was to care for her and support her 
emotionally. 
 
Although Nikiwe does receive support from her sisters and employer, she still 
needs care from her partner, of the kind that only a partner can provide. She 
even revealed that he had stopped being intimate with her, since she  made him 
aware of her status. Nikiwe knew this exactly, as she has been keeping a diary of 
these events! 
 
Nikiwe is also the only participant who went for an HIV test before she was aware 
that she was pregnant. The motivation for her testing was to ensure that she was 
able to care for herself, and to ensure that no one discerned her status because 
of becoming ill. She is afraid of becoming dependant on others. Nikiwe decided 
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to take the test so that she could take the necessary action before becoming sick 
and burdening others with her care. 
 
Nikiwe has one child, an eight-year-old son whom she is very keen to protect and 
to ensure that he does not discover her HIV status. 
 
She disclosed her status to her two sisters, her employer, as well as her partner, 
the father of the child. She seems to have a plan in place to ensure she follows 
the PMTCT guidelines well, and ensures the safety of her unborn child. 
 
4.3.2. Participant 2 
 
Her chosen name is Thandiwe. 
 
Thandiwe is 31 years of age. This is her first time on the programme as she 
tested negative with her first two children. 
 
Thandiwe appears to be a demure, soft-spoken lady. She is smart and carries a 
well-dressed baby. Thandiwe appears generally to be a very clean-looking, 
healthy, happy person. She is the only woman out of all the participants who had 
her partner with her at the clinic. Her partner was present, carrying her bags, and 
generally caring for her and the baby. Initially, she asked her partner to remain 
outside while we talked. Thandiwe later asked if he could be allowed in so that 
we could talk about his testing and generally discuss discordant couples. 
 
Thandiwe was at the clinic for her six-week post-delivery check-up and to have 
PCR done for her baby. She has two older children. The two younger ones are 
by the current partner, and they have been together for nine years. She decided 
to disclose her HIV status only to her partner. Thandiwe lives with her mother on 
a part- time basis, and spends the rest of the time with her partner. She has not 
said anything to her mother. She found it very hard to keep her status secret from 
her mother. Thandiwe describes her mother as someone who wants to know 
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everything and who is very nosy. She has made a point of ensuring that her 
mother has never seen her taking her medication, to the extent of hiding in the 
bathroom to take her medication. She has also had to empty the baby’s 
medication into a Gripe water container to hide the fact that she is on the PMTCT 
programme. 
 
When she disclosed her status to her partner, he also decided to go and test for 
HIV. He tested negative twice. Thandiwe is most amazed about the fact that he 
has still stayed with her. She kept on saying how grateful she was, and that her 
partner has done everything possible to support her, even moving out of his 
parent’s home to rent a room so that they can have privacy when she visits him, 
as in that way it is easier to follow the PMTCT guidelines without the prying eyes 
of family members. 
 
Thandiwe is keen to find out as much information as possible to protect her HIV 
negative partner. 
 
4.3.3. Participant 3 
 
Her name is Fikile. 
 
Fikile looks very tired, unhealthy and unkempt, and the baby looks just as bad. 
She has a sad, distant look about her. Fikile makes poor eye contact, is jumpy 
and generally looks uncomfortable. 
 
Fikile is 28 years old and has three children. This is the first time she has 
enrolled in the PMTCT programme. Fikile has been through a great deal of 
trauma and emotional grief. 
 
Fikile shared with the researcher that she lost both her parents while she was still 
very young, and, as a result she was brought up by her uncle. She is currently 
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residing in his home together with her male cousins. Fikile did indicate that she 
misses having a woman in the house to assist her with childcare. 
 
Fikile lost a child of eleven months, quite recently. The current child is her fourth 
child. She is not sure what was wrong with her baby. He died in his sleep, and 
she is not sure of the cause of death. She was visibly traumatised by this 
experience, having woken up to find that her child next to her was dead. 
 
On being diagnosed as HIV positive, she disclosed her status to her partner and 
a female friend. It was actually the friend who told her to disclose her status to 
her partner. No family member is aware of her HIV status. She feels that 
because there are only men in the house, they do not know why she is taking 
tablets and giving the baby syrups. Fikile thinks they assume that this is what all 
pregnant women do and what small babies need. Fikile is thus able to keep her 
HIV status private. She did feel a bit of pressure from well-meaning neighbours to 
breastfeed. Fikile told them she is not able to do so because of health reasons. 
 
Fikile is worried about how she is going to feed her baby. She decided on 
artificial feeds as she was not aware that there is a way to breastfeed while one 
is HIV positive. Had she known about this, she would have decided to 
breastfeed. 
 
The HCW have told her that the formula milk will be no longer be supplied by the 
state. She is not sure how she is going to feed her child should that happen, as 
both she and her partner are unemployed. 
 







4.3.4. Participant 4 
 
She will be known as Mancane. 
 
Mancane looks very young and could pass for a 15-year-old child, although she 
says she is 21. Even her manner when she speaks is very child-like. While 
talking, she kept giggling, as a typical teenager would, for no apparent reason.  
 
Mancane has already delivered, she was at the clinic for postnatal care. This is 
her first child. Mancane is from an urban area, with easy access to the health 
care facility. She enjoys good support in terms of baby care as her Mom and 
Granny are helping her. She has not told either of them about her status. 
Mancane decided only to disclose her status to her partner who did not seem to 
take this seriously. He refused to take the HIV test. 
 
It turned out that her CD4 is low, and she is eligible for HAART and was referred 
to an ARV site be initiated on HAART. She decided not to go. Mancane feels she 
is not ready, and that she needs to get used to her new HIV status, so much so 
that, at this point, she says she even forgets that she is HIV positive. Mancane 
admitted to having a problem even adhering to the Dual therapy, taking the AZT 
only when she remembers, and found the general PMTCT guidelines hard to 
follow. She explains amid fits of giggling. This provides all the more indication 
that she needs support from people who reside with her in the house, like her 
Mom and Granny. 
 
Mancane had a Caesarean section, and she found this very traumatic as she 
was alone. 
 
Mancane opted to bottle-feed, but will not collect from the public facilities as a 
way to conceal her status, as if she is seen with Pelagon, people will suspect she 




Mancane said that she found that the nurses adopted a parenting role with her, 
scolding her because of her age. She had a few questions about contraception 
and thought the nurses had injected her with contraception post-delivery without 
her knowledge. 
 
4.3.5. Participant 5 
 
She will be called Phambili. 
 
Phambili is very outspoken, and speaks with exaggerated hand gestures almost 
standing up from the chair, although she has a baby in her arms. She is very 
descriptive and elaborate in the way she recounts her story. You could see she 
cherished the chance to tell her story. 
 
Phambili has two children including the one she has just delivered. This is her 
first time on the PMTCT programme. She only started the ANC at 34 weeks as 
she was not aware she was pregnant because she had been menstruating 
throughout her pregnancy. It turned out that she also had a low CD4 count, and 
was asked to return for HAART initiation soon after delivery. 
 
Phambili only started to take AZT at 34 weeks as opposed to 14 weeks as 
indicated by the PMTCT Dual guidelines. In addition to this, her waters broke 
while she was still at home. She feels all this is the cause of her baby being sick 
post-delivery. 
 
A couple of days post-delivery, her baby was diagnosed with Meningitis. Phambili 
had to go back to the hospital and be a lodger mother for a couple of weeks. This 
means that she was not able to return for HAART as instructed. She was not 
able to return for HAART after delivery as her baby became sick and she stayed 
in the hospital as a lodger mother. 
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She is very vocal and passionate about having to make her partner support her 
emotionally. She makes him accompany her to the classes and has made him 
her treatment supporter. She plans to make him support her psychologically, 
even though the love relationship may be gone. He is the only person who knows 
her status, and as such, is obligated, according to her, to stand by her so that 
she can do the same for him. 
 
Phambili says she wants to ensure that they both stay alive and bring up the 
child. She is very spirited and is motivated to live a full life despite her HIV 
positive status. 
 
 4.3.6 Participant 6 
 
She will be known as Nokukhanya. 
 
It is her first time on the programme. Nokukhanya has an eight-year-old child. 
She is very shy and down-to-earth. She speaks softly. 
 
Nokukhanya started the PMTCT programme as normal, but, because of being in 
the rural area, she was unable to reach the health facility in time for delivery, so 
she had a home delivery.  
 
A problem with the MTCT is that the highest risk of infection is during 
confinement, yet she delivered at home, presumably with the assistance of family 
members who obviously would not have Personal Protective Clothing, like gloves 
and goggles etc. They were possibly not even aware of the risk they were taking 
helping her deliver. Nokukhanya also missed out on taking the prescribed ARVs 
that are taken before and during labour and delivery. 
 
This caused a great deal of grief and guilt for her, and the nurses also berated 
her when she finally made it to the hospital post-delivery. This means that she 
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did not take the single dose NVP, and the three-hourly AZT during labour. She is 
very worried about the health of her baby. 
 
Nokukhanya decided on exclusive breastfeeding. She feels she will enjoy this, as 
she did not breastfeed her first child and Breast feeding is seen by Nokukhanya 
another way to ensure that no one will suspect that she is HIV positive. 
 
Nokukhanya has not disclosed her status to her partner, only her mother knows. 
She wants to gain strength first, and get used to her own HIV positive status 
before disclosing this to her partner. She is scared of being abandoned by him 
and stigmatised by the community. 
 
4.3.7. Participant 7 
 
Her pseudonym is Thabile.  
 
Thabile is a 31-year-old mother of three. She looks very smart and sophisticated. 
She tries to preserve her smart facade. It was only when we started discussing 
her status that she began to fall apart, especially when talking about her partner. 
Then she became visibly distressed. 
 
Thabile started the PMTCT programme via the private sector. She attends the 
Public Sector PHC for vaccinations. She feels very unhappy with the PMTCT 
program in the private sector. According to her there is a lack of information and 
inadequate preparation for both PMTCT and HAART initiation. 
 
Thabile feels as if they just pounced on her and tested her. There was no formal 
request for her consent, nor was she offered counselling before and after testing.  
 
A doctor told her she was positive, and she was given a script to start HAART. 
Thabile received no literacy classes, nor any form of information about taking 
ARVs. The whole approach and care she received left her feeling exposed and 
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not properly cared for. Thabile had so many questions about the programme and 
her expectations. 
 
Thabile  has three children from one partner. She is so devastated about her HIV 
status and is very angry with her partner. She feels betrayed and sickened by the 
fact that he infected her, following numerous warnings that she gave him that this 
would happen. What gets to her is that, in addition to her own infection, she must 
now help him deal with his own HIV status when she feels he is the cause of her 
infection. She will do anything to hide her HIV status. Her ARV tablets have been 
emptied into a multivitamin container, but she still wants to adhere to the 
guidelines. Thabile  is very hungry for information about HIV and AIDS. 
 
Before leaving the room, she asks me to hold the baby while she puts herself 
together again, taking out a mirror and wiping away her tears, and sorting out her 
make-up before facing the world as a presentable, classy woman. 
 
4.4 Extracting Significant Statements 
 
The researcher used NVIVO 08 for data analysis. The researcher started by 
reading and re-reading each transcript which expressed the participant’s 
experiences of the phenomenon. 
 
The statements were grouped into nodes using the programme. The statements 
were labelled on NVIVO and grouped under nodes. The nodes were further 
grouped into significant themes. This was done using an Excel spreadsheet set 
out into columns, and grouping themes into significant meanings. Fourteen 
significant statements and phases relating to participants’ experiences of stigma, 






4.4.1. List of Themes 
 
The below is a summary of all the themes that emerged from the data. 
 
Table 4.2  
 
Themes  Sub-themes 
Antecedents of Stigma  Disclosure 
Denial 
Secrecy 
Protection of others  
Blame 
 






 External Stigma Loss of support  
Loss of control  
Physical exclusion 
Denial of care  
Verbal abuse  
Exclusion, Isolation  
Neglect 
Lack of empathy 
 
Consequences of Stigma  Feeding practices  
Initiation/Adherence to HAART 
Defaulting programme 
 
   
Coping With Stigma of 
HIV and AIDS 
 Resigned 
Motivation to live for children 
Positive living  
Support group 







4.5. Antecedents and experience of Stigma 
 
These are important background themes identified from the data, they relate to 
how stigma is experienced by the sampled   participants in the PMTCT 
programme. Although not an aspect of stigma these, were found to be actions 
and omissions caused by the fear of what could occur due to the assumption that 
they would be stigmatised if discovered to be HIV positive.  
 
All Participants in the study felt the need to disclose their status to someone, the 
people chosen to disclose to, were trusted would not share the information with 
anyone. 
The participants also exhibited denial of their status through their actions in order 
to protect their loved ones, especially children from associated stigma. The 
participants reported a couple of actions taken to ensure that they were not seen 
to be HIV positive, or to be associated with HIV and Aids, some of these actions 
included, hiding when taking medication, buying baby formula(against collecting 
from the clinic) and decanting ARVs into other containers. A strong feeling of 
being scared and secretive of their status to protect themselves from received 
stigma was also a common category that emerged within this theme.  
4.5.1. Disclosure 
This refers to Participants sharing their status with their significant others. In this 
study most Participants disclosed their status to their partners and close family, 
mainly for emotional and financial support. Disclosure of HIV status is done 
carefully. Only the trusted close people were informed of HIV status, this was 
often received with mixed reaction, Family members were by and large very 
supportive, while the partners in most cases, had negative response. 
 
As evident in the selected extracts below, it was apparent that there was a great 
deal of fear and worry experienced by the participants before disclosing their 
 92
status. The fear of being judged and received in a different manner was one of 
the primary reasons why many participants chose to hide their status.  
 
Yes, I did, [disclose my status] [pause] but I was scared. I told him. We talked. 
We decided that he must also go and test the next day. I accompanied him to the 
clinic; he discovered he was HIV negative. I thought he was going to leave me. 
He is negative and I’m positive. He did not. We are still together and okay. We 
have been together for nine years. (Thandiwe) 
 
I have not told anyone in the area. I see how they treat people they suspect to be 
positive. So I will hide my status. For that reason, I have only told my mother. 
(Nokukhanya) 
 
It also appeared as outlined in the selected extracts below, that disclosure 
particularly to partner’s was also motivated by the need to solicit their partners 
and motivate them to seek care and also get tested for HIV. The participants 
viewed this as being important so as to foster adherence between both partners 
in terms of treatment and care plans for the management of HIV/Aids, despite 
their partner’s lack of willingness to be tested.   
 
I did not tell anyone except my boyfriend. He did not seem to be shocked [when I 
told him]; it was like he was expecting it, or he knew. I asked him to go and get 
tested. He refused. (Mancane)  
 
Yes I did [disclose HIV status]. He did not seem to take me seriously; he did not 
even acknowledge what I told him with an answer. He just kept quiet. I then 
asked him to also go and test and he refused. [Sigh]. I then left it at that. (Fikile) 
 
Disclosure resulted in various reactions and responses .In some instances, the 
partners of the participants did not treat the HIV status with the seriousness one 
would expect as noted by the participants. Many participants noted that in many 
instances, their partners either ignored the news or reacted with a general 
indifference and even anger. In some cases as was evident in the case of 





I told him [partner] I’m HIV positive. No, [intimacy] ever since I told him I’m HIV 
positive. When I told him about the pregnancy he accepted it and seemed 
pleased. He even said he wanted a boy. It was only when I told him of my status 
that things changed. (Nikiwe) 
  
The other end of the spectrum though is shock and disbelief on learning the 
status as in the case of Phambile below. 
 
Yes, he is the only one I told [of my positive HIV results]. He was so shocked. He 
did not want to believe it. I asked him to also go and take the test. He refused. I 
said, “If you test it will help because we can be together in this” [putting arms 
together for emphasis], “I can also help you”. (Phambili) 
 
He knows, I told him [of my HIV status]. I think I know when it happened [got 
infected]. We had an incident, a burst condom and he tried to hide it. I asked him 
but he said there was no problem. I think he must have suspected that he was 
HIV positive. After the incident of the burst condom we decided not to use 
condoms any more. I felt, what is the use, if I’m pregnant, it has already 





This dimension is about the participants keeping their status private and only 
informing or disclosing their status to specific people who they trust to keep their 
status secret. 
 
Although all participants disclosed their status to significant others, they still 
wanted to keep their status private and they yearned confidentiality. The 
participants tried to minimize stigma by closely controlling who knows about their 
HIV status as stated by Nikiwe. 
 
They don’t know because I’m still well. I have also not made them aware, only 
my sisters and my close friend [know my status] and all have kept it quiet. That is 
why I tested early, so that no one will ever find out, as sometimes people 
discover your status when you become ill, and it is like an advert for everyone 
that you are POSITIVE. So no one knows. (Nikiwe) 
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The secrecy stems from the fear of how the community will treat them and their 
families, upon knowing their HIV status. The participants voiced fear of being 
excluded and shunned from the main stream community if their diagnosis was 
known. This was evidenced by the excerpts from Thandiwe and Nokukhanya. 
The fear of the reaction and the resultant outcome of stigma namely the abuse or 
exclusion from social activities was a major trigger that fuelled and was an 
enabler of secrecy that was expressed by the participants.  
 
I’m just scared people will treat me differently. They will be too scared to touch 
me and will even make me use separate plates and spoons. I don’t want that 
[pause]. This will also affect my kids, no! [rising voice for emphasis] I will not 
disclose my status I would rather die! People may say they will accept you no 
matter what while you are still talking, [that is] before they know your status, but I 
know people, once they know, they change. (Thandiwe) 
 
I have not told anyone in the area, I see how they treat people they suspect to be 




Furthermore, secrecy was also used as a mechanisms to sustain and save 
relationships that offered them financial (in the form of security and shelter) or 
emotional support (of being single and dealing with a new child) to deal with their 
lives. This illustrated in the following extract. 
I know how my mother is, it would be a big problem. She will disown me. I also 
have this very rude brother. If he were to find out, I would never have a place 
again at home [if HIV status were known]. I can just imagine the fights that would 
break out. (Thandiwe) 
 
In some cases the secrecy is temporal allowing the participants to get used to 
her HIV status before disclosing to others. This allows them to develop coping 
mechanism, so that they can deal better with the outcomes of disclosure. This is 
seen in the case of Nokukhanya. 
I decided not to tell him, [partner] until I also get used to the situation. I’m scared 
of how he is going to respond. I hear the way he talks about HIV even when we 
are just talking. (Nokukhanya) 
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Drastic measure are taken in some cases to hide the HIV status as in the case of 
Thandiwe, they decide to even move of out of their regular residence to be away 
from prying eyes as indicated by Thandiwe. 
We decided to move out and rent a room so that we can be free. Otherwise, no 
one knows, so we wanted to keep it that way. (Thandiwe) 
 
4.5.3 Protection of significant others  
Keeping their HIV positive status secret from their significant others is a way of 
protecting them from the emotional pain of knowing that they are HIV positive. 
They are mainly concerned about their kids, discovering that the participants are 
HIV positive. The significant others who are deemed to be   fragile and cannot 
deal with the news adequately are not informed of the HIV status., they are 
especially concerned about  children as Illustrated by Thandiwe and Nikiwe.. 
 
No, never! I don’t want them [the older kids] to know. It will cause them 
unnecessary stress. (Thandiwe)  
 
No I’m scared. I think he [her ten-year-old son] is very sensitive. I have asked 
him if he knows about HIV. I realised that he is not ready. So I have not told him. 
Maybe I will tell him when he is 15 years old. He has seen me taking the ARV for 
PMTCT, although he does not know why. He often helps me by bringing the 
medication to me and giving me water, but he does not know why I take these 
tablets. (Nikiwe) 
 
The family in some cases is not informed to protect them as there is a fear of 
how it will affects them. This is a way of protecting the family learning of 
potentially distressing news, as seen in the case of Nikiwe and Mancane below. 
 
Yes, I told my two older sisters. My mother is alive, but she is not at home, she is 
away training to be a ‘Sangoma’, so she stays where she is training. I’m 
particularly scared to tell her as I feel she will experience a great deal of stress, 
so I have not told her. (Nikiwe) 
 
 I just did not want to worry them [Granny and Aunt]. My granny is old and does 







This theme is about trying to block the HIV positive status from the mind by 
pretending it is not there, so the woman can forget she is HIV positive. It appears 
denial is used as a coping mechanism, to allow the participants piece of mind 
and not having to deal with HIV. 
 
You know the problem; [pause] is that I also forget sometimes that I’m HIV 
positive. That is why I also sometimes forget to take my medication. (Mancane) 
 
 
4.6 Experience of Stigma 
 
4.6.1. Internal Stigma 
 
This refers to self-stigmatisation. It incorporates thoughts and behaviours from 
the person’s own negative perceptions about herself, based on her own HIV 
positive status. This is the stigma that one brings to oneself. 
 
This happens even before the participants are exposed to stigmatising 
behaviour. It occurs just from the knowledge that HIV positive people are prone 
to being stigmatised. 
 
 
4.6.1.1. Fear and Anxiety  
 
This refers to the internal fear and anxiety of being stigmatised by others once 
they have been discovered to be HIV positive. 
 
There internal dialog of the PLWHA of fears that are felt by the participants. This 
is often based on assumed and anticipated reception they are going to get from 
the significant others, as stated by Thandiwe and fears that even the HCW will 
not give them proper care thus endanger their lives. 
 
HA! I cried the whole day when I got home. It got better when I told my sister, as 
before that, I could not talk to anyone. She calmed me down and also advised 
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me to tell my partner. I was very scared to tell him [partner], I thought he would 
leave me. (Thandiwe) 
 
The other thing that scared me was the delivery. I have often heard how people 
die in childbirth because of the nurses’ negligence and because they know your 
condition so they do not care. Luckily, things went well when I had my baby. 
(Thandiwe)  
 
The fear of being exposed as HIV positive compelled testing in the case of 
Nikiwe. This is done in attempt to manage the HIV so that they never have to fall 
sick as this will bring out suspicion of being HIV positive. Managing the disease 
will allow Nikiwe in this case to pass as HIV negative. 
 
I came to the clinic and I was not aware that I was pregnant at the time. I felt the 
need to know my status with all the drive on the TV and radios about knowing 
your status. I was healthy, and not feeling sick at all, I just decided to come to the 
clinic for the test. 
 
I wanted to be sure that I’m able to take care of myself, and be able to share with 
my family, so that, even if I’m positive, I’m still able to do things for myself. I have 
seen people who find out when they are too ill and need help, even to take 
medicine. That is when problems start and people have something to gossip 






This is about the blame of infection, by participants trying to figure out who 
infected them.   The other component of blame, is fear of being seen as the one 
causing the infection of others, and ultimately being blamed for their deaths. 
 
Testing HIV positive brings about question of the origin of infection. The PLWH 
try and look for the source of infection and who to blame. In the case of 
Nokukhanya, she is certain of the source of infection and there is some 
resentment and anger towards the boyfriend. Despite that she is planning to stay 
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in the relationship as her boyfriend is the only source of income for herself and 
the child. 
 
[Laughs shyly] He does not think he will ever have HIV. When we talk, he says 
he will never be HIV+. I know he infected me. I’m sure he infected me! [pause 
and stare at the researcher] I think he will blame me and leave me. I cannot care 
for the child on my own. I don’t work. (Nokukhanya)  
 
The Participants have tested and confirmed their HIV positive status. In the eyes, 
of the community, they will be seen as the people who brought the HIV into the 
relationship, as against the untested unknown partner. Thandiwe indicated this 
phenomenon. 
 
More often, the people who have had a relationship with you, like ex-boyfriends 
and their current girlfriends will say you infected them. You will be a laughing 
stock and get blamed for all the deaths that occur to those people. There is no 





This refers to thoughts about harming oneself rather than being exposed as HIV 
positive and thus being stigmatised for being HIV positive. These thoughts of 
harming themselves arise due to the fear of stigma and being stigmatised. 
 
This indicates the degree of fear of being HIV positive. and the reactions of 
others towards once know to be HIV positive. This is equivalent to end life as 
they knew it, so the participants feel it is best to die rather than face the 
inevitable. This is as evidenced by the statements by both Phambili and Thabile. 
 
You know that day, [pause] I felt like killing myself, thinking there is no hope for 
me, when the nurses shouted! (Phambili)  
 






4.7. External Stigma experience 
 
 
This refers to all types of external stigma as experienced and described by 
participants in this study. This was reported by all the participants. The reports 
were mainly in the Health Care context. Seven sub-themes were identified: 
 
4.7.1. Loss of Support and/or relationship 
This sub-theme relates to the experiences of the participants concerning the loss 
of emotional and financial support because the participants have disclosed their 
HIV status. The emotional support refers to simple things like phone calls, 
enquiring about health, and general empathy from a partner. The emotional loss 
reported in some cases involved partners moving to other relationships, and also 
generally neglecting the participants.  
 
There is evidence that disclosure of HIV status is seen as the reason partners 
lose interest and no longer want be associated with the participants. .In the case 
of Nikiwe, the pregnancy was welcomed by the partner with enthusiasm, only 
when she disclosed her HIV status   she noticed change. She mourns the loss of 
intimacy and there is a sense betrayal with the partner moving on with his life, 
starting new relationships when she so desperately needs his emotional support, 
to deal with being pregnant and HIV positive. 
 
No, ever since I told him I’m HIV positive. When I told him about the pregnancy 
he accepted it and seemed pleased. He even said he wanted a boy [change in 
facial expression and the voice is lowered, tone of sadness]. It was only when I 
told him of my status that things changed.  I asked him to also go and check [his 
HIV status], I even offered to accompany him to the clinic, but he kept avoiding 
the issue and said he would go on his own. He did not go. Not only that, he has 
started to behave differently towards me. I think he has started relationships with 
other women. I’m pregnant and HIV positive! I need love. He is not showing me 
the love and support that I expect from him! (Nikiwe) 
 
The intimacy is seen as an indicator of existence of a love relationship, once this 
stop, the participants see it as the end of the relationship and an indication that 
the partner must be with other women, as stated by Phambili and Nikiwe.  
 
 100
The fact that the Participants don’t work and those who work are unskilled, so the 
end of a relationship also translates to the end of financial support by the 
partners. 
 
 I also then told him, “I’m like this now [HIV+], and we must use condoms”. He did 
not like that. I will be honest with you, Sisi; we have not had sex since that day! 
[raising voice] Fortunately we do not live together. Hayi-ke, I’m sure he is 
involved with other women now. I told him I would not sacrifice my blood for love. 
[Using hand for emphasis] I want to live and look after my kids. I tried to convince 
him by telling him that since I will be on treatment, it is dangerous for him to have 
sex with me without a condom. (Phambili) 
 
I’m pregnant, he must still call me, and come and visit me, and he should do this, 
just as he did before I told him my status. He does not even care how things are 
going with my pregnancy, or even if I’m well or sick. [Close to tears]. I’m HIV 
positive! If a person does not call you the whole day, just to ask how you are 
[pause, while looking at researcher] - he used to do all these things before my 
disclosure that I’m HIV positive. (Nikiwe) 
 
 I can see that he is no longer interested in being intimate with me. Ever since I 
told him, we have not been together in that way. I can see he has lost interest. I 
think it made it worse that I told him I would only have sex with him if he uses a 
condom. I won’t lie; I think he no longer wants me. I suspect he is involved with 
another person. (Phambili) 
 
4.7.2. Loss of Control 
 
It is not possible to conceal the HIV status from the HCW, as they need the 
information in order to offer care. Unfortunately the HCW sometimes disclose the 
HIV status of their patients without their permission though their actions. Thus 
failing to respect the right to privacy and confidentiality. 
 
The information is shared verbally or on medical records.  
 
This results in loss of self determination and respect of personal space the 
minute the PLWHA enter the Health care system.  
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The gesture of creating protective physical barrier, drawing of curtains, before 
sharing information are desired action and shows respect for participants and are  
seen as preserving confidentiality. 
Eish, I was exposed to two hospitals. I started at hospital X; they screen [curtain 
around the bed] you before giving you your medication, so no one knows what is 
happening. I was moved to hospital Y. There, [pause] they don’t care... They talk 
aloud, saying, “You have to take this tablet” and calling out its name for everyone 
to hear and see. They come in and ask for your CD4 loudly, so all can hear. 
(Thandiwe) 
 
Even after delivery when we were moved to the ward, they [HCW] could do 
better. The beds are so close together, yet they do not even try to close the 
curtain. They just give instructions in front of everyone. (Thandiwe) 
 
Recording on the medical notes is seen as another form of disclosure of status 
by HCW without the permission of the participants and this brings about 
resentment as in the case of Thandiwe. 
 
They write on the card that the baby was given Nevirapine. This means I cannot 
ask anyone else to take my child to the clinic, as I will have to give him or her the 
card, and then they will then see what is written on the card. I also worry that 
when the child goes to school the teachers will see this. They [HCW] must come 
up with something private, which only the nurses will know and write on the card, 
so that the other people will not know. Even my clinic card also says that I am 
positive. I have to hide all my cards now! They must let us decide when we want 
our status to be known and not publicise it on the cards. (Thandiwe) 
 
4.7.3. Verbal abuse 
 
These are verbal utterance directed at the participants with the intention of 
harming them. This was reported by all the Participants, as shouting   and 
taunting with the aim of degrading and embarrassing them. 
 
The Participants are blamed for being HIV positive and thus the cause of 
infecting their children. This is evident in statements by Nokhanya and Fikile. 
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They were made by the HCW to feel that, they caused their own illness and now 
they were at fault for the causing harm to their children. 
They scolded me so much, saying my child will contact the virus because of me. 
Why I did not come to the hospital on time? I was hurt, as I did not do it 
deliberately. I went to the hospital and they kept me there for one night and gave 
the child medication. I hope my child will be safe, even if I did not take the tablets 
before and during labour. (Nokukhanya)  
 
The shouting, making us feel bad because we were making our children sick, 
when I know it is not my fault? What could I have done differently, nothing? You 
just ignore them and pray that you are discharged quickly with your baby. 
(Nokukhanya) 
 
All this broke my heart. I was not able to respond and she was saying all this in 
the labour ward full of other women. I started crying, but she did not seem to 
care. I could still hear her talking, but was not sure what she was saying, as she 
was moving away from me, yet I could see she was still talking about me. I 
thought I’m here because I need help, she starts judging me and generally taking 
my misfortune and using it against me. (Fikile) 
 
There was a sense that the participants were made to feel like irresponsible 
individuals who deserve to be HIV positive, this as stated by Mancane and 
Phambili. The HCW also showed instances of denying care to the indivisauls as 
stated by Phambili, refusing to give tablets as were seen as having caused their 
own illness.  
 
When I went to the Sister for palpation, she scolded me so much because of my 
age, and the fact that I was pregnant and HIV +. She kept on asking why I had 
not used condoms. Have I never heard of condoms? I tried to ignore her, but she 
just carried on about how irresponsible I was and so forth. She does not even 
know me. (Mancane) 
 
I had mine [AZT] in my bag; I then told the Sister and asked her to help me get it 
from my bag. She became very angry and started shouting at me saying, “You 
sleep around collecting diseases and you come here to worry us about tablets. 




There is evidence that the participants are treated with distaste and don’t get 
much help in making informed choices in self care as in case of Phambili. 
Women are also blamed for making incorrect decisions e.g.  Feeding choices as 
in the case of Fikile.  
 When I went to collect the CD4, there were [nurses] Sisters there. First I saw 
their eyes; they seemed to be talking with their eyes. I got such a fright; I thought 
my CD4 count must be so bad. They then started shouting asking why I had 
taken so long to return for the results and so forth. I had no chance to respond, in 
addition, I was so scared, thinking this meant that I was dying. At the time I 
thought I must just stop coming to the hospital as I was going to die anyway. The 
way the nurses were shouting, you would have thought I had killed someone. 
(Phambili) 
 
The other problem started with the feeding choice. I choose to bottle-feed. In the 
ward after delivery, the nurses shouted asking how I could bottle-feed when I 
was unemployed. How would I afford to buy the milk? I did get five tins of milk 
with lots of shouting accompanying those tins. The nurse said we will soon see 
what will happen, this milk supply will stop soon. (Fikile) 
 
4.7.4. Physical Isolation 
 
This refers to placing the women in a separate area because they are HIV 
positive, so that they are separated from other people. This was experienced in 
the Health Care setting. 
There participants felt as sense of exclusion from the general population in the 
hospital. This they felt was exposing them as being different because of their HIV 
status and  felt isolated and exposed to other women in the labour ward, as 
people to be avoided, as indicated by Thandiwe and Fikile. 
Even after delivery, they make us sit in another area of the room, so everybody 
can see we are different. You find that there are two or three of you, you hear 
them talking to the other people next to you, asking questions out loud and you 
can see , all those who are positive are made to sit here. That makes it obvious 
to all the other women that there is something wrong with us. That causes even 
the other women to discriminate against us. (Thandiwe) 
 
You are separated and put aside [those who are HIV positive]. It is as if they 
want people to see that you are different. (Fikile) 
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4.7.5 Denial of Care/Treatment 
 
Denial of care or treatment refers to avoiding offering the normal care, or giving 
sub-optimal care to persons known to be HIV positive. Different things happen to 
different Participants; in some cases, it is refusing to offer water, failing to help 
during labour and including failure to offer counselling. 
 
Testing positive for HIV is a traumatic life changing event, but the participants felt 
it was not treated as such by the HCW. There is feeling that the necessary care 
is not afforded to them to help them deal with this traumatic event. As stated by 
Thandiwe and Thabile. Both expressed a lack of adequate counselling to prepare 
them for the test as well as the possible outcomes of the test. 
  
When I was with the counsellor, I was very scared and concerned about my test. 
I was tested, and I tested positive and started crying. The counsellor just did not 
seem to care. She just carried on talking as if nothing had happened. She just 
ignored me. To this day, I have no idea what she was saying or doing. In my 
mind, her role as a counsellor is to help me deal with the situation I found myself 
in, and to assist me to learn to cope. She just did not seem to care. She just 
carried on doing whatever she was doing. She even got me to leave the room 
while I was still crying! She had no words of sympathy or general counselling to 
HELP me cope with the new diagnosis. Seeing that this was new to me, is this 
not her job? (Thandiwe) 
 
 I tested in [names a private hospital], I was admitted to a hospital because I had 
just miscarried at three months. I also had a belt [shingles]. While there, my 
doctor requested that I have bloods taken, including HIV bloods. A Sister from a 
private lab came to take my blood. She just came and took my blood. She did not 
say a word about the bloods she was taking. I also thought she would give me 
some counselling. (Thabile) 
 
Simple request for care is denied, as the participants felt the HCW saw them as 
the cause of their illness and thus did not deserve care. This is stated by 
Phambili below.  
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 When I got there I asked for water to take my tablet. Wow, was I in trouble? 
They said I had delayed coming to the hospital and taking the tablet. Why did I 
come to this hospital instead of hospital X as I live there? (Phambili) 
 
After this scolding they just left me there on the chair for what seemed like hours. 
I was in pain with labour pains and I was wet. I remember thinking I was 
supposed to get those tablets (AZT) every three hours, but no one was paying 
attention. By chance a nurse from another unit came in and saw me and said, 
“This person is going to deliver on the chair, her water has broken”. They were 
really trying to chase me away. It was only then that they started paying attention 
and I had my baby soon after that. I did not get those tablets they told me about 
in the clinic. Maybe that is why my child is sick, I wouldn’t know. (Phambili) 
 
 
4. 7.6. Lack of empathy 
 
This refers to the lack of sympathy and feelings for the HIV positive. This is again 
seen mainly in the Health Care context. This can take the form of just ignoring 
the women or failing to be sensitive about their HIV diagnosis. 
The participants have a sense of being seen and treated as objects by the HCW, 
they  are more interested in getting  their job finished and no concern of the 
participants,and assisting them to  are deal with their diagnosis. This was stated 
by both Thandiwe and Fikile. 
Yes, the counsellor must give you a chance to deal with the situation and help 
you calm down, not just carry on, showing that she is in a hurry. She should have 
given me time to think and compose myself, seeing that I was also pregnant at 
the time. I think it could have been dangerous for the baby for me to be so 
stressed. She just did not comfort me. She made me feel like I was wasting her 
time and that as this was my fault, I must deal with it. (Thandiwe)  
 
The counsellor was not that kind; she just matter-of-factly showed me my results, 
as if to say, whatever! They are more concerned with pushing the line along than 






4.8. Consequence of Stigma  
 
This dimension refers to the actions taken by the Participants in response to the 
internal or external stigma. These actions are taken in an attempt to conceal their 
HIV status. These reactions may have a detrimental effect on the health 
outcomes of the participants, as well as their babies. 
4.8.1. Feeding Practices 
This refers to the feeding choices women make in relation to PMTCT guidelines. 
The women end up making feeding choices guided by the fear of stigma, and 
trying to ensure that they are not identified as being HIV positive. 
Some participants chose breast feeding as this will conceal the fact that they are 
HIV positive and will pass as negative. 
I chose to breastfeed, that way no one would suspect my status. I will not have to 
collect milk tins at the clinic, as this is one of the things that show that you are 
positive. People will ask you why you are not breastfeeding and they will see you 
bringing the tins with you and they will know. (Nikiwe)  
 
I’m breastfeeding. I would not want to collect tins. People talk when you collect 
tins. So I breast feed. I did not get a chance to breastfeed my first one, so this is 
a good chance for me. (Nokukhanya) 
 
The participants tell of pressure at home from relatives to breast feed, this 
causes a great deal of distress and in some cases the participants even consider 
deregistering from the programme. This is likely to lead to poor adherence to 
medication and general programme advice. This is stated by Thandiwe.  
 
Hey, you have no idea! My mother, in particular, was not happy. She insisted that 
I breastfeed even if only for a short time. She asked me why I was depriving the 
child of breast milk. How could X [mentions name of partner] allow me to use 
tinned food instead of breast milk? I was under so much pressure with my family 
that I almost left the programme. It started with me having to take AZT while I 
was still pregnant. I had to hide the pills and also hide while I was actually taking 
the pills. You know how these tablets are taken at specific times. I had to hide 
from my mother, sometimes even hiding in the toilet to be able to take my 
medication. I found that I experienced the same difficulties with giving my child 
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NVP. My mother is the type of person who needs to know everything! I have 
somehow managed to conceal the medication. I pretend I’m giving my child 
gripewater. (Thandiwe) 
 
Those who opt to formula feed would rather buy milk from the shop, despite 
being unemployed rather than be seen with milk from the clinic. This signifies the 
lengths people are willing to go to pass as being HIV negative rather than face 
being stigmatises. This is clear in Mancane’s statement. 
 
I chose the tins. I will not collect them from the hospital. I will also not buy the 
ones like Nan and Pelagon [those given by the public sector facilities] as people 
will see that I’m HIV+. I will buy Infacare from the shop. (Mancane)  
 
The participants are also a confused by what they are suppose to doing, to 
ensure that they protect their children and also conceal their status. They need 
information to make informed decision. This is stated by both Fikile and Thabile. 
 
Yes I do, but they have told us here at the clinic that they will not be giving us 
milk. Not sure what I will do after the hospital milk is finished. You know I could 
maybe have breastfed if they had taken the time to explain to me nicely what the 
options are and how they worked. (Fikile) 
 
I must say that I’m still really confused by the whole medication for the baby and 
for me. I wish I had received those classes that they give in the public sector 
[more questions about baby medication]. It is still not clear to me why the baby 
takes medication. I have received no explanation at all about what is going on. 
(Thabile) 
 
4.8.2. Not starting HAART 
 
This refers to the instances where women have decided not to take up treatment 
as recommended to make sure that they are not identified as being HIV positive, 
due to the fear of stigma. 
 
Treatment is deferred, the participants are scared to start treatment as this will 
expose their HIV status, thus expose them to being stigmatised. They are more 
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concern about avoiding stigma then consequences of AIDS. This is indicated by 
Thandiwe’s statements. 
I know, [I need to start treatment] I’m just not ready to start treatment, as I’m 
scared it may be revealed that I’m HIV positive. I’m particularly worried about my 
family finding out. I have told my sister and nobody else at home. I trust my 
younger sister; I know she will never tell anyone at home. I just don’t want my 
mother and brothers to find out. (Thandiwe) 
 
The staff must make sure that they do not expose us as being HIV positive, 
because they make it hard for us to come to them for help. You feel like stopping 
the programme. (Thandiwe) 
 
Submitting for treatment means they will have to increase the number of people 
who know their HIV status, another group of HCW and according to Thandiwe 
they are cannot be trusted to keep the status confidential. 
 
 I even thought, maybe I should not have tested for HIV, at least I would not be 
exposed to so many people because of the nurses who fail to protect my status. I 
think they do it deliberately. We trust them with our information and secrets and 
they expose us. (Thandiwe) 
 
4. 8.3. Moving Facilities 
 
Participants in some cases have moved facilities to escape being stigmatised; to 
seek services elsewhere so as to avoid being stigmatised. 
I never went there again. I started coming to this clinic. You are in trouble and 
you get scolded. (Mancane) 
 
4.9. Coping with HIV and related Stigma 
 
This refers to how the Participants respond and cope with being HIV positive and 





4.9.1. Acceptance/Resigned to status 
 
This refers to how Participants accept and resign themselves to the situation of 
being HIV positive and take it as it is. 
 
The participants see HIV positive status a part of their new reality and part of 
their new life. Some  participant’s have accepted and are incorporating strategies 
to cope and moving on with life This is stated by T habile, Nikiwe and Phambili. 
 
I have made my peace with this situation. I have decided to also ignore him 
[partner], as this will cause me to be sick with other illnesses like high blood 
pressure. Maybe he is helping me not to be sick, as he may be, if we carry on 
being intimate while he is busy with his other friends. He is going to bring disease 
to my unborn baby and to me. I want this child to be healthy. (Nikiwe) 
 
I just told myself that this thing is all around. I may be looking after myself, but I 
don’t know how my boyfriend is behaving. So I just told myself I will accept 
whatever the result is, and try to learn to live with it. What else can I do? 
(Phambili) 
 
I just need to accept that I’m now HIV positive and learn to live again. I need to 
try and take it as it is. I have told myself that it means it was meant to be that I 
became HIV positive. (Thabile) 
 
Despite the stated need to want to move on, there is still that part that wants to 
be loved and be in a relationship as seen in Nikiwe’s case. She has to deal with 
rejection by the father of her child. 
 
My employer seems to understand [participant’s attitude changes again, look of 
sadness]. You see, the only person who seems to have a problem is the father of 
my child. Maybe it helps that he longer cares, and is not sleeping with me... It 
keeps my child and me safe from disease. I also told him that if we are ever 
intimate again he must use a condom, so I think this is another reason he may 
have lost interest in me, I don’t know....... 




4.9.2. Support Group 
 
This refers to Participants who have tried to identify other women in similar 
situations so that they can deal with the situation together. 
Support from other HIV positive is invaluable, as they share the same problem, 
Even the external stigma does not feel that bad as indicated in the statement by 
Nokukhanya. 
 I did sometimes feel that we were not treated the same as the other people who 
are negative. I found that identifying other women who are also HIV positive 
helped. We get to support one another. That way, whatever is done by the 
hospital staff does not feel that bad. Knowing that you are not alone helps. 
(Nokukhanya) 
 
4.9.3. Positive Living  
 
This refers to the efforts made by the Participants to stay healthy and prolong 
their lives in any way possible. In some cases, this involves helping the partners 
to stay healthy as well. It is like taking back control of their lives. 
 
The participants want to be healthy and additional they feel the need to help their 
partners to benefit from their positive efforts by getting them to also start caring 
for themselves. This is stated by both Phambili and Thabile. 
 
You know what I will do, I will make sure I get him to the clinic. I have decided to 
care for myself to look after my baby. I’m glad I have my own place to live. He 
also lives on his own and I don’t have to see what he is doing. My life has been 
so hectic with my baby being sick, my HIV status, and now the added burden of 
having to coax my boyfriend to look after himself. I have to help him too, so that 
we can look after our child. I don’t like it, but I have to. I have no choice. 
(Phambili) 
 
Right now, I’m also not really used to the idea of being HIV positive and being on 
ARV and on top of this I was pregnant, now I have a baby. I still need to get used 




There is a drive and eagerness to follow clinic directives to keep healthy, 
attending classes and taking medication as directed by the HCW. This is clear 
with Nikiwe and Phambili. 
I’m not fussy about what I get, as long as the child is healthy. This child in 
particular must be healthy because of my HIV status. I’m very careful about 
ensuring that I do everything they tell me to do here at the clinic. I want to make 
sure that my child is healthy. (Nikiwe)  
 
Sis I still want to live for my children. I have attended the classes and next week 
I’m starting the treatment. I’m relieved. (Phambili)  
 
There is a desire for a normal life and existence despite the HIV positive 
diagnosis.HIV is equated with other chronic disease that people suffer from but 
still lead a normal life. That is the aim for Nikiwe.  
 
They were shocked and cried a lot, but said they still love me and will still treat 
me the same way as before. They will try and help me. I’m glad I’m employed. 
Even though my job does not pay that much, I can take care of myself. This is 
what motivated me to test to be able to take care of myself, so that I don’t end up 
being bed-ridden and needing help even to swallow those ARV tablets, if it gets 
to that stage. I have seen people who die because they cannot eat, and as a 
result they cannot take the tablets and need other people to help them. I just 
want to be able to be like those people with high blood-pressure (Hypertension) 
and sugar (Diabetes). They go to work and take their tablets and no one worries 
them or asks questions about their illness. (Nikiwe) 
 
4. 9.4. Plans for the future 
 
This dimension refers to the strategies which the women put together with a view 
to securing a future for themselves and their families. The plans involve personal 
care and childcare and hopes for the future. 
 
Concrete plan have been put in place, there is desire to carry on leading a 
normal life despite the HIV positive status. This is with the support of families and 
in some cases the employer. This is stated by both Phambili and Nikiwe. 
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I’m using the bottle. I decided to bottle-feed as I need to go back to work soon. I 
will take my child back to Lusikisiki to be cared for by my family back home. I will 
buy the milk and I hope the father of my child will also help me, which is why we 
must stay healthy to work for our child. I just hope my baby is free from HIV. I did 
the test today (PCR), I hope it turns out negative. (Phambili) 
 
I have made arrangements with my employer to live with my child in her house till 
the baby is six months old. I will then give the child to my sister to care for after 
that. Fortunately, there is enough space in the house; [house of the employer] 
there are three bedrooms and it is just my employer, her husband, their ten-year-
old child and the grandchild I look after. 
 
I thought I would have to stop working. They asked me to carry on as I care well 
for the child and I know the status. They don’t want another person who will then 
know about the child and the family’s HIV status. I will stop in August just before I 
deliver. My sister will work in my place for a couple of weeks. I will then take over 
when I feel I’m ready to return to work. I’m happy with the arrangement. This will 











A discussion of the major findings, recommendations, limitations and the 
conclusion will be presented in this chapter. 
 
5.1. Introduction 
This chapter presents the summarised themes of the phenomenon of stigma 
which emerged from the analysis of the experiences of selected women 
participating in the PMTCT programme at selected PHC clinics in the eThekwini 
region. The findings will also be explored in terms of empirical evidence that has 
been documented by various researchers regarding HIV related stigma. The 
chapter will also conclude with recommendations that can be used by the 
respective health policy managers, clinic nurse managers, nurse practitioners 
and nurse educators. The limitations that have been experienced by the 
researcher in terms of data collection and design will also be discussed in this 
chapter followed by a final conclusion of the research study. 
 
The experiences of stigma will be presented in line with the identified themes as 
presented in Chapter 4 (pg 80-114) 
 
5.1 Antecedents of stigma  
 
HIV is an especially stigmatised illness because of the strong blame and dread 
attached to it, as it is connected to stigmatised groups and sexuality. HIV/AIDS is 
incurable and contagious. Diagnosis not only brings fear of death and 
devastation by the disease, but it also brings social issues of self-blame and 
dread in the self and in others (UNAIDS, 2002). It is against this backdrop that 
the participants of the current study do their HIV tests and are diagnosed as 
being HIV positive. 
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Six of the seven sampled participants tested for the first time during their 
antenatal care (ANC) visit. It was established that they tested because the HCW 
offered the HIV test as part of the battery of tests done for pregnant women 
attending the ANC clinic. In the Kwazulu-Natal province, HIV testing during the 
first Antenatal visit is mandatory. Even though most of the women were reluctant 
to test, they agreed to test because they were concerned about the health of their 
unborn children. Most of the women indicated that the counselling offered before 
and after testing their HIV status was not adequate to prepare them for their 
positive HIV results. As such these women were not adequately prepared 
emotionally to adjust to life with their newfound HIV status. 
 
 In sub-Saharan Africa, there is a drive to expand the Prevention of Mother-to-
Child HIV Transmission (PMTCT) programme. This means that a large 
proportion of women will be tested upon entry into ANC. Consequently, this 
phenomenon will become an increasingly common experience for pregnant 
women, i.e. adjustment to an HIV-positive test result superimposed upon the 
cares and concerns of motherhood (Klitzman & Bayer, 2003). The same 
phenomenon was also uncovered in the current study, with most participants 
being diagnosed for the first time during their routine Antenatal care visit. 
 
In the current study, when the participants received a positive HIV result, the 
initial reaction for most women was shock, denial, sadness, hurt and confusion. 
These reactions, according to Tilley (1990) are normal expected psychological 
responses. The women sampled in this study were shocked by the positive result 
however, over time, they gradually accepted their results. This is supported by a 
study done by Mukhoka (2000) who researched and analysed the psychological 
reactions to HIV positive results.  
 
Following HIV positive diagnosis, the participants in the current study, had a 
desire to disclose their HIV status to their significant others. The women wanted 
a few carefully chosen people to know their status hence they disclosed their 
status discreetly. They disclosed their status to people they trusted and were 
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confident would keep the news secret. Family members, usually female (which 
included mothers and sisters) and spouses or partners formed the main group to 
whom the participants disclosed their status. According to some reports, partners 
are the most likely disclosure target (Antelman et al., Kilewo et al., 2001; 
Matthews et al., 1999).The same is true in this study, with most of the women 
choosing to disclose to their partners. 
 
Disclosure, which was a major catalyst of stigma, was experienced and reported 
by all the study participants.  Holzmer et al. (2006) in their study indicate that the 
stigma process can be triggered or activated by a variety of factors, such as an 
HIV diagnosis or disclosure of HIV status. A trigger is any action that allows 
people to label themselves or others as HIV-positive, in the view of many 
authors; the trigger includes an element of “a marker of difference” (Derlerga et 
al., 2002).  
 
The phenomenon of disclosure was reported by a study conducted by Varga and 
his colleagues (2005) who discovered that disclosure of HIV-positive status is an 
important part of coping with the disease. In addition, a study by Greeff at al. 
(2007) identified disclosure as a major stressor, and found that women 
especially, feared to disclose because they experienced negative social effects, 
including rejection, discrimination, and violence. It has been suggested that, 
compared to their non-pregnant counterparts, pregnant women may be at 
increased risk for negative outcomes of HIV-disclosure (Maman et al., 2003).The 
outcomes of disclosure in the current study were indeed negative, especially with 
partners. Family members were, by and large, supportive. The negative 
responses were mainly received from the partners. On disclosing their HIV status 
to their partners, the women in the current study were rejected and neglected, 
and in most cases it spelled an end to their relationship.  
 
It is possible that the partners rejected the women as they did not want to be 
associated with HIV positive individuals. This may have been in an effort to avoid 
associated stigma and indirect disclosure. Holzemer et al. (2006) stated that 
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associated stigma involves examples of stigma that result from a person’s 
association with someone living with, working with or otherwise associated with 
people living with HIV/AIDS. This can include, for example, having a family 
member who is HIV-positive, (partner) or working with people who are HIV-
positive. Further studies indicate that many persons living with and affected by 
HIV/AIDS indicate that the suspicion of being HIV-positive is enough to trigger 
stigma. That is why they try and maintain their status as secretly as possible, and 
avoid being associated with HIV. In this case, having an HIV positive girlfriend 
implies that you are also HIV positive. Part of the reason the women disclose to 
their partners is financial support, as most of the participants reported a lack of 
employment. Rejection by their partners also meant a loss of financial support. 
Although no mothers reported partner violence as a result of disclosure, they did 
state that their spouses/partners had deserted them, or cut off their financial 
support. Mboi (1996) states that in many instances, African customary law 
entrenches women’s economic insecurity.  Society’s dependence on women and 
girls as care-givers within the household makes it impossible, or very difficult for 
females to enter the public sphere and realm of political decision-making. 
According to Mboi, (1996) these traditional concepts of mothering mean that the 
‘private’ is not allowed to become ‘public’, and the result is that women remain 
impotent, suppressed, and thus societally and economically insecure. Most of the 
women in the current study are unemployed; those who are employed are 
employed as unskilled labour and depend on their partners for financial support 
for themselves and the babies they are carrying. This means that, in disclosing 
their status, they not only lose a relationship, but also their livelihood. In the 
studies by Cusick & Rhodes (1999) and Green & Sobo (2008 ), research 
indicated that mothers harboured fears of the consequences of disclosure, 
including physical violence, rejection, blame and abandonment.  
 
The fear of disclosure can reduce access to care, support, and treatment both for 
HIV-infected persons and for those who care for them (Holzemer & Uys, 2004; 
Hong et al., 2004; Link & Phelan, 2006). This can have a profound impact on the 
spread of the epidemic. Health professionals should therefore assist PLWA and 
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not recommend disclosure without first exploring the possible consequences and 
different alternatives carefully with PLWA.  
 
5.2. Experiences of Stigma 
 
In this study, participants reported the experience of stigma even before being 
stigmatised by others. This was coded as experiences of internal stigma. These 
are the thoughts and feelings of the person diagnosed as HIV positive. This is 
demonstrated and by the participants’ declarations of fear and anxiety they 
experience at the thought of being known to be HIV positive and the fear of 
stigma they assume will be leveled against them once they are known to be HIV 
positive. They fear that the blame will be attached to them for infecting and killing 
other people, as they will be seen as the people spreading HIV to the community. 
This brings about thoughts of suicide and the desire to harm themselves rather 
than face the stigma associated with being HIV positive. Varga et al. (2005) 
describes self-stigmatisation as a socio-psychological process that operates 
through the stigmatised person. Stigmatised persons apply labels to themselves, 
believe in these labels, and live accordingly. This is a concept similar to the emic 
view of stigma, or the person’s perceived or self-interpreted view of stigma 
(Weiss et al., 1992). Themes related to internal or felt stigma include, self-
exclusion from services and opportunities, poor perception of self, social 
withdrawal, overcompensation, and fear (Holzemer & Uys, 2004).  
 
The internal stigma is closely linked to external stigmas, which are external 
stigmatising behaviours inflicted on the participants as experienced by them. This 
theme had eight sub-categories as described by the participants. This was 
reported by all of the women in this study. This type of stigma was reported in 
multiple settings, in the personal relationships, community, and health care. 
Received stigma refers to all types of stigmatising behaviour towards a person 
living with HIV/AIDS, as experienced or described by themselves or others. It is 
similar to the concept of the etic view of the world, where others direct stigma-
related remarks or actions at the person living with HIV/AIDS (Weiss et al., 
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1992). Sub-categories of received stigma include neglecting, fearing contagion, 
avoiding, rejecting, labelling, pestering, negating, abusing and gossiping. 
 
All of the participants in this study reported stigma experienced in the Health 
Care setting. It is not possible, nor is it wise to conceal the HIV status within the 
health setting. Once the women entered the Health Care setting, they 
experienced a loss of control and a loss of self-determination. The women took 
great care to ensure that they kept their HIV status confidential, but once in the 
Health Care setting this was lost. They found that they were physically isolated 
by being kept separate from other women; they felt this exposed them as being 
different. Additionally, their medication and the tests done for them were called 
out publicly for all within earshot to hear and so to conclude that they were HIV 
positive. The participants further gave reports of suboptimal care received from 
the health workers because of their HIV status. This was seen as avoidance and 
a failure to offer basic care. In the cases where they were attended to by HCW, 
they reported a lack of empathy. Most importantly, all the participants reported 
verbal abuse from the health care workers. This was directed at the participants, 
disguised as health education. They were blamed for being HIV positive and a 
burden to the health care system. Additionally, these women were held 
responsible by the HCW for deliberately infecting their children. The abuse came 
in the form of scolding, shouting, gossiping and mockery. To further compound 
this, this was done in front of other patients, thus exposing their HIV status to the 
general community.  
 
Aggleton (2000) suggests that while nurses and other health workers who care 
for persons living with HIV/AIDS have their own emic view of stigma that may 
lead them to promulgate prejudice and discrimination toward their patients, the 
impact of this type of stigma on patients is unclear. A study of stigma against 
persons with HIV/AIDS in Uganda demonstrated a strong gender bias (women 
were more stigmatised than men), rejection by their families, increased suspicion 
and gossip, and isolation from communities (Aggleton, 2000; Monico, Tanga & 
Nuwagaba, 2001). Dlamini et al. (2007) reported that in their study they found 
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that there was also the notion among health care workers that PLWA would die 
anyway, hence treating them meant that the resources in the hospital were being 
wasted. In the current study, participants were refused care and were treated 
with no respect or regard for their human rights. Similar findings were reported by 
Hong et al. (2004) in Thailand, where doctors stated that they did not 
discriminate against the PLWA, but insisted on not giving injections to PLWA 
because they feared this would lead to infection. 
 
 It is clear that the issue of the right to treatment should be addressed clearly and 
directly by health service authorities in each nation in order to ensure compliance 
with legal requirements for equal access to care for PLWA. In this regard, a 
human rights approach to the continuing education of health professionals should 
be considered. It is a frightening phenomenon that people facing serious illness 
and even death are neglected by their families, their communities, and even their 
health care providers. Although it seems that much of this neglect is based on 
fear of contagion and limited resources, it may also be based on judgmental 
views, if the utterances by the HCW are to be taken into account in this study. 
 
The National AIDS Research (date) which conducted a study on the high 
prevalence rate of HIV related stigma in health settings. This study by Mawar & 
Salovey (2006)    showed that (i) a wide range of feelings was exhibited by 
clinicians about HIV positives who often made moral and non-clinical attributions 
about individuals’ past “misbehaviour,” and “misconduct”; (ii) few providers 
reported fear of touching HIV/AIDS patients, while others considered it a special 
duty. Initial testing and disclosure often occur without the patient’s knowledge, 
consent, or counselling; (iii) hospital practices, such as a separate AIDS ward, 
HIV diagnoses on open charts, and the conspicuous use of biohazard labels 
serve to discriminate against HIV/AIDS patients; and (iv) hospital policy is often 




Individuals with HIV and AIDS are stigmatised because their illness is associated 
with behaviours that are not acceptable socially, both as a product and producer 
of such behaviour.  
 Sutterheim et al. (2009) indicate that individuals with HIV and AIDS are 
stigmatised because their illness is associated with behaviours that are not 
acceptable socially, both as a product and producer of such actions. It is viewed 
as the responsibility of the individual (Taylor, 2001), tainted by a religious belief 
as to its immorality and/or thought to be contracted via a morally sanctionable 
conduct, not well understood by the general community, and viewed negatively 
by health care providers. All these factors influence the appropriate health care 
that an HIV infected individual is otherwise entitled to as a right (Mawar et al., 
2005). 
 
HIV programme implementation and targets can be hindered by stigma. Much 
effort is needed to ensure that the stigma is also included in planning, if the HIV 
programmes are to be successful. 
 
5.3 Consequences of Stigma 
 
Being stigmatised brought about feelings of despair and loss of control, with 
some participants even contemplating suicide. Stigma and discrimination have 
been identified internationally as main barriers to HIV control and prevention in 
every country and region of the world, posing challenges to preventing further 
infections, alleviating the impact, and providing adequate care, support, and 
treatment (Sheng et al., 2008). The HCW in some cases disclosed the status of 
the PLWHA to other patients and the general public. The other form of abuse 
manifested by some health workers was in the form of refusing treatment of 
PLWA or at least limiting their access to certain treatments. 
 
While such an association has yet to be scientifically substantiated, several 
studies have revealed anecdotal evidence suggesting that participation in 
PMTCT initiatives places women at risk for involuntary disclosure through 
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engagement in socially stigmatised practices such as breastfeeding, avoidance 
or use of a particular infant formula brand (Bond et al., 2000, 2002; Brookes et 
al., 2004; Nyblade & Field, 2002; Varga, 2002, 2003a). Similar results were noted 
in the current study. Women decided on feeding choices based on what method 
they thought would bring less attention and questions from relatives and the 
community. In some cases, the women even when using artificial feeds would 
rather buy from shops, to avoid being seen with a specific brand of baby 
formulary milk that is known to be supplied as part of the PMTCT programme. In 
some instances, the participants go against the guidelines just to protect the 
secret of their HIV status. This may be one of the reasons for programme failure, 
as 30 % (Coovadia, 2009) of vertical transmission occurs in the postpartum 
period.  
 
The social consequences of both felt and enacted stigma are experienced by the 
individuals in terms of their rights, freedom, self-identity and social interactions 
that often influence the decisions to seek HIV testing and to access prevention 
services. Link and Phelan (2001) proposed that stigma contains five elements. 
Firstly, differences are identified and labelled. Secondly, differences (labels) are 
linked to undesirable attributes. Thirdly, a separation of ‘them’ and ‘us’ occurs. In 
the fourth instance, the resulting discrimination and loss of status leads to 
devaluation, rejection, exclusion, and blame, which Fife and Wright (2000) 
described as social rejection, financial insecurity, internalised shame, and social 
isolation. Finally, this process can take place only if a group is able to enforce the 
stigma.  
 
Environmental factors include the cultural, economic, political, legal and policy 
environment (Castro & Farmer, 2005). Politics, in the sense of power 
relationships, may play a role in the approach taken towards people living with 
HIV/AIDS in the cultural, economic, and legal and policy environments. There 
may be secondary gain for those involved in stigmatising people living with 
HIV/AIDS, and this might lead to them using their power to stigmatise (Bird et al., 
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2004). In the case of the current study, HCW are in a position of power and are 
able to use this power to stigmatise the PLWHA who need their care. 
The other theme that emerged from the study is that the stigma had 
consequences for the women stigmatised. In response to the stigma women took 
certain actions to respond to the feeling of being stigmatised and to find ways to 
minimise the stigma. Three sub-themes emerged from the analysis, i.e. change 
in feeding practises, initiation and adherence to HAART and defaulting on the 
PMTCT treatment guidelines.  
It appears that stigma impairs the PLWHAs’ ability for self-care, to access care or 
to participate in HIV preventive programmes. This means some people prefer not 
to know their HIV status, for fear of loss of confidentiality and the associated risk 
of stigma, loss of jobs, break-up of relationships, social ostracism or even 
violence. It also means people may not take preventive measures to protect 
themselves and their partners from HIV infection. A study conducted in Botswana 
to indentify the barriers to the PMTCT programme uptake pinpointed one of the 
barriers as fear of exposure of being HIV positive through the PMTCT process, 
which would result in being stigmatised (Kebaabetswe, 2007).  In the current 
study, choices are guided by the attempt by the women to ensure that they are 
not identified as being HIV positive and thus stigmatised.  
In the case of feeding options, the women seemed to choose methods according 
to their circumstances that would not raise questions about their status. Some 
women decided on exclusive breastfeeding to avoid the pressure and questions 
anticipated if they decide to bottle-feed. The reason given was that if they were 
seen collecting tins, this would be a form of behavioural disclosure; this would 
expose them to the community as being HIV positive. Those who decided to use 
artificial feeds did so with a plan to buy the tins from the shop, rather than risk 
being seen bringing home the government supplied milk formula and thus being 
seen to be HIV positive. 
More detrimentally, women who were informed that they are eligible for HAART 
opted not to start the treatment as they feared this would be a form of disclosure 
to their families. There is also a fear that the HCW don’t treat their status as 
private, and talk about them, exposing the women’s HIV positive status to others. 
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Some participants reported moving facilities, in order to move away from Health 
Care facilities where they are known, and the community using that Health Care 
facility will know them. 
 
5.5 Coping with Stigma 
 
Kylma et al. (2000) described hope as an essential resource in life which can be 
viewed as a baseline of life. Feelings of hope emerged from the data of their 
study which examined hopelessness and hope in HIV/AIDS, indicating that hope 
is “believing life to be worth living at the present and in the future”. Similar 
themes also emerged from the current study, with the participants choosing to 
live, and not only that, but making plans for the future. The motivation comprised 
the need to live long enough to see their children grow up. In the same study by 
Kylma et al. (2000), optimism emerged as an attribute of a person who 
experiences hope. The meaning attached to this was that a positive attitude was 
adopted, and in some cases those studied referred to a denial of reality. 
 
Coping by seeing oneself as okay, is a strategy that reflects a strong will to 
survive in the face of illness. This was manifested through being socially active, 
and participating in community and social gatherings. Talking to others builds 
social networks through formal or informal networks, and these networks provide 
platforms where all can tell their stories, share their pain, chat, and develop 
friendships. Nyblade et al. (2003) reported on a woman who said that when she 
met with and saw each one of the support group members, she knew that they 
shared the same problem. They talked about their illnesses and began to visit 
each other. (Makoae et al.,2008). Another method of coping is by letting the 
situation be, or avoiding confrontation. This is a passive way of protecting 
oneself. Some researchers, Horizons Programme (2002) believe that being 
proactive in disclosure may expose the stigmatised person to more stigma and 
discrimination, including violence, and they support a coping strategy of being 
more passive. Others argue that avoidance behaviour can lead to activities or 
mental states such as social withdrawal, increased alcohol consumption, or risk-
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taking behaviours, which keep HIV positive people from directly addressing the 
stressful event. In the current study, some of the participants used the same 
passive coping mechanism, coded as acceptance and resignation to being HIV 
positive. These participants decided not to respond in any way to their HIV 
status, but just to accept it as their new reality. 
 
5.6 Conclusion  
 
The study successfully met its aim, notably to explore experiences of stigma in 
HIV positive pregnant women enrolled in the Prevention of Mother to Child 
Transmission programme. The phenomenological approach allowed for the 
exploration of stigma experienced by women in the PMTCT programme without 
imposing a framework on the study regarding what might be found out about the 
phenomenon. Phenomenological analysis confirmed the complexity of the 
concept of stigma as well its impact on care. 
In the study, women’s experiences of stigma emerged in various forms and 
different settings. Most worrying, is the stigma experienced by the participants in 
the Health Care setting. This has a detrimental effect, as the women reported the 
tendency to avoid Health Care facilities, and this is closely linked to poor 
adherence to programme recommendations. 
 
Stigma and discrimination fuel the HIV/AIDS epidemic by creating a culture of 
secrecy, silence, ignorance, blame, shame and victimisation. This causes 
increased pain and suffering and devastating social and economic consequences 
for the people living with HIV/AIDS (PLHA), their families and communities. The 
stigma and discrimination felt by individuals are major barriers to utilising health 
services for prevention, diagnosis and treatment. The shame associated with “felt 
stigma” discourages individuals from seeking voluntary counselling, testing and 
treatment.  
 
Discrimination against people living with HIV/AIDS is a violation of their human 
rights. A framework based on human rights provides a means of monitoring and 
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enforcing their rights, as well as addressing discriminatory practices. Similarly the 
UN Commission on Human Rights’ (2006) resolutions have confirmed, that, 
“discrimination on the basis of HIV/AIDS status, actual or presumed, is prohibited 
by existing human rights standards”. 
 
5.7 Recommendations  
 
5.7.1 Community Action 
 
HIV/AIDS-related stigma and discrimination is a challenge for everyone which 
includes the communities, health care workers and civil society, as these are the 
areas where stigma is played out. Success in the fight against HIV/AIDS can only 
be achieved if PLWHA are treated dignity and compassion. Interventions to 
address stigma are necessary. To be effective, interventions must involve all the 
stake-holders, through partnerships between governments, health care 
professionals and civil society.  
Hopefully, this strategy will increase communities’ knowledge and positive 
attitudes towards those infected with HIV/AIDS, and contribute to a willingness to 
treat them with dignity. 
Spirituality is one of the coping strategies used by the PLWHA, manifested 
through prayer, meditation and hope in God. Religion as a self-care strategy for 
HIV has also been reported as a strategy to relieve HIV-related symptoms, and 
as a form of emotional support (Cichocki, 2010). Religious organisations and 
their leaders are seen as part of the community, and are trusted to shape 
behaviour and morals. Religious leaders should thus participate in providing 
spiritual and emotional support, and incorporate ways to reduce stigma in the 




Counselling can decrease stigmatising behaviour. It is for this reason that mental 
health should form part of the Antenatal care team’s regimen would allow the 
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women to access continuous support through the journey of the PMTCT 
programme.  
The disclosure of results to significant others is important. Health Care workers 
need to assist patients to disclose their status and should offer continuous 




It is important that a further study be carried out on these women a few years 
from now, to see if the stigma subsides as they learn to survive with HIV/AIDS. A 
more longitudinal study would be desirable, as well as a follow-up on the post-
natal stage.  
 
Additionally, it could be of value to conduct a study to explore the feelings of 
Health Care workers on caring for PLWHA,  stigma inflicted on them and how it 
affects the type of care they render to the PLWHA. 
 
5.7.4 Limitations of the study 
 
The study was performed with a homogenous race group. This means the study 
results cannot be generalised to all race groups of South African society. 
All of the women interviewed had known their HIV positive status for less than a 
year. There was no way of telling how they would progress with their dealings 
with stigma or even their own viewpoints as time passed. Furthermore, all but 
one woman underwent testing because they were told to go for testing by the 
clinic staff as part of their routine ANC. This may indicate they were not yet ready 
to know their HIV status, and were thus more likely to be sensitive to stigma, and 
more likely to experience internal stigma as they had not had time to think about 
and deal with the consequences of a positive HIV result, compared to people 
who volunteer for an HIV test. 
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Interviews were done at the clinic which may have inhibited the women from 
expressing their experiences about the HCWs freely, for fear of being reported 
and also in the fear that they might be discriminated against as a result of their 
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Date: 23 June 2010-06-28  
Time Started: 10h15 
Time finished: 10h55 
Venue: Operations Managers’ office  
Age: 28 years 
 
First time on PMTCT.  
Gestational age: + 24 weeks 
 
So this is your first child? 
 
No my second one, but I was negative with the first one. How old is the child? 
He is 10 years old; he will be turning 11 on the 21st of August. He is in Grade 6, 
he started school early. 
 
Wow, he must be clever. So you now hope for a girl? 
 
Yes, he has never failed. Other kids his age are in grade 4 and 5. 
I’m not fussy about what I get, as long as the child is healthy. This child in 
particular must healthy because of my HIV status. I’m very particular to make 
sure that I do everything they tell me to do here at the clinic. I want to make sure 
that my child is healthy. 
 
Is this your first time on the PMTCT programme? 
 
Yes it is. 
 
How did you find out that you are HIV positive? 
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I came to the clinic and I was not aware that I was pregnant at the time. I felt the 
need to know my status with all the drive on the TV and radios about knowing 
your status. I was healthy not feeling sick at all, I just decided to come to the 
clinic to test. 
I wanted to be able to make sure I’m able to take care of myself and be able to 
share with my family, so that even if I’m positive I’m still able to do things for 
myself. 
I have seen people who find out when they are too ill and need help even to take 
medicine. That is when problems start and people have something to gossip 




(A staff member walks into the office to collect some supplies; the client keeps 
quiet till the staff member leaves the room) 
I came here (clinic) on the 18th of March this year for my test. They tested me 
and found that I’m HIV positive. On the same day they took blood and said it is 
check my CD 4 count. I was told to come back after two weeks for my CD 4 
results. 
When I returned for my results, the y told me my CD4 is 695.They asked me to 
attend literacy classes and said I must check my CD4 again after three months. 
I then went home, a couple of weeks later I realized that I was pregnant. I then 
came back to join the clinic for pregnant women. That made things easy for me, 
as I did not need to be retested and they already knew all my results. The Nurses 
also said that I did well by testing myself, now things are quick and easy no 
delays. I came with all my papers, I was just showing them. 
They said they will redo my CD4 in October after I deliver. My baby is coming in 
September. They said it (CD4 count) may drop they just want to make sure that 
I’m okay. 
 
 After testing positive did you share this information with any one? 
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Yes, I told my two older Sisters. My mother is alive but she is not at home she is 
away for training to be a ‘Sangoma’ so she stays where she is training. I’m 
particularly scared to tell her as I feel she will experience a great deal of stress, 
so I have not told her. 
I called my three sisters who are older than me. So I can get their support. I also 
told my one friend that I really trust. 
 
How did your Sisters take this? 
 
They were shocked and cried a lot, but said they still love me and will still treat 
me the same way as before. They will try and help me. I’m glad I’m employed, 
although my job does not pay that much I can take care of myself. This is what 
motivated me to test to be able to take care of myself, so that I don’t end up 
being bed ridden and need help even to swallow those ARV if it gets to that 
stage. I have seen people who die as they cannot eat and as a result they cannot 
take the tablets and need other people to help them. 
I just want to be able to be like those people with High, high and sugar. They go 
to work and take their tablets and no one worries them or asks questions about 
their illness. 
 
You have the right attitude 
 
My sisters love me. They said I’m going to be fine.  I don’t stay at home, I live 
where I work. I look after a retarded child. The child attends school during the 
day. I go home three days or so a month where I’m off. 
 
How is the rest of the community treating you? 
 
They don’t know because I’m still well, I have not also made them aware only my 
sisters and my close friend and all have kept it quiet. That is why I tested early, 
so that no one will ever find out, as sometimes people discover your status when 
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you become ill and it is like an advert for every one that you are POSITIVE. So 
no one knows. 
 
Have you told the father of your child about your status? 
 
(Total change in the stance, look of sadness. No longer maintaining eye contact, 
close to tears) yes I have told him, he did not take it well. Ever since I told him 
things have not gone well. 
 
Do you mean ever since you fell pregnant? 
 
No ever since I told him I’m HIV positive. When I told him about the pregnancy he 
accepted it and seemed pleased. He even said he wants a boy. It is only when I 
told him of my status that things changed.   
I asked him to also go and check, I even offered to accompany him to the clinic, 
and he kept avoiding the issue and said he will go on his own. He did not go. 
Not only had that he started to behave differently towards me. I think he started 
relationships with other women.  
I’m pregnant and HIV positive, I need love. He is not showing me the love and 
support that I expect from him! 
 
What do you mean? 
 
Like as I’m pregnant, he must call me, come and visit me as before I told him my 
status. He does not even care how things are going with my pregnancy or even if 
I’m well or sick. I’m HIV positive. If a person does not call you the whole day, to 
just say how are you? He used to do all these things before my disclosure that 
I’m HIV Positive. 
Other people care for me, when I’m pregnant with his child! I don’t want to say he 
infected me, but are we not suppose to be in this together? 
Look, I’m sure it is because of my HIV status that he no longer wants to be 
associated with me. When I told him I was pregnant he was fine, but since I told 
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him of my status he is neglecting me. The last time we were together, I mean 
intimately was the 21 of May. I have a habit of noting everything down, so I know 
the date for sure. I also know when I told him I’m positive. So it a couple of weeks 
after disclosure, he is no longer interested in me? 
I tried to keep the relationship going, by calling him to tell him, things that are 
happening in my life, my clinic visits etc. He never seems to care. He no longer 
bothers to even come and visit me at work as he used to. Maybe he now finds 
me irritating (uyangaliswa), he no longer has desire to be with me. 
I have made my peace with this situation. I have decided to also ignore him as 
this will cause me to be sick with other illnesses like high blood. Maybe he is 
helping me not to be sick as may be if we carry on being intimate while he is 
busy with his other friends he is going to bring disease to me and my unborn 
baby. I want this child to healthy. 
 
So how did you find the staff at the clinic when you first came for testing? 
 
I was really scared, the counselor helped to try and relax. She did the test and 
told me it was positive and counseled me. 
In general health workers have not been bad to me. The Sisters ask me a lot of 
questions about my health. They say I must be open tell if anything is painful or 
any worries about my health. You know even if they were not that kind to me, I 
would not have cared, I just want my baby to be free of HIV! 
 
You are now past 14 weeks, have you started on the ARVs? How is that 
going with the people who live with you, are you able to take the tablets 
without fear? Will you be able to follow all the other things you need to do 
with the PMTCT programme? 
 
You know the child that I care for is also HIV positive besides being retarded. So 
when I discovered my status I told the women I work for. She is a nurse, she 
works at (Names the clinic); she also told me she is HIV positive. The child I look 
after is her grandchild, so I had no idea that she is also positive. So I was very 
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lucky to be employed there. She also told me she has started ARVs. She said 
you are better off because you have not started taking ARVs. She has started 
taking ARVs. 
My employer seems to understand. (Participants' attitude changes again)You see 
the only person who seems to have a problem is the father of my child. Maybe it 
helps that he longer cares, and not sleeping with me...... It keeps me and my 
child safe from disease. I also told him if we are ever intimate again he must use 
a condom, so I think this is another reason he may have lost interest in me, I 
don’t know....... 
I think I’m alright, I getting used to the situation. 
 
Do you feel that if you had not told your boy friend about your HIV status, 
things would have been different; you would still be together like before? 
 
I think so, but as I said maybe he is helping me to stay healthy. 
 
Have you told your 10 year old child about your status? 
 
No I’m scared. I think he is very sensitive. I have asked him if he knows about 
HIV, I realized that he is not ready. So   I have not told him. I will tell him maybe 
when he is 15 years. He has seen me taking the ARV for PMTCT, although he 
does not know why, he often helps me to with bringing them to me and giving me 
water, but does not know why I take these tablets. 
 
Did you experience any ill effects when you started to take the tables? 
 
Not really. Once I started to have an itch in my privates and a bad smelling 
discharge and I told the Sister and she gave me some tablets to take. That has 
since resolved. 
 
Have you been given the tablet you take before labour? 
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Oh yes the Nevarapine? I always carry it with me, so there will be no problem 
when labour stars. 
 
What was your feeding choice? 
 
I chose to beast feed, that way no one will suspect my status. I will not have to 
collect the milk tins at the clinic as this is one of the things that show you are 
positive. People will ask you why you are not breast feeding and they will see you 
bring the tins with you and they will know. 
 
How are you going to manage exclusive breast feeding because you are 
employed? 
 
I have made arrangements with my employer to live with my child in her house till 
the baby is six months old; I will then give the child to my sister to care for that 
after. Fortunately there is enough space in the house; there are three bed rooms 
and it just my employer, her husband, their ten year old child and the grandchild I 
look after. 
I thought I would have to stop working, they asked me to carry on as I care well 
for the child and I know the status they don’t want another person who will then 
know about the child and the families HIV status. I will stop August just before I 
deliver; my Sister will work in my place for a couple of weeks, the will then fetch 
when I feel I’m ready to return to work. I’m happy with the arrangement; this will 
also protect my status. I just hope my baby will be healthy. 
 
It looks like you have a plan worked out. 
 
Yes. 
Do you have any questions for me?  
 
No 







Time started: 09h45 
Finished: 10h30 
Venue: Consulting room in the Clinic 
The Participant is bringing her baby for 6 weeks vaccination and PCR test. Her 
partner is with her to give support. 
Age: 31 
Interview: 
Is this your first baby? 
No, it is my 3rd one. The old one is 11 and followed by a 6 year old then this one. 
One girl and 2 boys. The first one does not belong to my current partner. 
How old is the baby? 
He is six weeks old. We are here for PCR testing, I’m so worried. I hope my child 
tests negative. 
Let’s hope for the best. 
(Explained the purpose of the study.)What do you understand by stigma or 
discrimination? 
“Ukubandlulula” Treating you differently in a bad way. 
What made you to test .When did you first discover that you were HIV 
positive? 
I first tested when I fell pregnant with my current child. The clinic offers the test 
with all other pregnancy bloods. 
How was that experience of testing? 
HA! I cried the whole day when I got home. It got better when I told my sister. As 
I could not talk to anyone. She calmed me down and also advised me to tell my 




Did you tell him? 
Yes, I did but I was scared. I told him. We talked. We decided that he must also 
go and test the next day. I accompanied him to the clinic; he discovered he was 
HIV negative. I though he is going to leave me. He being negative and I’m 
positive. He did not. We are still together and okay. We have been together for 9 
years. 
He went again to test now in June and he is still negative. I also got my CD4 test 
at the time and the results came back and they told me it is 345. 
So you are eligible to start treatment? 
I know, I’m just not ready to start treatment as I’m scarred I may be exposed that 
I’m HIV positive. I’m particularly worried about my family finding out. I have told 
my sister and nobody else at home. I trust my younger sister; I know she will 
never tell anyone at home. I just don’t want my mother and brothers to find out. 
WHY? 
I know how my mother is; it would be a big problem. She will disown me. That is 
where I feel I will stigmatised, by my own family. I also have this very rude 
brother, if he were to find out, I will never have a place again at home. I can just 
imagine the fights that will break out. 
I see, so you feel you will definitely be dishonoured at home if they ever 
found out. 
Oh yes. I will do anything to make sure they never find out. 
What about in the health facilities, how did you find you were treated? Let’s 
start with when you first tested? 
I will say good and bad. 
Tell me more. 
When I was with the counselor, I was much scarred and concerned about my 
test. I was tested and I tested positive and started crying. The counsellor just did 
not seem to care. She just carried on talking as if nothing has happened. She just 
ignored me Up till now I have no idea what she was saying or doing.  
In my mind her role as a counselor is to help me deal with the situation I found 
myself in and assist me to learn to cope. She was just did not seem to care, just 
carried on doing whatever. She even got me to leave the room while I was till 
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crying, no words of sympathy or general counseling to HELP me cope with the 
new diagnosis.  
Seeing that this was new to me and is this not her job? It is like I caused my own 
illness. 
I only got sympathy with the young man responsible for taking bloods. When I 
walked into his room I was still crying. He at least stopped and spoke to me and 
tried to help me see that I will still live and see my baby grow up, it up to me to 
take care of myself. He said this is not a death sentence it is just a disease like 
any other. He said people live long and other people die of car accidents. That is 
when I started to feel a bit relived. 
So you feel counselling is vital? 
Yes, the counselor must give you a chance to deal with the situation and help 
you calm down, not just carry on, showing they are in a hurry. She should have 
given me time to think and compose myself, seeing also that I was pregnant at 
the time. This I think it could be dangerous to the baby to be so stressed. She 
just did not comfort me. She made me feel like I was wasting her time and this is 
my fault, I must deal with it. 
I only felt better after the encounter with the guy who takes bloods. The other 
thing that scarred me was delivery. I have often heard how people die in child 
birth because of the nurses’ negligence and because they know your condition 
so, they do not care. Luckily things went well when I had my baby. 
Did you get any information from the counselor, like feeding choices and 
why specific choices? 
I think she did ask me, it is just that I was too upset. I was only able to make that 
decision with subsequent visits. 
We decided with my partner that I will bottle feed as he will be able to buy the 
milk, as he is employed. 
Have you experienced any pressure from family and friends to breast feed? 
Hey, you have no idea. My mother in particular was not happy. She was insisting 
that I breast feed even if it is for a short time. She was asking why I’m depriving 
the child breast milk. How can X (mentions name of partner) allow me to use 
tinned food instead of breast milk. 
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I was under so much pressure with my family. I almost fell off the programme. I t 
started with me having to take AZT while I was still pregnant. I had to hide the 
pills and also hide when taking the pills. You know how these tablets are taken at 
specific times. I had to hide from my mother, sometimes had to hide in the toilet 
to be able to take my medication. 
I found I have the same problem with giving my child NVP, my mother is the type 
of person who needs to know everything! I managed somehow to conceal the 
medication. I pretend I’m giving my child gripe water. 
On your partners side does anyone knows? 
We decided to move out and rent a room, so that we can be free, otherwise no 
one knows, so we wanted to keep it that way. 
How did you find the hospital experience? 
Eish, I was exposed to two hospitals. I started at hospital X; they screen you 
before giving your medication, so no one knows what is happening. I was moved 
to hospital Y. There, they don’t care. That is where I really felt discriminated. You 
are separated and put aside (those who are HIV positive). It is as if they want 
people to see that you are different. They also talk aloud, you have to take this 
tablet, calling it out by name for everyone to hear and see. They come in and ask 
your CD4 count out loud for all to hear. 
Even after delivery they make us sit in another area of the room, so everybody 
can see we are different. You find there are two or three of you, you hear them 
talking to the other people next to you asking questions out loud and you can see 
them, all those who are positive are made to sit here. That makes it obvious to all 
the other women that there is something wrong with us. That causes even the 
other women to discriminate us. 
Even after delivery when we moved to the ward, they can do better .The beds 
are so close together, they do not even try to close the curtain. They just give 
instructions in front every one. 
How do you feel we can improve this? 
The nurses must call you aside and explain things in private. That way no one 
will know. Often as I’m worried people can hear my story, I don’t   even 
consecrate well to what is being said to me. 
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I even though, maybe I should not have tested for HIV at least I will not be 
exposed to so many people because of the nurses who fail to protect my status. I 
think they do it deliberately. We trust them with our information and secret and 
they expose us. 
Another issue is, why write on the baby’s card my status? 
What do you mean? 
They write on the card that the baby was given Nevaripine. This means I cannot 
ask anyone to take my child to the clinic, as I will have to give them the card, they 
will then see what is written on the card. I also worry when the child goes to 
school the teachers will also see this. They (Nurses) must come up with 
something private, only the nurses will know and write that on the card so that 
the other people will not know. Even my clinic card is also written positive. I have 
to hide all my cards now! They must let us decide when we want to be knowing 
our status, not publicise it on the cards. 
The staff must make sure they do not expose us as being HIV positive, because 
they make it hard for us to come to them for help, you feel like stopping the 
programme. 
May I find out what is your greatest fear if people were to find out your 
status? 
I’m just scared people will treat me differently. They will even be too scared to 
touch me and even make me use separate plates and spoons. I don’t want that. 
This will also affect my kids, no, I will not disclose, rather die! 
People may say they will accept you no matter what while you still talking, before 
they know your status, but I know people, once they know they change. 
More so if the people who have had a relationship with you like ex boyfriends and 
their current girlfriends will say you infected them. You will be laughing stock and 
get blamed for all the deaths that occur to those people. There is no way I will tell 
people I’m positive. 
 
Do you think you will tell your older kids at some point? 





Date : 14/07/2010 
Start: 09h00 
End:  09h48 
Age: 28 years  
Residence: Urban 
First time on programme 
 
How many kids do you have? 
 
Four, but one died last year while he was 11 months old. 
 
How did the baby die? 
He died in his sleep. 
So sorry to hear that. How old are the other kids. 
11 years 6 and current baby who is 10 days old. 
 
What do you understand by the word Stigma or discrimination? 
 
It when people talk about you and treat you bad, because of something they 
know about you. 
 
When did you first test for HIV? 
 
The tested when I was pregnant with the current child. 
 
How was that experience of testing? 
 
Very traumatic, I cried a great deal. I did not expect to be HIV positive. I was 
really devastated, not able to accept my status. I was not adequately prepared. 
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That day, I felt the clinic as soon as I heard my status; I did not do most of the 
clinic things that day. I did not even see the Sr. 
 
Why did you leave? 
 
I was not ready to face the clinic people and the general public. Since I was so 
shocked, I felt so se sensitive. I just if someone were to say one thing that did not 
I agree with me, it would have been a big problem. You know how sometimes 
they clinic people talk to you anyhow. I would have caused a scene. So I thought 
I better leave. More so once they know your status. I felt like not returning to the 
clinic ever, but I thought of my unborn baby. 
 
The counselor was not that kind, she just matter of factly showed me my results. 
Like whatever. They are more concerned with pushing the line than caring about 
the patients. I did return a week later when I felt better. 
 
Did you share this with any one when you got home? 
 
Initially I was not sure who to tell. You see I stay with male in the house. My 
uncles and cousins. My parents have died. I eventually decide to tell my friend. 
 
Did you tell your partner? 
 
Yes I did. He did not seem to take me seriously; he did not even acknowledge 
what I told him even with an answer. He just kept quite. I then asked him to also 
go and test and he refused. 
I then left it at that. 
 
I see. Please tell me what discrimination if any have you felt towards you, 
from health workers since you became positive? 
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The clinic people were not so bad. I did not see any change in treatment or being 
targeted. It is only when I went to hospital X that I can say I felt the 
discrimination? 
 
Why? What happened? 
 
You know one of the things they told us that when we start labour pains we take 
the Neviripne and then we will be given tablets every three hours in the labour 
ward. We were told we can use the same AZT that we were taking at home to tell 
the nurses if we still have some left over. 
 
I had mine in my bag; I then told the Sr and asked her to help me get it from my 
bag. She became very angry and started shouting at me saying: “You sleep 
around, collecting diseases and you come here to worry us about tablets. You 
carry on having children with no fathers and you become our problem” 
All this broke my heart. I was not able to respond and all this she is saying in the 
labour ward full of other women. I started crying, she did not seem to care. I 
could still hear her talking, but just was not sure what she was saying as she was 
moving away from me, but I could still see she is still talking about me. I though 
I’m here because I need help, she starts judging me and generally taking my 
misfortune and using it against me. 
 
The other problem started with the feeding choice. I choose to bottle feed. When 
in the ward after delivery the nurses shouted there, asking how I can bottle feed 
when I’m UN employed. Will I afford to buy the milk? I did get five tins of milk with 
lots of shouting accompanying those tins. She said we will what will happen; this 
milk is going to stop soon. 
 
I was glad to leave the hospital. 
 
SO sorry to hear that. Do you still have the milk? 
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Yes I do, but they have told us here at the clinic that they will not be giving us 
milk. Not sure what I will do after the hospital milk gets finished. You know I could 
have maybe breast feed if they had taken time to explain to me nicely what the 
options are and how it works. 
 
You did not get much pressure at home to breast feed? 
 
Some relatives and neighbours did ask me, I just said, I’m not able to feed, I 
have no milk in my breast. 
 
How did you manage at home to take tablets and follow the other advice 
from the clinic? 
 
At home I was fine. Because I leave with men, they do not know much about the 
things that I done when pregnant. So I took my tablets in front of them and they 
never knew any better. 
I tried to involve my boyfriend on what was happening, with the aim of 
encouraging him to test as well. He just does not show nay interest.  I even 
offered to accompany him. That is that. 
I’m just interested to make sure that my child is healthy. (Child starts to cry) 











Tell me about the time you came for a test? 
 
I tested at the hospital. They said I have to test because I’m pregnant so that we 
can protect the baby I went in to test. 
 
Were you not scarred? 
 
I was a bit, but it helps that they talk to us in a group and then again alone before 
they prick your finger one person talk to you and then you go to another room to 
prick the finger and then they tell you. 
 
How did you feel with positive result? 
 
I was shocked, I cried a bit. The testing person tried to help me. 
When I went to the Sr for palpation, she scolded me so much because of my 
age, being pregnant and HIV +. She kept on asking why I did not use the 
condoms. Have I ever heard of condoms? I tried to ignore her; she just carried on 
about how irresponsible I was and so forth. She does not even know me. 
I never went there again. I started coming to this clinic. You are in trouble and 
you get scolded. 
After the HIV test did you share the outcome of your HIV test with any one? 
 
I did not tell anyone but my boyfriend. 
 
How did he take it? 
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He did not seem to be shocked; it was like he was expecting it or he knew. I 
asked him to go and test. He refused. 
 
Who leaves with you at home? 
 
I lived with my granny while pregnant and I never told her anything. After I 
delivered my (Mamncane) My Moms sister said I must come and live with her so 
she can look after me and help me with the baby. I did not tell her either. 
 
Why not? Did you not have a problem with taking your AZT and giving NVP 
in front of them? 
I just did not want to worry them. My granny is old and does not pay much 
attention. My Mom’s sister has not noticed either. You know the problem is that I 
also forget sometimes that I’m HIV positive. That is why I also forgot my 
medication sometimes. 
 
Is that not why you need someone to remind you? Did you check Your 
CD4? 
 
Yes, they said it is 394.They said as soon as I deliver I will be started on ARVs. 
They said they do not want to confuse me as I started the clinic late. 
 
Where did you delver your baby? 
 
I went to the local hospital; I was then transferred to hospital X. There I was done 
an operation because they said the baby was big. 
 
How did that go? 
 
I don’t remember much from that experience, lots of pain then I was told I needed 
to be operated. I was just scarred and alone. I was made to sign some papers 
and I was not even sure what I was signing. No explanation. 
 158
 
Which feeding method did you choose, breast or bottle? 
 
I choose the tins. I will not collect them from the hospital. I will also not buy the 
ones like Nan and Pelagon (those given by public sector facilities) as people will 
see that I’m HIV+. I will buy Infacare from the shop. 
 
How are you going to pay for the milk? 
 
My Boyfriend , he does work, he will buy the milk. 
 
Is there anything you would like to ask me? 
No. 






Date: 13 July 2010 
Start: 08h30 
End: 09h18 
How many kids do you have? 
 
Two, this is my second one. The oldest is 8 years. 
I’m from the Easter Cape; I’m here with my boyfriend. 
 
When did you first test? 
 
When I was seven months pregnant. It was the first time. I was not aware that I 
was pregnant I was menstruating the whole time, that is why I started the clinic 
so late. 
 
How did you cope? 
 
I just told myself that, this thing is all around. I may be looking after myself, but I 
don’t know how my boyfriend is behaving. So I just told myself I will accept 
whatever the result and try and learn to live with it. What can I do? 
I have been through a lot. Just after I delivered my baby he became ill. They told 
me he has got meningitis’s I had to stay longer at the hospital. I was not able to 
do anything about my status. We were also referred to another hospital to test 
my baby to see if he can hear and many other tests. 
After I was discharged, I went back to the hospital that had first tested my 
CD4.You know that I started the clinic late so I was to advanced to be started on 
ARV and they told me return as soon as I deliver. I was not able to do that as my 
child was sick. I only went back two months later. 
When I went to collect the CD4, there were Srs there. First I saw their eyes, like 
talking with their eyes. I got such a fright; I thought my CD4 count must be so 
bad. They then started shouting saying why I took so long to return for the results 
and so forth. I had no chance to respond, in addition I was so scared, thinking 
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this means I’m dying. At the time I thought I must just stop coming to the hospital 
as I’m going to die anyway, the way the nurses were shouting, you would have 
though I killed someone. 
I was only relived when I decided to attend classes anyway as I was thinking 
about my kids, I went to the classes for treatment; they told me my CD4 is 180 or 
something like that. I also heard other person talking saying their CD4 is much 
lower than mine. I remember one in particular who said their CD4 is 3. 
You know that day I felt like killing myself thinking there is no hope for me, when 
the nurses shouted! Sis I still want to live for my children. 
I have done the classes and next week, I’m starting the treatment. I’m relieved. 
 
How did you find other people who helped you? 
 
Shame they treated me well. 
 
Did you tell your Partner about your HIV results? 
 
Yes, he is the only I told. He was so shocked. He did not want to believe it. I 
asked him to also go and test. He refused. I said; if you test it will help because 
we can be together in this. I can also help you. 
 
He still refused? 
 
You know the other thing they ask you to do there is to bring a partner to the 
social workers before you start medication. 
I said to him you are the only person I have told, you will be coming with me to 
support me as I will do the same for you. There is no turning back. This is it. That 
seemed to win him over, he came with me. I told him his turn will come and I will 
be there for him. 
I also then told him, 'I'm like this now (HIV+), and we must use Condoms’. He did 
not like that. I will be honest with you, Sisi we have not had sex since that day! 
Fortunately we do not live together. Hayi-ke, I’m sure he is having other women 
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now. I told him; I will not sacrifice my blood for love. I want to live and look after 
my kids. I tried to convince him by telling him that since I will be on treatment it is 
dangers for him to have sex with me without a condom. 
I try and talk to him when I see him and tell him this is our life now this HIV. 
 
When you went to deliver, how did it go? 
 
You know the Srs get angry. 
 
What do you mean? Tell me more? 
 
When I had my first child I was young and had my family around and elders who 
have had kids. They were able to tell me; yes you are in labour and so forth. This 
time, I was saw waters running out of me. I told the neighbor who said I’m in 
labour. I had this tablet, I was supposed to take. I took it with me in my bag. I 
boarded a taxi and went to the hospital of my choice. When I got there I asked for 
water to take my tablet. Wow was I in trouble! They said I delayed coming to the 
hospital and taking the tablet. Why did I come to this hospital instead of hospital 
X as I live here? 
After this scolding they just left me there on the chair for what seemed like hours. 
I was in pain with Labour pains and I was wet. I remember thinking I was 
supposed to get those tablets (AZT) every three hours no one was paying 
attention. By chance a nurse from another unit came in and saw me and said, 
this person is going to deliver on the chair, her water has broken. They were 
really trying to chase me away. It is only then they started paying attention and I 
had my baby soon after that. I did not get those tablets they told me about in the 
clinic. Maybe that is why my child is sick, I’d not know. 
After that things were not so bad. I delivered, I went home and we can back 
again when my baby became ill. The care was okay in the hospital with my baby. 
You know, I’d not want to blame all the nurses, people are not the same. Some 
of the nurses took good care of us; it is not all of them. 
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My challenge is to get my boyfriend to test and we together live and look after our 
child. 
I can see he is no longer interested in being intimate with me. Ever since I told 
him, we have not been together that way. I can see he lost interest. I think it 
made it worse that I told him I will only have sex with him if he uses a condom. I 
won’t lie; I think he no longer wants me. I suspect he is having another person. 
You know what I will do; I will make sure I get him to the clinic. I have decided to 
care for myself to look after my baby. I’m glad I have my own place to live, he 
also lives on his own, and I don’t have to see what he is doing. 
My life has been so hectic with my baby being sick, my HIV status and now an 
added burden of having to coax my boyfriend to look after himself. I have to help 
him also, so that we can look after our child, I don’t like it but I have to. I have no 
choice. 
 
How are you feeding your baby? 
 
I’m using the bottle. I decided to bottle feed as I need to go back to work soon, I 
will take my child back to Lusikisiki to be cared for by my family back home. I will 
buy the milk and I hope the father of my child will also help me, which is why we 
must stay healthy to work for our child. 
I just hope my baby is free from HIV, I did the test today (PCR), I hope it turns out 
negative. 
 
Is there anything you would like to ask me? 
 
No,Sisi. 




Date: 14 July 2010 
Start: 09h00 
End: 09h32 
Age: 34 years 
 
Attending well baby clinic. 
 
Is this your first baby? 
 
No, I have an 8 year old child. 
 
Wow you look so young? 
 
Yes I had my child early. She is in school now in grade 2. 
 




When did you first test for HIV? 
 
I tested with my first pregnancy. 
 
What was the result? 
 
I was negative. 
 
I tested again with this pregnancy when I was three months pregnant. 
 
Mhh, which is 12 weeks...., so when you tested where you did test? 
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I tested at a hospital. 
 
What made you test this time? 
 
The Sr motivated me to test; she said I can protect the baby if I’m positive. 
 
So you accepted the test, and it came out positive, how did you feel? 
 
I felt bad, but the talk before testing helped. 
 
After testing positive, when you got home, did you share this information 
with any one? 
 
I told my Mother. She stays in Eastern Cape, which is my home. 
 
Do you only live with your mother? 
 
Yes, my father stays here in Durban where he works. 
 
Did you tell the father of the child? 
 
No, I have not told him. 
I decided not to tell him, until I also get used to the situation. I’m scared of how 
he is going to respond. I hear the way he talks about HIV even when we are just 
talking. 
 
Tell me a bit more how you found care in the hospital and clinic? 
 
I did sometimes feel that we were not treated the same as other people who are 
negative. I found that identifying other women who are also HIV positive helped. 
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We get to support one another. That way whatever is done by the hospital staff 
does not feel that bad. Knowing that you are not alone helps. 
 
How do you mean you were not treated the same? 
 
The shouting, making us feel bad as were making our children sick, when I know 
it is not my fault? What could I have done differently, nothing? You just ignore 
them and pray you are discharged soon with your baby. 
 
I see, how did you manage with the tablets (AZT) that you took while 
pregnant since your boyfriend does not know your status? 
 
He does not know much pregnancy and medication needs to be taken. I took 
them in front of him and he did not know what I was taking. 
 
At home in the area? 
 
I have not told anyone in the area, I see how they treat people they suspect to be 
positive. So I will hide my status. I have only told my mother for that reason. 
 
Were you able to take (NVP) that tablet that you take when you start having 
contractions? 
 
No, I did not. I delivered at home. I went to the hospital with the baby. 
 
What did they say at the hospital? 
That is where I really felt mistreated, what .did you call it, the stigma. They 
scolded me so much, saying my child will contact the virus because of me. Why I 
did not come to the hospital on time. I was hurt as I did not do it deliberately. 
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I went to the hospital and they kept me for one night and gave the child 
medication. I hope my child will be safe, even if I did not take the tablets before 
and during labour. 
 
Let’s hope so. How are you feeding your baby? 
 
I’m breast feeding. I’d not want to collect tins. People talk when you collect tins. 
So I breast feed. I did not get a chance to breast feed my first one so this is good 
chance for me. 
How are managing exclusive Breast feeding? 
 
I’m at home the whole time, so it not too bad. My mother is also at home she 
helps me. 
Did you say you are still together with the father of your child? 
Yes we are together. I’m using condoms now. 
How did you introduce the condoms? 
 
I told him after I had the baby that I’m not able to use the contraceptives, they 
make me sick. So he agreed. 
Will you at some point share your status with him? 
 
Yes when I get used to the idea of being HIV positive I will tell him. 
 
May I please find out why you are reluctant to tell him? 
 
(Laugh shyly)He does not think he will ever have HIV, when we talk, he say he 
will never be HIV+.I know he infected me, I’m sure he infected me. I think he will 
blame me and leave me. I cannot care for the child on my own, I don’t work. 
 
Is there anything you would like to ask me? 
No 








Is this your first baby? 
 
No, my third child. 
 
How is the baby? 
 




Please share with me your experience of your first test? 
 
I tested with my second baby and it was negative. So I was fine. 
This one I tested in (Names a private hospital).I admitted to a hospital because I 
had just miscarried at three months. I also had a belt (Shingles) .While there my 
Dr I requested that I have bloods taken, including HIV bloods. Not even telling 
me! The nest thing I see a Sr from a private lab coming to take my blood. She 
just came and took my blood. Not a word about the bloods she was taking! I also 
though she will give me some counseling. Is because of the disease I’m having? 
 
How did you feel? 
 




You know I remember with my second child, I came to a public clinic. I got 
counseling before testing, at the time I was HIV negative, still they counseled me. 
I can say I know how it should be done. The Sr just came in the ward and said, 
did I get counselling I said, no. She then just taking bloods and said I get my 
results from my Dr. I was expecting some form of counseling before the bloods 
were taken. Nothing! 
 
So how did you get your results? 
 
My next appointment with my Dr, he told me I was HIV positive. I must say I had 
even forgotten about the bloods. I also did not fear that I may be HIV positive. I 
did not change anything from the time I tested the last time. I was shocked. The 
Dr did try to talk to me but, it did not help much, I was in too much shock and lack 
of counseling before testing made it worse. Maybe I could have been more 
prepared it was counseled before testing. 
 
So you feel there is a gap? 
 
Yes, the Sr said, just take all the bloods once off, it is the same, I was just 
confused so I agreed to having HIV bloods without any counseling. 
 
By the way how many kids did you say you have? 
 
This is my third one. All girls. They all have the same Father. So I know he 
infected me. I discovered that he has another child with another woman. My kids 





I think whenever I’m pregnant my partner always gets himself another sexual 
partner. He believes he must have someone on the side each time I fall 
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pregnant. That way his sex life stay on track as he believes that, he must not 
have sex with a pregnant women. To keep himself sexually active, when I’m 
pregnant he gets himself a new sexual partner. I think that is how he contracted 
HIV, probably during my second pregnancy and I tested negative at the 




In addition following my positive test I was done a CD4 count and they found it to 
be 210.The Dr said my CD4 is too low. He then gave me a script to go and 
collected ARV from the chemist. He said I can start taking the tablets any day. 
He said I must choose the time. I chose 8.Is that fair? Is that part of the stigma 
for the people who are HIV positive? No information! 
 
Today I did not take the tablets as I did not eat. Now I’m not sure what to do then 
I missed a dose. I never even had any one tell me how to take these tablets. I’m 
just in the dark. (She shows me her tablets; she has decanted the tablets to a 
multivitamin bottle) 
I’m just trying to be compliant, but not sure how to be good as didn’t have 
information. No one ever told me anything.(Short discussion on mode of action of 
ARV drugs).I must be doing something right as the Dr said my CD4 has 
increased to 400.I need I think I need more information on these tablets. 
I just need to accept this, that I’m now HIV positive and learn to live again, try 
and take it as it is. I have told myself that it means it was, meant to that I become 
HIV positive. 
 
Have you shared your status with your partner? 
 
He knows I told him. I think I know when it happened. We had an incidence a 
burst condom’s he tried to hide it. I asked him he said there is no problem. I think 
he must have suspected that he is HIV positive. After the incidence of the burst 
condom we decided not to use condoms any more. I felt, what is the use, if I’m 
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pregnant it has already happened, why bother with a condom. I think that is when 
I fell pregnant and got infected. 
 
Do you think he got tested? 
 
No, he must just suspect. To make matters worse he drinks a lot. He is probably 
making himself even worse by drinking. If my CD4 was so low, his must be just 
as low. 
Right now, I’m also not really used to the idea of being HIV positive and being on 
ARV and on top of this I was pregnant now I have a baby. I still need to get used 
to my new life, before I start to deal with him. I need to take care of myself. 
I tried to ask him to come with me to my private Dr, to get him to test. Hayi, he 
refused. As I said I need to care for me. 
 
That is nice. 
 
Initially when I told him I was positive he did not believe me. He said I looked so 
calm he though I will throw a tantrum. I though, how will being angry help me? 
He only believed me when after delivery, my baby was not well. He had weak 
lungs and I was not discharged. The Dr wrote a script for him to collect ARVs for 
the baby. It is only then that he started to be believed and it started to sink in for 
him. 
I started to notice that he lost weight because I think he was stressed. To make 
matters worse, he does not have a family. Now I have to look after him as well, 
when it is his fault we have this HIV. 
He also started to have these verbal outbursts! I feel this is so unfair, he infected 




You what hurts me is that I kept on telling him that we may end up being HIV 
positive if he carries on with these other women. One time asked him to break up 
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till he sorts himself out, he refused. Look what has happened now. Immediately 





He now feels I should be angrier, so I think that is why he doing this for me to say 
something to make me angry, so that I also burst so that it can easy his guilt so 
that he can say I said this and that. 
 
How did you find the care in the hospital? 
 
Hayi Sisi It was quite good. My Dr also took good care of me. It just that I had a 
belt (Shingles) while I was pregnant. I started immediately after imitating 
treatment. Dr said it is part of recovery. My immune system is waking up, I will be 
fine. 
I’m just praying for my God to keep me safe and to live long so I can care for my 





We have not been intimate with my boyfriend ever since my pregnancy. Not sure 
why, maybe it is because I told him I’m positive or it is that I said, if we ever 
resume sexual activity, I will make sure I protect myself. That is why I told him my 
status 
 
Which feeding option did you choose? 
 
I’m bottle feeding. You imagine the questions, but I tell the people that I work, I 
cannot breast feed. 
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I believe I will be fine. I always thought I would hang myself if ever found myself 
to be HIV positive. So scared of how people will treat me if they ever found out, I 
coped. What made me decide to live is my parents died, I look after my siblings. 
The only relative is my Mom’s sister. She can to live with us for a couple of 
months. She looks after me and the baby. She reminds me to give the baby 
medication; she cooks for us and generally is a shoulder to cry on. She is the 
only family member who knows my status. I want to keep that way. 
I think support is important if you are HIV positive. There is no way I could have 
coped with the baby and being HIV positive as the same time. 
I must say I’m still really confused by the whole medication for the baby and for 
me. I wish I had those classes they give in the public sector. (More question 
about baby medication)It is still not clear to me why the baby takes medication. 
No explanation at all about what is going on. 
I must say I have not had any side effects? The only thing was the belt. I must 
say I would love to know more about my illness. I will give myself time to find out 
once I get used to being HIV positive and my baby is a bit bigger. 
I have no parents and me now I end up with this problem. If anything happens to 
me what will happen to my younger siblings and my kids. I need to stay healthy; 
too many people depend on me. 
 
Is there anything you would like to ask me? 
 
No, not at the moment. 
 










Ethics approval number: HSS/0051/10M 
 




Exploring HIV related stigma experienced by women enrolled in the Prevention of 




You are invited to participate in a study find out about your experiences of 
discrimination if any, that you may have felt while you were a part of the 
programme that aims to prevent your unborn baby from getting infected with HIV 
and AIDS while you were pregnant. This discussion will take about 45 minutes to 
an hour.  




We will find a quite spot within the clinic to sit and talk. This conversation will take 
about 30 minutes to an hour. I will be recording the conversation, so that I can 
make sure that I can capture our discussion accurately will then type this out 






Benefit and Risk: 
 
You will benefit by learning a bit more about prevention of HIV and AIDS in 
pregnant women as you can ask me questions as we talk if you need 
information. This information may help you as you take care of yourself and your 
baby. 
There is no risk to your life, maybe minimal psychological discomfort. The major 
inconvenience is the take it will take for our discussion. 
 
Cost: 




Your name will not appear on any of my research material .I will use only use 
code number, I will assign this numbered and it will be known only to me. The 
purpose is to file accurately and you will not indentify. The information will be 
confidential. 
The decision whether to participate or not will not prejudiced you, you can 
withdraw any time without penalty. 
Please feel free to ask any questions you may have about the study and your 
rights as a participant in a research study. 
 
I can give you a copy of this form to keep. Your signature show that you are 
willing to take part, and you may withdraw from the study at any point. 
 
Signature of Participant____________________     Date__________________ 
 
Signature of Investigator ___________________     Date__________________ 
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Name of Investigator: Zamasomi Luvuno 
Student Number: 208528960 
Contact details: 
Cell: 0832646394 
Email Address:  luvuno@ukzn.ac.za 
Name of Institution: University of KwaZulu Natal School of Nursing 
Name of Supervisor: Mrs Joanne Naidoo 
Contact Details of Supervisor 
Email Address: kisternjr@ukzn.ac.za  












How old are you? 
Where do you live? 
Who stays with you in the house? 
How many children do you have? 
How old are they? 
Tell me, why did you do an HIV test? 
Tell me about the time you first did an HIV test. 
Tell me about the time you found out you were HIV positive? 
Did you tell anyone about your HIV status? 
What was the reaction from the people when you shared this information with 
them? 
Probing: How did they treat you after they found out about your HIV status? 
How have you experienced your relationship with health workers who cared for 
you during the PMTCT programme? 
Tell me about the time you were attending the PMTCT clinic  
How did you experience the PMTCT guidelines such as: VCT, CD4 count, 
Treatment, feeding choices, labour ward experience? 
How did you manage to stay within the programme? 
In general how have you experienced being an HIV positive woman who is in the 
PMTCT programme?  
What have been your experiences because of your HIV status? 
Probing 
Would you say you have experienced stigma because of your HIV status 
(Researcher to explain this in simple terms if the participant does not understand 
stigma) 
Probe further 
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Appendix 6 
P.O. BOX 671 
Kloof 
3610 
15 March 2010 
 
The Manager  






REQUEST FOR A PERMISION TO CONDUCT A STUDY IN ETHEKWINI 
MUNICIPALITY PRIMARY HEALTH CARE CLINICS 
 
My name is Zamasomi Luvuno. I am student currently studying with the 
University of KwaZulu Natal, Howard College. 
 
I’m doing course work masters in Community Health Nursing. As one of the 
requirements for my masters' course work I have to conduct a mini dissertation 
as part of my studies. 
The purpose of the letter is to request a permission to conduct a study in the 
PHC Clinis. The title of the study is: EXPLORING HIV RELATED STIGMA 
EXPERIENCED  BY WOMEN ENROLLED IN THE PREVENTION OF MOTHER-TO-CHILD 
TRANSMISSION (PMTCT) PROGRAMME IN ETHEKWINI, KWAZULU NATAL. 
 
Attached are the research proposal and the letter of approval from the University 
of KwaZulu Natal's ethical committee. 
Kind Regards 
Zamasomi P.B. Luvuno 
Student Number:208528960 
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9 Old Fort Place 
Durban 4001 
P O Box 2443 
Durban 4000 
Tel: (031) 3113679 










ETHEKWINI MUNICIPALITY  
Health, Safety and Social Services  
Health Unit   
 
   
Enquiries:Dr Cheryl WEAICH  
0313113500 
 
14 April 2010 
 
MASTERS COMMUNITY NURSING UKZN 




PROTOCOL TITLE: PMTCT Related Stigma  
 
Approval is granted for research to be conducted at Ethekwini Local Clinics: 
 
We wish you all the best in your research. Please provide us with a report on 
completion of your study.. 
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I then told the Sister and asked her 
to help me get AZT tablets from my 
bag. She became very angry and 
started shouting at me saying: “You 
sleep around, collecting diseases 
and you come here to worry us 
about tablets. You carry on having 
children with no fathers and you 




 When in the ward after delivery the 
nurses shouted at me, asking how I 
can bottle feed when I’m un-
employed. How will I afford to buy 
the milk? I did get five tins of milk 
(from hospital) with lots of shouting 
accompanying those tins. The 
nurse said, “we will see what will 






They scolded me so much, saying 
my child will contract the virus 
because of me. Why I did not come 
to the hospital on time. I was hurt 
as I did not deliver at home 
deliberately. 
I went to the hospital and they kept 
me for one night and gave the child 
medication. I hope my child will be 
safe, even if I did not take the 
tablets before and during labour. 
6 
External stigma 
 When I went to the Sisters room for 
palpation, she scolded me so much 
because of my age, being pregnant 
and HIV +. She kept on asking why 
I did not use the condoms. Have I 
ever heard of condoms? I tried to 
ignore her; she just carried on 
about how irresponsible I was and 
External stigma 
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so forth. She does not even know 
me. She calls me irresponsible! 
 
4 
 When the one Nurse pulled out my 
results, she showed them to the 
other Sisters. First I saw their eyes, 
like talking with their eyes. I got 
such a fright. They then spoke 
amongst them self, I could not hear 
them, but I could see they were 
talking about me or my results. I 
thought my CD4 count must be 
very bad. They then started 
shouting saying why I took so long 
to return for the results. Saying I 
have delayed initiation of ARV, that 
is how we die because we are 
careless, that is how we get 
infected and who will care for my 
child and so forth. I had no chance 
to respond, in addition I was so 




 When I got to the hospital, I told the 
Nurses about my HIV status and 
the tablets I had to take (3 
HOURLY AZT) I then asked for a 
glass water to take my tablets. 
Wow was I in trouble! They 
(Nurses) said I delayed coming to 
the hospital and taking the tablet. 
Why did I come to THIS hospital 
instead of hospital X, as I live in 
another area? I though they do not 
want to care for me because of my 
HIV status, maybe they are scarred 
I will infect them. They were 
thinking of all sorts of excuses not 
to give me care. The hospital I went 
to seemed more convenient for me 
and easy to get to since I was in 
labour. If I had tried to go hospital 
X, I would have taken so long as I 








I decided not to tell him (My 
partner), until I also get used to the 
situation. I’m scared of how he is 




Always talks about HIV even when 
we are just talking. I fear he will 





 More so if the people who have had 
a relationship with you like ex -
boyfriends and their current 
girlfriends will say you infected 
them. You will be a laughing stock 
and get blamed for all the deaths 
that occur to those people. There is 












 (Laugh shyly)He does not think he 
will ever have HIV, when we talk, 
he says he will never be HIV+.I 
know he infected me, I’m sure he 
infected me. I think he will blame 
me and leave me. I cannot care for 













all have the same Father. So I 
know he infected me. I discovered 
that he has another child with 
another woman. My kids are 8, 6 
and then this one. This child by the 





You know what hurts me, is that I 
kept on telling him that we may end 
up being HIV positive if he carries 
on with these other women. One 
time asked him to break up with 
me, till he sorts him out, he refused. 
Look what has happened now. 
Immediately after I talk to him, it 
seems like he stops his affairs, but 




 Before testing, I just told myself that 
I may test HIV positive, because 
this thing (HIV) is all around. I may 
be looking after myself, but I don’t 
know how my boyfriend is 
behaving. So I just told myself I will 
accept whatever the result and try 





   
 I did not want to blame him, but I 
know he infected me. He did not 
like that. I will be honest with you, 
Sisi; we have not had sex since that 
day (Day of disclosure of HIV 
status)! Fortunately we do not live 
together. Hayi-ke, I’m sure he is 
having other women now. I told 
him, I will not sacrifice my blood for 
love. I want to live and look after my 
kids. I tried to convince him by 
telling him that since I will be on 
treatment it is dangers for him to 
Internal stigma 
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Concealing Status  
I wanted to be able to make sure 
I’m able to take care of myself and 
be able to share with my family, so 
that even if I’m positive I’m still able 
to do things for myself. 
I have seen people who find out 
when they are too ill and need help 
even to take medicine. That is 
when problems start and people 
have something to gossip about 
and treat you badly, everybody 







 My mother is alive but she is not at 
home she is away for training to be 
a ‘Sangoma’ so she stays where 
she is training. I’m particularly 
scared to tell her of my HIV status 
as I feel she will experience a great 




Antecedents of stigma 
 That is why I tested early, so that 
no one will ever find out, as 
sometimes people discover your 
status when you become ill and it is 
like an advert for every one that you 
are POSITIVE. So no one knows. 
1 
 
Antecedents of stigma 
 I chose to beast feed, that way no 
one will suspect my status. I will not 
have to collect the milk tins at the 
clinic as this is one of the things 
that show you are positive. People 
will ask you why you are not breast 
feeding and they will see you bring 





 Oh yes. I will do anything to make 


































Antecedents of stigma 
 We decided to move out and rent a 
room, so that we can be free, 
otherwise no one knows, so we 




  External stigma 
  Antecedents of  
stigma 
 I choose the tins. I will not collect 
them from the hospital. I will also 
not buy the ones like Nan and 
External stigma 
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Pelagon (those given by public 
sector facilities) as people will see 





from the shop. That way no one will 
know or suspect my status. 
4 
 
 He does not know much pregnancy 
and medication needs to be taken. I 
took them in front of him and he did 
not know what I was taking. 
6 
 
Antecedents of stigma 
 I told him after I had the baby that 
I’m not able to use the 
contraceptives, they make me sick. 
So he agreed to use condoms. 
6 
 




I’m not fussy about what I get, as 
long as the child is healthy. This 
child in particular must healthy 
because of my HIV status. I’m very 
particular to make sure that I do 
everything they tell me to do here at 
the clinic. I want to make sure that 
my child is healthy. 
 
1 
Coping with Stigma 
 Oh yes the Nevarapine? I always 
carry it with me, so there will be no 
problem when labour stars. 
 
1 
Coping with Stigma 
 I almost fell off the programme. I t 
started with me having to take AZT 
while I was still pregnant. I had to 
hide the pills and also hide when 
taking the pills. You know how 
these tablets are taken at specific 
times. I had to hide from my 
mother, sometimes had to hide in 
the toilet to be able to take my 






 found I have the same problem with 
giving my child NVP, my mother is 
the type of person who needs to 
know everything! I managed 
somehow to conceal the 
medication. I pretend I’m giving my 





 When in the ward after delivery the 
nurses shouted there, asking how I 
can bottle feed when I’m 
unemployed. Will I afford to buy the 
milk? I did get five tins of milk with 
lots of shouting accompanying 
those tins. She said we will what 
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